Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,41771,0.542520385193635,0.0127352811012021,0.517559234235279,0.567481536151991,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,42063,0.224500860003163,0.00456658894314649,0.215550345674596,0.233451374331731,0
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,39895,0.343907731760274,0.00887159717260042,0.326519401301977,0.36129606221857,1.59279892862929e-308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39904,0.152616896770237,0.00403439025306363,0.144709491874233,0.160524301666242,5.72152596642877e-295
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,42187,0.245767848958831,0.00659723601677451,0.232837266365953,0.258698431551709,2.58177915286835e-289
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,42007,0.156860044230044,0.00435547605260408,0.148323311166941,0.165396777293148,3.31773542382765e-271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42108,-0.12324033952142,0.00347245716394607,-0.130046355562754,-0.116434323480086,7.31108960175996e-264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,39927,-0.211139416002673,0.00600787779849326,-0.222914856487719,-0.199363975517626,6.63849585341279e-257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,42091,0.292730635523992,0.00894188194888291,0.275204546904182,0.310256724143803,2.91731987654753e-226
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42213,-0.433397240839995,0.0133623550495624,-0.459587456737137,-0.407207024942853,2.34021756918556e-222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,42222,0.175259803749499,0.00541576518264089,0.164644903991523,0.185874703507476,2.09182391765337e-221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,41995,0.292704645656983,0.009271553176693,0.274532401430665,0.310876889883301,4.63045246384015e-211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,39512,0.332455667398272,0.0105231802704725,0.311830234068146,0.353081100728398,1.07868478288369e-209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39858,0.187858725919572,0.00595481181374793,0.176187294764626,0.199530157074518,2.14911788307299e-209
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42063,-0.102578571609369,0.00339691761599823,-0.109236530136726,-0.095920613082013,6.89938857293408e-194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,42072,0.200679828625725,0.00665755180422455,0.187631027089445,0.213728630162005,3.18120031714553e-193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42097,0.152940395605819,0.00539419788888353,0.142367767743607,0.163513023468031,7.98061403441354e-172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41828,0.243029408395635,0.00867139455288507,0.22603347507198,0.26002534171929,5.91474497701804e-168
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42111,-0.0857827061647343,0.00312289214906145,-0.0919035747768947,-0.0796618375525738,1.09264658682201e-161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,39895,0.264588047694504,0.00962716990565779,0.245718794679415,0.283457300709593,5.09990831518907e-161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,41842,0.237074307589714,0.00879616550035918,0.21983382320901,0.254314791970418,8.29415155423533e-156
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FURIN,Furin,42108,0.0941856705612084,0.00352539545932609,0.0872758954609293,0.101095445661488,2.81965798907071e-153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,42172,0.341419930066734,0.0127871565229809,0.316357103281692,0.366482756851777,4.07377232191625e-153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,42121,0.0956528259133596,0.00362407192079655,0.0885496449485983,0.102756006878121,9.71667795422064e-150
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,39927,-0.0726959507031241,0.00275688972451637,-0.0780994545631762,-0.067292446843072,9.12546721916486e-149
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,42072,-0.134592260048815,0.00512684228258986,-0.144640870922691,-0.124543649174939,3.46005149871646e-148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,42063,0.110758738544518,0.00422813206514673,0.102471599696831,0.119045877392206,1.43826378326325e-147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42174,0.404531262255584,0.0154563512489927,0.374236813807558,0.434825710703609,2.39823386112839e-147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42048,0.146980487031424,0.00565694148110472,0.135892881728459,0.158068092334389,2.92395745548763e-145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41943,0.0820247626637051,0.00323209582231193,0.0756898548519737,0.0883596704754364,8.37949700783533e-139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41828,0.147401244495321,0.00582021830497862,0.135993616617563,0.158808872373079,3.18173211954519e-138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,39927,-0.126658099930446,0.0050011750483183,-0.13646040302515,-0.116855796835742,1.08176250179266e-137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,42017,0.274550853163154,0.0110129146214095,0.252965540505191,0.296136165821116,3.88864057567407e-134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39849,0.229337230967676,0.00924313628682129,0.211220683845506,0.247453778089846,2.33536805587945e-132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,41154,0.109232801668432,0.00442201514072375,0.100565651992614,0.117899951344251,1.37083235668126e-131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39575,0.133400286514827,0.00541299245491372,0.122790821303196,0.144009751726458,1.43497145982425e-130
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,41972,0.186796036792289,0.00764182967447065,0.171818050630326,0.201774022954251,3.9032921707708e-129
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,41995,0.202507896233013,0.00833099880194901,0.186179138581193,0.218836653884833,9.31007851309839e-128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41864,-0.139974162021662,0.0057804706847986,-0.151303884563867,-0.128644439479457,8.56458584428207e-127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,39917,-0.17741463710276,0.00733190637285767,-0.191785173593561,-0.163044100611959,3.65819215056816e-126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42046,0.217570036907796,0.00908552312653626,0.199762411579785,0.235377662235807,3.8846404699121e-124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39675,-0.0777273472508814,0.00328941075203897,-0.0841745923248778,-0.071280102176885,1.77908421407289e-120
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,42222,0.0723795674242342,0.00312658732742375,0.0662514562624837,0.0785076785859848,2.53884790795062e-116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41828,0.156273150735579,0.0069911298938331,0.142570536143666,0.169975765327492,1.14584475408166e-108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39422,0.0772689376460175,0.00346318497257081,0.0704810950997787,0.0840567801922563,7.55065872040631e-108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42155,0.114132187993682,0.00519330015963356,0.1039533196808,0.124311056306564,3.26632980668353e-105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,42149,0.114800361902587,0.00522703398935057,0.10455537528346,0.125045348521714,4.4067698527827e-105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,42050,0.133034628030199,0.00606387538252859,0.121149432280443,0.144919823779955,7.55069077324144e-105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,42063,-0.0632457962375363,0.00289866166002397,-0.0689271730911832,-0.0575644193838893,9.52437638727967e-104
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42213,-0.140442132314565,0.00649328395462655,-0.153168968865633,-0.127715295763497,4.97642804742615e-102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,42056,-0.412165060216952,0.0191107005927303,-0.449622033378704,-0.374708087055201,1.88802109672472e-101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,42072,0.143947662573545,0.00672304376530535,0.130770496793547,0.157124828353544,4.85386480226115e-100
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,39869,0.17466473042221,0.00817849505973947,0.15863488010512,0.190694580739299,3.09186509011685e-99
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,42187,-0.0838855762675502,0.0039496994417127,-0.0916269871733071,-0.0761441653617934,1.66936317225551e-98
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,39590,0.190006220449139,0.00895371959604623,0.172456930040888,0.207555510857389,5.57037152900658e-98
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41771,0.148266177806726,0.00702373688799261,0.134499653506261,0.162032702107192,2.64943541185426e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFM,Afamin,39917,0.0458734717832607,0.00217248427931946,0.0416154025957946,0.0501315409707268,4.20286303963483e-97
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41771,0.174010909483443,0.00831241745755001,0.157718571266645,0.190303247700241,9.47168509772129e-96
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,41995,0.126372120042909,0.00605740017141635,0.114499615706933,0.138244624378885,3.80268069369479e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41834,0.187078882440392,0.00897715923603209,0.169483650337769,0.204674114543015,6.31286923560405e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,39575,0.141447277962705,0.00678247768018333,0.128153621709545,0.154740934215864,9.35659764735915e-95
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41847,0.326590287269876,0.0157163441931241,0.295786252651353,0.357394321888399,2.07714366744603e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,42236,0.114607402785596,0.0055244656906962,0.103779450031831,0.125435355539361,3.81030840614045e-94
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39895,0.0626099400252301,0.00303090485784101,0.0566693665038617,0.0685505135465985,4.37034637037584e-93
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,41766,0.116902296906243,0.00568101005122169,0.105767517205849,0.128037076606638,1.23760271884408e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,39675,0.0622698176076307,0.00303677198126921,0.0563177445243431,0.0682218906909184,9.65229758328517e-92
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,42187,0.0742100662707856,0.00363140796553928,0.0670925066583286,0.0813276258832425,1.900992983789e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,42063,0.0621667668685397,0.00304696838456019,0.0561947088348017,0.0681388249022776,3.75058340506839e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,42118,0.0725675548536486,0.00355755199100645,0.065594752951276,0.0795403567560213,4.06180990935201e-91
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,39800,0.0542042831010052,0.00266345984408742,0.0489839018065938,0.0594246643954165,1.94114628527439e-90
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42165,0.0694588191385217,0.00342172289212186,0.0627522422699629,0.0761653960070806,2.84043535606375e-90
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41771,0.130304642583546,0.00646475678607922,0.11763371928283,0.142975565884261,5.19743441493396e-89
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,42124,0.0396662802069108,0.00197824741964209,0.0357889152644123,0.0435436451494093,3.74335249256019e-88
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,39904,-0.123725790005885,0.0061794402971359,-0.135837492988271,-0.111614087023498,1.1572205757759e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39667,0.104562254916647,0.00522572268221139,0.0943198384595125,0.114804671373781,1.60181590652315e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42039,0.111179267413054,0.00557722401103825,0.100247908351419,0.122110626474689,3.69578021826952e-87
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,42236,0.107727222715814,0.00544544634387644,0.0970541478818158,0.118400297549811,6.65559753226278e-86
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41995,0.169802554918462,0.0086248058169242,0.152897935517291,0.186707174319633,4.36662375966154e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,42119,0.0658900713712739,0.00334977163724505,0.0593245189622736,0.0724556237802742,5.97835628413556e-85
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42187,0.261629817777806,0.0133331658163848,0.235496812777692,0.28776282277792,1.46608399433476e-84
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42108,0.0733166491477422,0.00378565833574254,0.0658967588096868,0.0807365394857975,1.91708058580572e-82
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41771,0.174263965977451,0.00907191896690401,0.156483004802319,0.192044927152583,3.97669505861458e-81
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41995,0.175430695566807,0.00916634532491304,0.157464658729978,0.193396732403637,1.42904428702522e-80
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42063,-0.0762023170987734,0.00401055132651847,-0.0840629976987496,-0.0683416364987972,1.84689843025514e-79
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,42129,0.140237980259961,0.0074256523426396,0.125683701668387,0.154792258851534,1.52912861166628e-78
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,39652,0.0799807938107698,0.00423366319885953,0.0716828139410051,0.0882787736805345,2.27971906673182e-78
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42198,0.104136075401147,0.00552282674454849,0.0933113349818315,0.114960815820462,2.62998416608908e-78
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39904,0.0695924757689112,0.00374486959182463,0.0622525313689349,0.0769324201688875,5.89402322572827e-76
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41995,0.136364728296806,0.00741783267139215,0.121825776260878,0.150903680332735,1.47089725931236e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42088,0.0638696930393294,0.00347688418093437,0.057055000044698,0.0706843860339607,1.85029963168957e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42187,0.0639727123850432,0.00348959281374792,0.0571331104700972,0.0708123142999891,3.56691147224543e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41995,0.168696148734041,0.00921192545283876,0.150640774846477,0.186751522621605,5.2205246122243e-74
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,42085,-0.0379044971770728,0.00207581770220951,-0.0419730998734035,-0.0338358944807422,1.32414630678004e-73
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39675,0.149050383695952,0.00824442210014712,0.132891316379663,0.16520945101224,5.04391337618464e-72
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,42222,0.088162588936979,0.00490955970996537,0.0785398519054469,0.0977853259685111,2.78508809610996e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39868,0.149218255776916,0.00832242270297244,0.13290630727909,0.165530204274742,6.65908364920039e-71
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39895,0.127954599075397,0.00715153057929663,0.113937599139975,0.141971599010818,1.28086677789302e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39675,0.0965952188757535,0.00539985267428591,0.0860115076341532,0.107178930117354,1.42043821348312e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41710,0.105760522207053,0.00592261266789181,0.0941522013779854,0.117368843036121,1.73717481116233e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42072,0.0596723268307336,0.00335358912882545,0.0530992921382357,0.0662453615232314,5.00664412804019e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39858,0.10262312924087,0.00576607304218823,0.0913216260781807,0.113924632403559,6.64618805482198e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42142,-0.0741162129525456,0.00417339407409159,-0.0822960653377652,-0.0659363605673261,9.0251923982465e-70
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,39740,0.0447959410676097,0.00252837622711911,0.0398403236624562,0.0497515584727631,2.74120965730734e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41828,0.174439947816125,0.00989556132657812,0.155044647616032,0.193835248016218,9.1472906302e-69
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42029,0.0548648955720688,0.00313767382414451,0.0487150548767456,0.061014736267392,1.03141378120834e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42187,0.0534106201294384,0.00305700069648446,0.0474188987643288,0.0594023414945479,1.2917078852413e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41943,0.063431719370392,0.00365258347152209,0.0562726557662087,0.0705907829745753,8.05381418930154e-67
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39754,0.0491289294604304,0.00283467832128864,0.0435729599507047,0.0546848989701562,2.01444646336775e-66
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42236,-0.0620444881198466,0.00361997964416503,-0.0691396482224101,-0.0549493280172832,3.62327972873129e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42124,-0.0538396121220271,0.00315143696570534,-0.0600164285748096,-0.0476627956692446,9.29756146818289e-65
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,39675,0.118967950631084,0.00696236461855582,0.105321715978714,0.132614185283453,1.23906884251662e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,39897,0.0538430833841313,0.00315328185330947,0.0476626509516447,0.0600235158166178,1.46040198891992e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,39872,0.0778316650412527,0.00456892594703002,0.0688765701850738,0.0867867598974315,2.86983361817361e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,39410,-0.0775232876138695,0.00456134678451848,-0.0864635273115257,-0.0685830479162132,5.96201065637589e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,39575,0.0982369672791256,0.0057822758470474,0.0869037066189127,0.109570227939339,6.44383061080792e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,42130,0.121941749030781,0.0071923590224573,0.107844725346765,0.136038772714798,8.13923973695501e-64
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELN,Elastin,39895,0.0636733956119416,0.00376424664480194,0.0562954721881297,0.0710513190357534,2.08769878567765e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,42138,0.111247822768879,0.00659848700282065,0.0983147882433502,0.124180857294407,3.92555506177278e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39575,0.105031283475935,0.0062285642823275,0.0928232974825735,0.117239269469297,5.22894261422295e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEP,Leptin,42072,0.126542439779184,0.00752952887656986,0.111784563181108,0.141300316377261,9.57122728169187e-63
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42187,0.0668139948471175,0.00398373572315157,0.0590058728297404,0.0746221168644946,1.66984547545361e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,39575,0.114281106182656,0.00681816750503849,0.10091749787278,0.127644714492531,2.77957369308013e-62
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42236,-0.0452177406146562,0.0027176699347143,-0.0505443736866963,-0.0398911075426162,1.48354380221748e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41995,0.192125047500004,0.0115586731028172,0.169470048218482,0.214780046781526,1.99832960318671e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,39869,0.200401930337304,0.0120892712057584,0.176706958774017,0.22409690190059,5.39198568286282e-61
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42048,0.0494277930407003,0.00300747830076438,0.0435331355712021,0.0553224505101985,4.13950561069508e-60
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,39675,0.0488434398027522,0.00298920506130342,0.0429845978825975,0.0547022817229069,2.52990641803233e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42222,0.0580979279128072,0.00357675522312199,0.0510874876754881,0.0651083681501263,8.8952117482237e-59
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41771,0.144742386810452,0.00892202085832794,0.12725522592813,0.162229547692775,1.28103718035935e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42027,0.0350500502849862,0.00216777904792351,0.0308012033510562,0.0392988972189163,2.97598314902956e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,42063,0.0975768421010651,0.00603715461112827,0.0857440190632537,0.109409665138877,3.25940195894931e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42187,0.0584960145179199,0.00362609062314408,0.0513888768965576,0.0656031521392823,5.25456477882103e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42019,0.091975138845377,0.00570269427604438,0.08079785806433,0.103152419626424,5.65082420644995e-58
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41842,0.0950943517238365,0.00591163582957014,0.083507545497879,0.106681157949794,1.12546801099927e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39883,-0.086396362991786,0.00536802177602013,-0.0969176856727854,-0.0758750403107865,1.21688010773693e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,42174,0.0651503887995765,0.00405220742415457,0.0572080622482336,0.0730927153509195,1.24344075073943e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41995,0.0642295318362143,0.00400654198681726,0.0563767095420525,0.0720823541303761,2.63979402924403e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,41995,0.114387499188317,0.00713539608627877,0.10040212285921,0.128372875517423,2.64684835879007e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42172,0.0731655281021624,0.00456939556337056,0.0642095127979561,0.0821215434063687,3.51184305032957e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,42072,0.109156299902514,0.00684080614375685,0.0957483198607507,0.122564279944278,8.48237586119801e-57
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41943,0.0996077063297213,0.00624772462713109,0.0873621660605443,0.111853246598898,1.06248884233324e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41893,0.0846937660449228,0.00531307981709545,0.0742801296034157,0.0951074024864299,1.10861212036871e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39895,0.0990636126886663,0.00622556979511133,0.0868614958902481,0.111265729487085,2.12833764600695e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41766,0.0870433470526334,0.00548211275302555,0.0762984060567033,0.0977882880485635,3.00572050590125e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39575,-0.0972624153322108,0.006128831525778,-0.109274925122736,-0.0852499055416859,4.31505743448153e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,42051,-0.0764407775966426,0.00483583157348785,-0.0859190074806788,-0.0669625477126065,8.81753310697708e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,42194,-0.0646215626840011,0.00408867971131719,-0.0726353749181828,-0.0566077504498194,9.01162279085231e-56
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41995,0.137713163919776,0.00872304991149702,0.120615986093242,0.15481034174631,1.20758787737806e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39927,0.0370578184081115,0.00234988403407708,0.0324520457013204,0.0416635911149025,1.94083526189658e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,39744,0.0457283956877653,0.00291249225255257,0.0400199108727623,0.0514368805027684,5.78840454260716e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,42108,0.0922339670920868,0.00588085559492252,0.0807074901260386,0.103760444058135,5.95891334499323e-55
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,42222,0.0516476916363881,0.00331270879123253,0.0451547824055723,0.0581406008672038,2.47785545424084e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42063,0.0896140488471343,0.005762291010423,0.0783199584667052,0.100908139227563,4.56505974473657e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42108,0.0378120065890239,0.00243772110532798,0.0330340732225811,0.0425899399554668,8.47311899408318e-54
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39858,0.0946517520532096,0.00611183562553075,0.0826725542271693,0.10663094987925,1.52078182995576e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,42222,0.0577695533426382,0.00373902065303167,0.0504410728626961,0.0650980338225803,2.12478271464078e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,39904,-0.0634219444042544,0.00410429226494355,-0.0714663572435438,-0.0553775315649651,2.53952159578043e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42142,-0.0533342346924412,0.00346800968756247,-0.0601315336800637,-0.0465369357048188,6.34662733424802e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39675,0.0624518785382954,0.00406439584193751,0.0544856626880979,0.070418094388493,9.73107692593526e-53
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42048,0.0809402910142006,0.00528806254277354,0.0705756884303645,0.0913048935980368,1.92153700995622e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41667,0.165971471551296,0.0108819498906977,0.144642849765529,0.187300093337064,4.48145247653097e-52
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39895,0.138119340104633,0.00908718192419167,0.120308463533217,0.155930216676048,1.15694048333454e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,42155,-0.0447801184385873,0.00295595591452674,-0.0505737920310597,-0.0389864448461149,2.02358680608967e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,42048,0.086131255045863,0.00570580575755428,0.0749478757610566,0.0973146343306694,4.54992354537511e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,42108,0.0658098897084413,0.00437285194854263,0.0572390998892977,0.0743806795275848,8.94930644221687e-51
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42072,0.0551846790779734,0.00368176768064298,0.0479684144239131,0.0624009437320336,2.21825716657704e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39773,0.0489394666667501,0.00326408668938106,0.0425418567555632,0.055337076577937,2.50303360999433e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42236,0.0644737599859507,0.00431463099685812,0.0560170832321087,0.0729304367397926,4.30488338079714e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,42111,-0.0664109703894201,0.00444810718703774,-0.0751292604760141,-0.0576926803028261,5.25053859635359e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41662,0.0334179360013883,0.00224077157644351,0.029026023711559,0.0378098482912175,6.91612892431659e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,41755,0.0958750124529011,0.00643046119565556,0.0832713085094162,0.108478716396386,7.29576500652492e-50
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,42048,0.063698350339123,0.00428595979626753,0.0552978691384387,0.0720988315398074,1.43609888170179e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,42164,0.0322849280430767,0.00218733021524174,0.0279977608212029,0.0365720952649505,6.35683094742878e-49
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39597,0.0733377883703839,0.00501444435746499,0.0635094774297525,0.0831660993110153,5.46059032778082e-48
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42121,0.0373262650096769,0.002563256286187,0.0323022826887504,0.0423502473306034,1.12364389067471e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42142,0.0677009716862449,0.00465088711806511,0.0585852329348373,0.0768167104376525,1.21433157728291e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42174,-0.0334666906846366,0.00230357141570714,-0.0379816906594226,-0.0289516907098506,1.82352895500451e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42072,0.120753343486845,0.00832819108923325,0.104430088951948,0.137076598021743,2.77543861173776e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42108,0.0585501609868956,0.00404282728016099,0.0506262195177801,0.0664741024560112,3.52716109062348e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39512,0.0881125173042931,0.00608261356016838,0.0761905947263631,0.100034439882223,4.06270461096508e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39512,0.107806531001166,0.00745345228047896,0.0931977645314272,0.122415297470905,5.56024147811873e-47
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,42072,0.0549323192381501,0.00383191185259644,0.0474217720070611,0.0624428664692391,2.8745069153289e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39675,0.0343634388822643,0.00239763801394489,0.0296640683749323,0.0390628093895963,3.56004058071191e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,42222,0.0405750259800208,0.00283885921292747,0.035010861922683,0.0461391900373586,5.22425545359723e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41995,0.0638747244214042,0.00448131351689065,0.0550913499282986,0.0726580989145099,9.20052404881316e-46
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,42187,0.0728106720702068,0.00512134243629744,0.0627728408950639,0.0828485032453498,1.52175430785353e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,39904,0.175099270432857,0.0123517115594486,0.150889915776338,0.199308625089376,3.1408033483194e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41924,0.110693815860607,0.00782342540119082,0.095359902074273,0.126027729646941,4.01697312659066e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42222,0.115711658663844,0.0081872476968708,0.0996646531779774,0.131758664149711,4.93536955567183e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,42077,0.0502962203862901,0.00355994764061735,0.0433187230106801,0.0572737177619002,5.3194304887124e-45
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,41995,0.0537272208808528,0.00381691826804773,0.0462460610754792,0.0612083806862263,1.10898618748849e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41943,0.0551502484332733,0.00394130559450785,0.0474252894680379,0.0628752073985086,3.53435930374305e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41766,0.0802909073186928,0.00573828135346994,0.0690438758658917,0.0915379387714938,3.60490066575381e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,42063,0.0352728225647866,0.00252585934914417,0.030322138240464,0.0402235068891091,5.19036387381832e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41995,-0.0295763469301649,0.00212357357663571,-0.0337385511403709,-0.0254141427199589,8.6909898559776e-44
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39895,0.115189696193632,0.00827155640768805,0.0989774456345631,0.1314019467527,1.01137733890977e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39858,0.10739130723604,0.00774299420948452,0.0922150385854504,0.12256757588663,2.20387969745353e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42108,0.0366447452110094,0.00265189432763769,0.0314470323288396,0.0418424580931793,3.88301220642506e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41943,0.109315562875184,0.00792851833278192,0.0937756669429314,0.124855458807437,5.95758243996535e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,41995,0.058473166726845,0.00425262586603686,0.0501380200294127,0.0668083134242772,9.9459866071064e-43
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41995,0.170152109524874,0.0123988782615836,0.14585030813217,0.194453910917577,1.4308973306114e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,39895,0.0412306056993053,0.00300920783369203,0.0353325583452689,0.0471286530533417,2.16941735604982e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,41766,0.0992270918344167,0.00726452922773527,0.0849886145480555,0.113465569120778,3.45243116256035e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39872,0.0943042102355839,0.0069124767214367,0.080755755861568,0.1078526646096,4.81634346691297e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,41995,0.105066025519427,0.00771231077979099,0.0899498963910371,0.120182154647818,5.5528728207114e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39852,0.163186076138739,0.0119804705978908,0.139704353766873,0.186667798510604,6.45323728048691e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41771,0.164934809825316,0.0121387436159311,0.141142872338091,0.188726747312541,9.08423597041067e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42142,-0.063352289387834,0.0046649252684863,-0.0724955429140671,-0.0542090358616008,9.79691371845768e-42
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41943,0.0776095800531128,0.00572655408161852,0.0663855340531405,0.0888336260530851,1.44080380581938e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,42098,-0.0573477850930565,0.00423260140816359,-0.0656436838530572,-0.0490518863330559,1.49968619901092e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41972,0.0382565893009445,0.00282454014567976,0.0327204906154122,0.0437926879864769,1.60686329648483e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39597,0.101837310840185,0.00751371952696988,0.0871104205673237,0.116564201113046,1.62621738490196e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41995,0.185379936421662,0.0137132818364936,0.158501904022134,0.212257968821189,2.2779596101441e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41771,0.100021028422672,0.00742226653247871,0.085473386019014,0.114568670826331,4.06442180184008e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39512,0.0891880233198907,0.00661637662702714,0.0762199251309175,0.102156121508864,4.37653012306485e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,42142,0.0835519701910697,0.0062062220650171,0.0713877749436362,0.0957161654385032,4.76619475989259e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,42236,0.0635132136654431,0.00473018412700845,0.0542420527765066,0.0727843745543797,7.61127737073632e-41
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,42236,0.0900764194130738,0.00674070145239362,0.0768646445663823,0.103288194259765,1.78590164024869e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41929,0.0526257042733316,0.00393837183214979,0.044906495482318,0.0603449130643452,1.82837495237263e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39675,0.0595310985608636,0.00445918014235816,0.0507911054818416,0.0682710916398856,2.41955366117395e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,42063,-0.0405750986338776,0.00305564272991663,-0.0465641583845142,-0.034586038883241,5.48577312802671e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39868,0.0697309975107736,0.00525318780353354,0.0594347494158479,0.0800272456056994,6.52515107542635e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39868,-0.0531418507290973,0.00401040508743141,-0.0610022447004628,-0.0452814567577317,8.83081229557906e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42174,0.0749142950254552,0.00566119273408184,0.0638183572666548,0.0860102327842556,9.97506521579099e-40
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,39868,0.188315359363226,0.0142348398926186,0.160415073173694,0.216215645552759,1.17534149366323e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,39675,0.0550391593692159,0.00416980966236443,0.0468663324309816,0.0632119863074502,1.75495890635916e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,41624,0.0576671668673228,0.00437639502332737,0.0490894326216012,0.0662449011130445,2.13016058663426e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,42181,0.0349777309851309,0.0026569452391308,0.0297701183164345,0.0401853436538272,2.44116197212783e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,42141,0.0858261765205808,0.00653797648339925,0.0730117426131183,0.0986406104280434,3.9795877719327e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,41757,0.0700677296376113,0.00534443788202875,0.0595926313888349,0.0805428278863876,5.04078210245903e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,42080,-0.0722484558312101,0.00551378268754881,-0.0830554698988058,-0.0614414417636144,5.45929180444769e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,39868,0.0550294781736027,0.00420749721655926,0.0467827836291466,0.0632761727180589,8.3272624023845e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42210,0.0552072064047702,0.00422417329925069,0.0469278267382389,0.0634865860713016,8.43764710031433e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42236,0.0943134666520012,0.00721688051171094,0.0801683808490478,0.108458552454955,8.52794258583835e-39
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,42010,0.04434706835607,0.00340031984458777,0.037682441460678,0.0510116952514621,1.21210525456894e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39872,0.0829439293921298,0.0063575002207459,0.0704832289594678,0.0954046298247918,1.26434741227585e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,39597,0.119056524450089,0.00912647919988976,0.101168625218305,0.136944423681873,1.3089597030674e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39895,0.0422811392614614,0.00324239337805045,0.0359260482404825,0.0486362302824402,1.37380676823626e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,39917,0.0275431899409293,0.00211314343518244,0.0234014288079717,0.0316849510738869,1.48031333388968e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42048,0.0832534317018016,0.00639239685733475,0.0707243338614254,0.0957825295421777,1.53195503739455e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42108,0.129558167779889,0.00995639604360117,0.110043631534431,0.149072704025347,1.76799833832864e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,42187,0.0370293321748065,0.00284639414499257,0.0314503996506211,0.042608264698992,1.84055604914858e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42010,0.0273675645079357,0.00210466769434119,0.0232424158270269,0.0314927131888444,2.00107612606541e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39597,0.177398314666596,0.0136373517688542,0.150669105199642,0.20412752413355,2.10745576448365e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42092,-0.0629042646977702,0.00484005251652346,-0.0723907676301562,-0.0534177617653842,2.17387456045668e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,42174,0.0342875988071321,0.00264154423453002,0.0291101721074533,0.0394650255068109,2.68024933868772e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41995,0.137608792436481,0.0106227612521633,0.116788180382241,0.158429404490721,3.77214685132903e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,42041,0.129816022620042,0.0100485545224243,0.110120855756091,0.149511189483994,5.92496468284485e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,42200,-0.075457602667472,0.00585019028311123,-0.08692397562237,-0.063991229712574,7.66664418187792e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42222,-0.0357175864128543,0.00277128313389341,-0.0411493013552853,-0.0302858714704232,8.6909662958872e-38
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,39892,-0.0498211729539088,0.00386749524571959,-0.0574014636355192,-0.0422408822722984,1.04691151328748e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41995,0.0458080651657315,0.00355877292142199,0.0388328702397444,0.0527832600917187,1.08396598692162e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42050,-0.0484419586019465,0.00376722404436194,-0.0558257177288959,-0.0410581994749971,1.2785445096718e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42048,0.139613679142352,0.0108763468110108,0.118296039392771,0.160931318891933,1.70078061578012e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41771,0.10220140083998,0.00796773873852832,0.0865846329124645,0.117818168767495,1.94135925661696e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42156,0.0424679518622128,0.00331223386614974,0.0359759734845593,0.0489599302398663,2.04858674497682e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,39895,0.127433008573542,0.00994475750317093,0.107941283867327,0.146924733279757,2.48708940630825e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,39895,0.0938444009861432,0.0073246423514365,0.0794881019773277,0.108200699994959,2.54919383746633e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,39575,0.0828493715488028,0.00648030875420004,0.0701479663905707,0.0955507767070349,3.66980590165201e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41696,0.116227761185453,0.00911862438108491,0.0983552573985267,0.13410026497238,5.42878686723961e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39869,0.151062580944706,0.0118506700947648,0.127835267558967,0.174289894330445,5.81562034013283e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42142,0.0592269863784123,0.00465315884402621,0.0501067950441209,0.0683471777127037,6.69449271620684e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41842,0.0979908776735528,0.00770196242488918,0.0828950313207701,0.113086724026336,7.25517947306524e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,42187,0.0883885975983317,0.00695486611648024,0.0747570600100304,0.102020135186633,8.54800174008844e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,39904,-0.0560594672279211,0.00440843725725314,-0.0647000042521373,-0.047418930203705,8.56216645656705e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42048,0.1469009935715,0.0115689000755614,0.1242259494234,0.169576037719601,9.86609343208566e-37
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,42187,-0.0637616953913493,0.00504105332628817,-0.0736421599108741,-0.0538812308718244,1.83049901568337e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,39927,0.0400380727792514,0.00316438424336076,0.0338358796622643,0.0462402658962385,1.90590244526434e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42174,0.0789380903383118,0.00624451769672984,0.0666988356527213,0.0911773450239022,2.00748119446556e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,41766,0.0705228722232972,0.005584174876851,0.0595778894646692,0.0814678549819252,2.37191515874836e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REN,Renin,42072,0.111486335660105,0.0088296472577848,0.0941802270348464,0.128792444285363,2.42688418337684e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,39858,0.138449753043303,0.0109635831881937,0.116961129994443,0.159938376092162,2.60274195931777e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41842,0.0844068510459679,0.0067040392909189,0.0712669340357668,0.0975467680561689,3.83830579963578e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39848,0.107492581875557,0.00854413812784983,0.0907460711449712,0.124239092606142,4.70438511995076e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39895,0.0994876350671739,0.00791811798830804,0.0839681238100901,0.115007146324258,5.75218312819238e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42174,-0.063522868285506,0.0050622033737925,-0.0734447868981393,-0.0536009496728728,6.41332026478875e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,41943,0.119780899479912,0.00955593275486484,0.101051271280377,0.138510527679447,7.67314776267239e-36
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,42174,0.0623047928925919,0.00498029642429116,0.0525434119009813,0.0720661738842026,1.03248903824757e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,42056,0.0517245383761483,0.00415431618858763,0.0435820786465165,0.05986699810578,2.16887278039734e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42048,0.0891073875295855,0.00716053488731567,0.0750727391504468,0.103142035908724,2.35300926127405e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41995,0.0598959654329251,0.00482116900134763,0.0504464741902837,0.0693454566755665,3.04508872310438e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39869,0.138755310660942,0.0111679288988389,0.116866170019218,0.160644451302666,3.27357446256396e-35
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41771,0.0872544638343519,0.00708652861581222,0.0733648677473599,0.101144059921344,1.19966424696548e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,39512,0.103381099829643,0.00842218249928335,0.0868736221310475,0.119888577528238,2.08371985665344e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41771,0.0849261143738013,0.00693133941710432,0.0713406891162769,0.0985115396313258,2.50517770532338e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,42155,0.0920491467142001,0.0075300019751005,0.0772903428430032,0.106807950585397,3.48830225703223e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42048,0.121307765339539,0.00994133760529496,0.101822743633161,0.140792787045917,4.57090920776019e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41915,0.0491433454437801,0.00402864867604046,0.0412471940387408,0.0570394968488194,4.81176877118805e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,42111,0.0559982125133025,0.00459241059027819,0.0469970877563572,0.0649993372702477,5.07157305636495e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,42048,0.118314512957336,0.00970450378452165,0.0992936855396732,0.137335340374998,5.20178474601859e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39883,-0.096990050759615,0.0079581346540808,-0.112587994681613,-0.0813921068376166,5.91904441675033e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39512,0.089890287881455,0.00737593182251482,0.075433461509326,0.104347114253584,6.05888201484047e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42048,0.0990839777081656,0.00816188371860819,0.0830866856196935,0.115081269796638,9.75062385626996e-34
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,39904,0.0993699975809425,0.00819339343680569,0.0833109464448034,0.115429048717082,1.21308497320869e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42092,0.111683121100146,0.00921773509776647,0.0936163603085242,0.129749881891769,1.29695440382628e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42072,0.0570816435296926,0.00471329048046096,0.0478435941879891,0.0663196928713961,1.38388852543718e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,42236,0.0851458668566043,0.00703480225273433,0.071357654441245,0.0989340792719635,1.50336078765176e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39872,0.131681364542845,0.0108990533487537,0.110319219979288,0.153043509106402,2.11651914594933e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,41943,0.0695555399974023,0.00576040745069487,0.0582651413940403,0.0808459386007642,2.1437658074052e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41995,0.0369352466653967,0.00306287381166031,0.0309320139945424,0.0429384793362509,2.58629564888356e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39858,0.104666543161479,0.00868146504783694,0.087650871667719,0.12168221465524,2.87852271548544e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,39675,0.0607863978146526,0.00504497052363797,0.0508982555883221,0.070674540040983,3.17015537586832e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41771,0.0635326579896137,0.00531227997873353,0.053120589231296,0.0739447267479314,8.55227548359971e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42063,-0.0350317762506442,0.0029318079965083,-0.0407781199238005,-0.029285432577488,9.6354626833361e-33
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41995,0.0876765347772539,0.00734432364974586,0.073281660423752,0.102071409130756,1.09863331112739e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39597,0.112894426259536,0.00945562505694693,0.0943614011479198,0.131427451371152,1.1735701943731e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42063,0.0311074906637525,0.00261043281458891,0.0259910423471583,0.0362239389803468,1.41403262549676e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41995,0.047658105503587,0.00400227773432124,0.0398136411443173,0.0555025698628566,1.57376673172248e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,41950,0.0936996426985031,0.00787839499807043,0.0782579885022851,0.109141296894721,1.87149759070866e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41981,0.136331426913521,0.0114872081221198,0.113816498994166,0.158846354832876,2.51784540754637e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39868,0.0900955777299063,0.00761498118802614,0.0751702146013751,0.105020940858438,4.16182768772145e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42198,0.0252194665821879,0.00213495996033416,0.0210349450599329,0.0294039881044428,4.81809067739907e-32
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42108,0.106208819656066,0.00905260206229499,0.088465719613968,0.123951919698164,1.2380206151377e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,42108,0.0713951234203434,0.00609623229880215,0.0594465081146912,0.0833437387259956,1.58343056639117e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41919,0.113903534083926,0.00976827285914489,0.0947577192800022,0.13304934888785,2.87573391949558e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,42059,-0.0496332678645484,0.00425802839280854,-0.0579790035144531,-0.0412875322146437,3.00746819887366e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42048,0.109983391268976,0.00945249605830546,0.0914564989946968,0.128510283543254,3.83989344885926e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,39675,0.0672050835979521,0.00578222586804026,0.0558719208965932,0.078538246299311,4.7835192955428e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42128,-0.0404880982046688,0.00348838424667983,-0.0473253313281612,-0.0336508650811763,5.35271919338565e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,39575,0.0652458521941595,0.00562651718469259,0.054217878512162,0.076273825876157,6.52623321474682e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,42048,0.121624528592382,0.0105058544950804,0.101033053782024,0.142216003402739,7.56198778450346e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39512,0.094403914867366,0.00816633044672218,0.0783979071917905,0.110409922542941,9.90399917825723e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,41943,-0.0433359004308872,0.00375097584379255,-0.0506878130847206,-0.0359839877770538,9.95406659590769e-31
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39696,0.143401833963078,0.0124621087943614,0.11897610072613,0.167827567200027,1.81006853297159e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,42048,-0.0423795011643103,0.00368758507479838,-0.0496071679109151,-0.0351518344177055,1.99597096775551e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42072,0.108697649750746,0.00946117617304096,0.0901537444515852,0.127241555049906,2.08057094293574e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,42222,0.0466551614744025,0.00406306772342731,0.038691548736485,0.05461877421232,2.22243167928078e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39895,0.0785125412500117,0.00683556001172191,0.0651148436270367,0.0919102388729866,2.28945968011345e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42048,0.0505844502495893,0.00440710942629155,0.0419465157740578,0.0592223847251207,2.35838305193992e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39597,0.0645930574135253,0.00562529442415773,0.0535674803421761,0.0756186344848744,2.40209771553744e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41828,0.069466060000768,0.00605682467006603,0.0575946836474386,0.0813374363540974,2.62428905463147e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39800,0.0364711162160056,0.00318281555014017,0.0302327977377308,0.0427094346942803,3.13180809697653e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39575,0.105738568388207,0.00925530502746007,0.0875981705343852,0.123878966242029,4.65585707014911e-30
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42164,0.0796470693592391,0.00704746983278244,0.0658340284869855,0.0934601102314926,1.74706019882351e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,42048,0.0989709036598594,0.00876222895757346,0.0817969349030155,0.116144872416703,1.88141082014095e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42050,0.0336025031859069,0.00297782148841507,0.0277659730686134,0.0394390333032004,2.12764542636314e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,42124,-0.0347494145354692,0.00308044713505227,-0.0407870909201717,-0.0287117381507668,2.21246174113578e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42048,-0.0438079227210651,0.00388384112201548,-0.0514202513202155,-0.0361955941219148,2.2439577012821e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,39872,0.0543520939887894,0.00482881138143388,0.044887623681179,0.0638165642963998,3.10510140733044e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,39917,0.0251015526047375,0.00223335690448476,0.0207241730719474,0.0294789321375277,3.72687789812163e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,42124,0.0313158947388552,0.00279141290696832,0.0258447254411973,0.0367870640365132,4.43859415188502e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41856,0.0555098183178587,0.00495732485428016,0.0457934616034696,0.0652261750322478,5.65530287457726e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,42063,0.0469248855687529,0.00419747318315397,0.0386978381297711,0.0551519330077347,6.90022674060821e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,42236,0.0556392258165349,0.00497796962985872,0.0458824053420118,0.065396046291058,7.0477198065642e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,39895,0.0370793347300301,0.00331690991186303,0.0305781913027785,0.0435804781572816,7.33196886852832e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42174,0.0421663615601595,0.00377410419778668,0.0347691173324976,0.0495636057878214,7.42406847109744e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39597,0.0543319601473302,0.00486237804123136,0.0448016991865168,0.0638622211081437,7.81887301941655e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39889,-0.0180561503573089,0.00161734638773937,-0.0212261492772781,-0.0148861514373398,8.64924525754952e-29
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,42048,0.0678435498430072,0.00609282844066344,0.0559016060993068,0.0797854935867075,1.13118305493493e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,42048,0.0883662736280394,0.00794480096059241,0.0727944637452783,0.103938083510801,1.29915214988659e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42174,0.115187617879748,0.0104026039396861,0.0947985141579629,0.135576721601532,2.24468877023248e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,42048,0.111263129692377,0.010056582555182,0.0915522278842199,0.130974031500533,2.49285063324484e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41995,0.0719522017372476,0.00650982527514051,0.0591929441979722,0.084711459276523,2.81336519322342e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39512,0.0434359912195619,0.0039285226547284,0.0357360868162942,0.0511358956228295,2.87790262218323e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,42056,0.0365521127537754,0.00330995962478679,0.0300645918891933,0.0430396336183576,3.13052112093402e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42072,-0.0324751054115307,0.00294473658193803,-0.0382467891121293,-0.0267034217109322,3.68749664252358e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,42175,0.0607517447940277,0.00551130927505258,0.0499495786149247,0.0715539109731308,3.89164377023335e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39869,0.0339418051354287,0.00307890098444331,0.0279071592059199,0.0399764510649376,4.07478110250614e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42048,0.0513742411115675,0.0046648068930733,0.0422312196011438,0.0605172626219911,4.35336649157157e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42072,0.0333512898759802,0.00302996327937406,0.027412561848407,0.0392900179035533,4.64787656825501e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42222,0.0907499082082531,0.00825013091973163,0.0745796516055791,0.106920164810927,5.02367574190608e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41771,0.0591540842781618,0.00537894720478311,0.0486113477567869,0.0696968207995367,5.21033032988735e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42179,0.0677134057858547,0.00617177597473322,0.0556167248753776,0.0798100866963318,6.8637761243431e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41771,0.0792670229412757,0.00722791602361014,0.0651003075349999,0.0934337383475516,7.28472557434054e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39868,0.0493993335086027,0.00450572391407632,0.0405681146370132,0.0582305523801923,7.89520832039285e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41995,0.0727729635926691,0.00664346665386149,0.0597517689511006,0.0857941582342377,8.33541561619448e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42048,0.124099252723762,0.0113331021152127,0.101886372577945,0.146312132869579,8.69033518683895e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39869,0.167556811677028,0.0153078312187694,0.13755346248824,0.197560160865816,9.59666978021023e-28
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42187,-0.0400963024767891,0.00366685414358627,-0.0472833365982182,-0.03290926835536,1.02518267317496e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42070,0.0606853636267188,0.00555050758974963,0.0498063687508095,0.0715643585026281,1.04447777654395e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39597,0.0959708679871274,0.00877970035350822,0.0787626552942513,0.113179080680004,1.13710462931831e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,42072,0.0811175112088906,0.00742501900601906,0.0665644739570933,0.095670548460688,1.14492446531584e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41995,0.0992123432273775,0.00911945334508906,0.081338214671003,0.117086471783752,1.88644627483324e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,42072,0.0315714154358899,0.00290581737162799,0.0258760133874991,0.0372668174842808,2.20026159725733e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39597,0.0384003685132503,0.00353610096164894,0.0314696106284184,0.0453311263980822,2.47260368179594e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39538,0.0606861797000298,0.00559148691647098,0.0497268653437467,0.071645494056313,2.64902396229501e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39590,0.146072041228068,0.0134589726180388,0.119692454896712,0.172451627559424,2.65026954767369e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,39880,-0.0223616481406915,0.00206747100291051,-0.0264138913063961,-0.0183094049749869,3.93012420532021e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39675,0.0977754441814946,0.00905763519013219,0.0800224792088355,0.115528409154154,4.96383982009203e-27
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42141,0.0673534433454883,0.00628367121683811,0.0550374477604856,0.079669438930491,1.06296538079625e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,39904,0.0328513476826043,0.00306499465129841,0.0268439581660594,0.0388587371991492,1.12251271467087e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42222,0.0452368109089214,0.00422319056613786,0.0369593573992912,0.0535142644185516,1.14753618046499e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,39840,0.0854974515854976,0.0079803605893633,0.0698559448303455,0.10113895834065,1.18309697005078e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42070,-0.0382899905351812,0.00358358996902033,-0.0453138268744611,-0.0312661541959014,1.53134929132292e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39869,0.035024721952813,0.00327880250097837,0.0285982690508954,0.0414511748547306,1.65176569858296e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42063,0.0537343374039542,0.00504147531218137,0.0438530457920788,0.0636156290158297,2.02914219372026e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39845,0.128236390940517,0.0120272457231031,0.104662989323235,0.151809792557799,2.04563671927118e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39904,0.0273419222601081,0.00257031057729828,0.0223041135286034,0.0323797309916127,2.65233963745402e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39869,0.0596193688337732,0.00561930025313161,0.0486055403376352,0.0706331973299111,3.56712434086442e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39868,0.100554001294364,0.0094842807521267,0.0819648110201961,0.119143191568533,3.86524628416096e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,42048,0.0931823356955564,0.00879776791777384,0.0759387105767197,0.110425960814393,4.13117233560968e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41943,0.060279643103713,0.00571518162775958,0.0490778871133042,0.0714813990941218,6.61198512924116e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42236,-0.036767763844891,0.00348797763037839,-0.0436042000004327,-0.0299313276893494,7.00883672088722e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41842,0.0980986720481176,0.00931700383244428,0.0798373445365268,0.116359999559708,8.03253433800555e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42111,0.0340814756563659,0.00324004422743326,0.0277309889705967,0.0404319623421351,8.89843397674113e-26
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,39869,0.120340346751418,0.0114509998960462,0.0978963869551673,0.142784306547668,1.03071036774245e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,41943,0.0492141120797136,0.0046868170965498,0.040027950570476,0.0584002735889512,1.08166587289604e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39917,-0.030433450428881,0.00289880903367754,-0.036115116134889,-0.024751784722873,1.15008171446235e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42048,-0.0449518528055412,0.00430158281957801,-0.0533829551319141,-0.0365207504791683,1.83270363987771e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42174,0.077522779253031,0.00742300435047972,0.0629736907260907,0.0920718677799712,1.95727923866509e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,41901,-0.0311425988921873,0.0029861486497689,-0.0369954502457343,-0.0252897475386403,2.2892780129149e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,41922,-0.0310723745530187,0.00298406654818802,-0.0369211449874672,-0.0252236041185702,2.71133000884723e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,39868,0.0439167358365066,0.00421700017856352,0.0356514154865221,0.0521820561864911,2.78102130610722e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39869,0.0980690370249999,0.00941757728175438,0.0796105855527613,0.116527488497238,2.8044553693493e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,39872,0.121497036005001,0.0116725769546572,0.0986187851738728,0.144375286836129,2.9431384231339e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39895,0.0875340668440089,0.0084309035593548,0.0710094958676735,0.104058637820344,3.86332914297667e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,42093,0.0364614905835012,0.00351753103237607,0.0295671297600441,0.0433558514069583,4.41331712821948e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39858,0.129331189700511,0.0124777697429603,0.104874761004308,0.153787618396713,4.64059893800295e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41766,0.0693097568844169,0.00669270078526593,0.0561920633452957,0.0824274504235381,4.90285539901497e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,39696,0.145842747499342,0.0140935468588062,0.118219395656082,0.173466099342602,5.5391247410498e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42108,0.0309028094308191,0.00298786682278173,0.0250465904581669,0.0367590284034713,5.59346348457654e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,39915,0.062984173437239,0.00609071016157201,0.0510463815205579,0.0749219653539202,5.93555834296005e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNST,Consortin,42072,0.122807935771469,0.0118823987038109,0.0995184343119993,0.146097437230938,6.0475576575781e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,41771,0.0724960311599013,0.00701717486828062,0.0587423684180713,0.0862496939017313,6.33738583527555e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,41725,0.0791753631383795,0.00766795299649678,0.0641461752652458,0.0942045510115132,6.72993891635056e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42236,-0.0319114227976297,0.00309126038437902,-0.0379702931510126,-0.0258525524442468,6.84128372260777e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39850,0.0649357422066715,0.00629688238407102,0.0525938527338923,0.0772776316794507,7.99090158702984e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41766,0.0329894846695796,0.00320614190270759,0.0267054465402728,0.0392735227988865,9.7535754651542e-25
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,42222,0.105548401506545,0.0103259526474076,0.0853095343176262,0.125787268695464,1.94319150231046e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,41771,0.0837945233714214,0.00819726358532003,0.0677278867441942,0.0998611599986487,1.94483747497741e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,41995,0.114067056333999,0.0111629669385643,0.092187641134413,0.135946471533585,2.01719010927189e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41771,0.0677632793454665,0.00664540014780082,0.0547382950557769,0.0807882636351561,2.51734997066217e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,42187,0.0434913864099113,0.00426942614257624,0.0351233111704619,0.0518594616493607,2.779256381054e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,42003,0.0255862560896497,0.00251490615736353,0.0206570400212172,0.0305154721580822,3.1775602705011e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,42048,0.0944287536059637,0.00928267104699208,0.0762347183538592,0.112622788858068,3.21635730164844e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41766,0.0876466876830403,0.00862833616757329,0.0707351487945967,0.104558226571484,3.74712640119568e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39798,0.030607746848135,0.00301413189295744,0.0247000483379384,0.0365154453583316,4.01447142274824e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,39895,0.0830443462476326,0.00819645434291026,0.0669792957355285,0.0991093967597367,5.05974019202655e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,42048,0.0954536023356485,0.00944297758043921,0.0769453662779876,0.113961838393309,6.17254827052783e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42185,0.0895827402314947,0.00887844546638133,0.0721809871173873,0.106984493345602,7.42947969444802e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39575,0.0757011380637352,0.00749985331576869,0.0610014255648286,0.0904008505626418,7.48675711696889e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,42110,0.0314040808865406,0.00311861261185049,0.0252916001673136,0.0375165616057676,9.10475057896056e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39868,0.0704537738789906,0.00699635662899292,0.0567409148861645,0.0841666328718167,9.4421990841595e-24
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39868,0.0678282119132395,0.00678153898563988,0.0545363955013854,0.0811200283250937,1.87264736831869e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,39584,0.0303924069424602,0.00303959577478376,0.024434799223884,0.0363500146610363,1.94206263341893e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42055,0.0548655515313486,0.00551086311842996,0.0440642598192259,0.0656668432434713,2.86074808470832e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42072,0.0798235726744995,0.00802111868746876,0.0641021800470607,0.0955449653019382,2.98294731380594e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39575,0.0807259729739757,0.00811364052851354,0.0648232375380892,0.0966287084098623,3.18107788690704e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42056,0.0827381474846225,0.00832061437912759,0.0664297433015324,0.0990465516677126,3.22885683168097e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,39752,0.119722850665186,0.0120359768283631,0.096132336081594,0.143313365248777,3.24422044379357e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39868,0.0959720338867235,0.00965478539738013,0.0770486545078584,0.114895413265589,3.46088781220532e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42072,0.067991989865551,0.00684784580279544,0.054570212092072,0.0814137676390301,3.74076598957678e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,39858,0.0912017206217769,0.00918270190918915,0.0732036248797661,0.109199816363788,3.76527011725783e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41995,0.148289402267831,0.014939778730476,0.119007435956098,0.177571368579565,3.86397156468643e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,41771,0.10643599517449,0.0107403656189748,0.0853848785612993,0.127487111787681,4.54009678149698e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,42222,0.0456676494211695,0.00461045854557704,0.0366311506718385,0.0547041481705004,4.72689774322572e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42046,0.0663058026245862,0.00669407355802599,0.0531854184508553,0.0794261867983172,4.7416939769945e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42048,0.0645267253701444,0.00652156757878949,0.051744452915717,0.0773089978245718,5.27770902248412e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,42048,0.0354745321857366,0.003589456530821,0.0284391973853274,0.0425098669861458,5.90795993751121e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41995,-0.0438002209119589,0.00443385362885245,-0.0524905740245097,-0.0351098677994081,6.17507898980573e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39858,0.0401213141520472,0.00406122437362656,0.0321613143797391,0.0480813139243552,6.3557670129927e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42138,0.0356039881232381,0.00360779628625021,0.0285327074021877,0.0426752688442885,6.80251431010434e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39895,0.0785475301099262,0.00796028603250144,0.0629453694862234,0.0941496907336291,7.12968827025857e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42051,0.0823487773902069,0.00836022743038849,0.0659627316266455,0.0987348231537683,8.18212511201174e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,39675,-0.0255717190880236,0.00259630235019132,-0.0306604716943986,-0.0204829664816486,8.56386237860655e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41766,0.0712913681999715,0.00724512831261321,0.0570909167072496,0.0854918196926934,9.08004448891383e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39603,0.0292846900851442,0.00297528062534216,0.0234531400594736,0.0351162401108148,9.15416443713175e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,39675,0.0749531268161128,0.00761658817926693,0.0600246139847496,0.089881639647476,9.31326849400286e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42172,0.0306013802296669,0.00311173806699637,0.024502373618354,0.0367003868409798,9.55639814532719e-23
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,42111,0.0382817220742027,0.00389627407960798,0.0306450248781711,0.0459184192702344,1.04475303514237e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42048,0.0742502563052159,0.00756189538596061,0.059428941348733,0.0890715712616987,1.11159287180797e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,42111,0.0507765079167275,0.00517352188413346,0.0406364050238259,0.0609166108096291,1.15885838316733e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39575,0.078260661009525,0.00797056892852406,0.0626383459096179,0.0938829761094322,1.15954931082562e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,42142,0.0597156882702631,0.00608503720964644,0.0477890153393561,0.0716423612011702,1.17170219413488e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,42010,0.0449761029699043,0.00460069806969728,0.0359587347532976,0.053993471186511,1.69816819522969e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42048,0.0404727962858015,0.00414384160983594,0.0323508667305231,0.0485947258410799,1.85307400742178e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,39869,0.101676807385289,0.0104075917184208,0.0812779276171847,0.122075687153394,1.86887498612149e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41766,0.0906762414785357,0.00928468793180609,0.0724782531321958,0.108874229824876,1.87380342998791e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41995,0.0824853528578748,0.00845749383646298,0.0659086649384074,0.0990620407773423,2.12765883760331e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,39868,0.0648842302270251,0.00666776367368407,0.0518154134266043,0.0779530470274459,2.72089393794956e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39679,0.0487912393162492,0.00501627533132145,0.0389593396668592,0.0586231389656393,2.851142825335e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39858,0.051924721263517,0.00535059655209475,0.0414375520214113,0.0624118905056227,3.52454316735597e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,39917,-0.0246091730290981,0.00253750691573703,-0.0295826865839426,-0.0196356594742535,3.74339311794712e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,42187,0.0576082743817835,0.00595230631268404,0.0459417540089228,0.0692747947546443,4.3931807791947e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,42174,-0.0395443012345348,0.00408716367809435,-0.0475551420435997,-0.0315334604254698,4.52677187362272e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41943,0.0452162321301439,0.00467749822148845,0.0360483356160265,0.0543841286442612,4.92931049061117e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39904,0.0415401686901475,0.00430150829915243,0.0331092124238087,0.0499711249564862,5.57543920796123e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39872,0.0771629750969633,0.00799426172643093,0.0614942221131587,0.092831728080768,5.84494637371686e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,42072,-0.0534204186648629,0.00554847377585696,-0.0642954272655426,-0.0425454100641833,7.16598568154897e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39858,0.0758949630644694,0.00789890948780127,0.0604131004683789,0.0913768256605599,8.94093646143191e-22
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39868,0.114161353318844,0.0119057319149202,0.0908261187656007,0.137496587872088,1.07855341785637e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39858,0.046713227878252,0.00487228641515682,0.0371635465045446,0.0562629092519594,1.09161705332458e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,41919,0.0525856913359683,0.00548907258892419,0.0418271090616769,0.0633442736102597,1.138986175596e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39869,0.0647345071249845,0.00676115415024515,0.051482644990504,0.077986369259465,1.23729808130138e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41828,0.0991426933112873,0.0103643214407324,0.0788286232874518,0.119456763335123,1.3081956335613e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39872,0.0848880811330451,0.00887516016339485,0.0674927672127912,0.102283395053299,1.3591308098863e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42222,0.101588677153639,0.0106556153904524,0.0807036709883527,0.122473683318926,1.76892546644606e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,42174,0.0632359168525865,0.00663937800535835,0.0502227359620841,0.0762490977430889,1.93722939593904e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42172,0.0579025611983046,0.00608094538446149,0.04598390824476,0.0698212141518491,1.9823717978556e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,42222,0.0493510449351174,0.00518532524987681,0.0391878074453589,0.0595142824248759,2.06878567206761e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,39675,0.12254287541078,0.0128743389637023,0.0973091710419239,0.147776579779637,2.12349260246535e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39869,0.112543248480371,0.0118311693539829,0.0893541565465645,0.135732340414178,2.24019988416279e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,39872,0.053881475890801,0.0056651823007724,0.0427777185812871,0.0649852332003149,2.27127542122602e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39868,0.0931672144626568,0.00980900891250827,0.0739415569941406,0.112392871931173,2.56761164750418e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,42174,0.0592914230767703,0.00624550125270691,0.0470502406214648,0.0715326055320759,2.60236293296169e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41842,0.0454035795060198,0.00478633962216969,0.0360223538465672,0.0547848051654723,2.80271656206495e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42050,0.0981338472091394,0.010356639678784,0.0778348334387227,0.118432860979556,3.09358374649706e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,39675,0.0354444194757024,0.00374355573316578,0.0281070502386975,0.0427817887127074,3.42650011067769e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,42010,0.0335989647715769,0.00355979637924819,0.0266217638682504,0.0405761656749033,4.39816299864187e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39675,0.079470201752049,0.00841853691245486,0.0629698694036375,0.0959705341004605,4.47717497847097e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42063,0.0513153760792266,0.00544192364588088,0.0406492057333001,0.0619815464251531,4.77834064727343e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,42063,0.0462733308492107,0.00490907138710143,0.0366515509304919,0.0558951107679296,4.94182584074247e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41842,0.0717898669164067,0.00761882365179389,0.0568569725588907,0.0867227612739228,5.11559422442313e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,39917,0.0353553676816913,0.0037513036280422,0.0280028125707286,0.042707922792654,5.1440649691726e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42108,0.0974765836883055,0.010355919319661,0.07717898182177,0.117774185554841,5.60925427743287e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,41771,0.0491194542943492,0.00522170194262667,0.0388849184868009,0.0593539901018974,5.9506883383718e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42222,0.040695187892945,0.0043271355220845,0.0322140022696594,0.0491763735162306,6.0421254184471e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39872,0.0572374530903892,0.00609113762895665,0.0452988233376341,0.0691760828431442,6.70397490621398e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39575,0.0387249720432369,0.00412996297309076,0.030630244615979,0.0468196994704948,8.15068782437164e-21
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,41759,0.0405076432375361,0.00433307837929325,0.0320148096141213,0.0490004768609509,1.03086533222391e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41995,-0.0246433782377057,0.0026365823227752,-0.0298110795903451,-0.0194756768850663,1.04528013321062e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,39895,0.0468714162556836,0.00501908580411251,0.0370340080796231,0.0567088244317441,1.15816453702377e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,42174,0.0599566363693367,0.00642794572095175,0.0473578627562713,0.0725554099824022,1.24940667569806e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39674,0.0673853842792592,0.00722803079904789,0.0532184439131253,0.081552324645393,1.34800500608268e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39895,0.083935851770735,0.00902933129733345,0.0662383624279614,0.101633341113509,1.72692361576372e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,39904,0.0412087308341385,0.00443981200586043,0.032506699302652,0.0499107623656249,1.9724156014006e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39927,-0.0275192608242739,0.00296587948892277,-0.0333323846225625,-0.0217061370259853,2.02802881512303e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39675,0.0233716209587409,0.00252328039965767,0.0184259913754118,0.0283172505420699,2.36732062920668e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41924,0.0232200856603748,0.00250798746679965,0.0183044302254475,0.0281357410953022,2.38694717550839e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42066,0.0398412664456191,0.00430338447800607,0.0314066328687272,0.048275900022511,2.39075382793942e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41943,0.0563382898860437,0.00610668997181019,0.0443691775412958,0.0683074022307917,3.23603358585908e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41972,0.0760144394510405,0.00825266351643381,0.0598392189588302,0.0921896599432508,3.70949774188568e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41752,0.059368937526324,0.00644770193495566,0.0467314417338109,0.0720064333188371,3.82729184148921e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41943,0.0407583677416679,0.0044277930299553,0.0320798934029555,0.0494368420803803,3.91441070834218e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,42074,0.046708048945262,0.00507734097857222,0.0367564606272605,0.0566596372632636,4.12496274692897e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",39917,0.0167223277456251,0.0018172449417285,0.0131605276598372,0.0202841278314129,4.12770091649327e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,42222,0.0340042476508674,0.0037002448397731,0.0267517677649121,0.0412567275368227,4.50046247597117e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42137,0.10276656214544,0.0111829079414515,0.0808480625801948,0.124685061710685,4.50917921187451e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,41995,0.0538649690574902,0.00586845730637219,0.0423627927370007,0.0653671453779797,4.99284789692736e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,39869,0.0681465708804099,0.0074280816911792,0.0535875307656987,0.0827056109951212,5.34008053193223e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,42174,0.0227262889183738,0.00248059159488429,0.0178643293924006,0.027588248444347,5.83436313982064e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39868,0.0835130079196458,0.00911344096867108,0.0656506636210505,0.101375352218241,5.88018008864532e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,41580,-0.0313900292651725,0.00342943682451708,-0.038111725441226,-0.0246683330891191,6.34882752439397e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42111,0.124996213565506,0.0136696001397344,0.098203797291627,0.151788629839386,6.86052385592417e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,39895,0.0464241974281841,0.0050766597973332,0.036473944225411,0.0563744506309571,7.00514121893515e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39858,0.0620160716403784,0.00678503547737803,0.0487174021047175,0.0753147411760394,7.30501900059128e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39564,0.0788984494675174,0.0086487868435011,0.0619468272542553,0.0958500716807796,8.62344705575501e-20
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42111,0.10315604480715,0.0113342523767485,0.080940910148723,0.125371179465577,1.01627471179618e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,39868,0.0654055852950221,0.00718783584062191,0.0513174270474031,0.079493743542641,1.05981674799436e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42111,0.0386946796453098,0.00425775236657805,0.0303494850068168,0.0470398742838028,1.14681582718838e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,39869,0.0709601655189424,0.00780820586444791,0.0556560820246245,0.0862642490132603,1.1781082242455e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39868,0.0631205199446925,0.00695920976335902,0.0494804688085088,0.0767605710808762,1.38610439341717e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,41771,0.038810158387951,0.00428491296100204,0.030411728984387,0.047208587791515,1.52193883317926e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,42213,-0.0432728848214992,0.00479008408393738,-0.0526614496260164,-0.0338843200169819,1.87771476288439e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,42187,-0.0163805591554631,0.00181573457923839,-0.0199393989307703,-0.0128217193801558,2.10195792774224e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,42072,0.120986997645403,0.0134130300014142,0.0946974588426315,0.147276536448175,2.12994029220316e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39512,0.0619511820955759,0.00686766875987078,0.0484905513262292,0.0754118128649227,2.18147461143041e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39590,0.0691324677291061,0.00766695396344278,0.0541052379607583,0.084159697497454,2.25460185149497e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,39872,0.0654577866760824,0.00726632128765306,0.0512157969522824,0.0796997763998824,2.42704402649929e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,42056,0.0303233710022872,0.00337233633265291,0.0237135917902875,0.0369331502142869,2.75309806479313e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39575,0.06090565998029,0.0067754320327948,0.0476258131960122,0.0741855067645678,2.89840053153613e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39917,0.0249019993598488,0.00277374196557016,0.0194654651073313,0.0303385336123663,3.19878948167858e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41766,0.0522111769373069,0.00582402301208186,0.0407960918336264,0.0636262620409873,3.52307390707745e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42236,0.0491120152822276,0.00548255813366071,0.0383662013402526,0.0598578292242025,3.73419737972201e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),39713,-0.178108478185872,0.019905856753495,-0.217123957422722,-0.139092998949021,4.21075030721929e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,42185,0.0261084768394046,0.00292118939369811,0.0203829456277564,0.0318340080510529,4.48292980268591e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,41919,0.0504554703195947,0.00565025788540232,0.0393809648642061,0.0615299757749832,4.82237512562321e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,42063,0.0567131158579713,0.00636227346529286,0.0442430598659973,0.0691831718499453,5.54984478052026e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39696,0.0526308411539585,0.00591058773853129,0.0410460891864372,0.0642155931214798,6.19640539551752e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41995,0.051995484201988,0.00585055127982938,0.0405284036935224,0.0634625647104536,7.05299478061363e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42072,-0.0775811380980944,0.00873554791816684,-0.0947028120177014,-0.0604594641784874,7.44966950822407e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41995,-0.0414124840077738,0.0046636451380775,-0.0505532284784057,-0.0322717395371419,7.53718706509595e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42149,0.0705898257102921,0.00795902434261808,0.0549901379987606,0.0861895134218235,8.28182462465487e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,42156,0.0362482533594228,0.00408938421722846,0.0282330602936551,0.0442634464251906,8.67219885242952e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39869,0.0747472342630511,0.00843251398534004,0.0582195068517846,0.0912749616743176,8.86398226918058e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39869,0.0462998832334429,0.00522648763089013,0.0360559674768983,0.0565437989899876,9.3066781045293e-19
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42114,-0.0289351730564518,0.00327133445271804,-0.0353469885837792,-0.0225233575291245,1.0268958403438e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,39575,0.042949160448824,0.00485762117803687,0.0334282229398717,0.0524700979577763,1.08759230154257e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,41943,0.0642279673715516,0.00727413881730984,0.0499706552896243,0.0784852794534788,1.1797773264966e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42111,0.0379019795562565,0.00429767251759229,0.0294785414217756,0.0463254176907374,1.29261823425654e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41995,0.0815604086331132,0.00925623554118207,0.0634181869723963,0.09970263029383,1.38645739968172e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39575,0.0933065785035561,0.0105916730658306,0.072546899294528,0.114066257712584,1.44696023067715e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39895,0.057223089725038,0.00651254909276049,0.0444584935032274,0.0699876859468486,1.7640308095382e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,39868,0.104032433146022,0.0118615487197523,0.0807837976553078,0.127281068636737,2.03284855628236e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,42072,0.0539331683361123,0.00615946709110902,0.0418606128375387,0.066005723834686,2.2587762035832e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41924,0.106294840041426,0.0121624961481905,0.0824563475909729,0.130133332491879,2.61729479701398e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42025,-0.0616188468813737,0.00705698586165923,-0.0754505391702258,-0.0477871545925216,2.80449755936161e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,42142,-0.0459223100780578,0.00526614650447484,-0.0562439572268285,-0.0356006629292871,3.09496938355237e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42111,0.101514295745846,0.011652090270848,0.078676198814984,0.124352392676708,3.32613269621275e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,41828,0.0507639854907796,0.00583789862357451,0.0393217041885736,0.0622062667929857,3.85328407067662e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41943,0.0897923281538746,0.0103300966726142,0.0695453386755508,0.110039317632198,3.9621249017407e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41771,0.0264755644173581,0.00304942768863179,0.0204986861476398,0.0324524426870764,4.33665235016119e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42041,0.0761569277163416,0.0087759292085403,0.0589561064676026,0.0933577489650806,4.48929173224019e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,39895,0.0308449842277774,0.00355357929528606,0.0238799688090167,0.0378099996465381,4.50080482900824e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39872,0.0600979986251921,0.00692554036174655,0.0465239395161688,0.0736720577342153,4.59099653430365e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39872,0.0798682559008644,0.00924222513785917,0.0617534946306604,0.0979830171710683,6.28631432303228e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39453,0.0501986906323832,0.00580985703339315,0.0388113708469326,0.0615860104178338,6.39467584581709e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,41842,0.0444533056292731,0.00514685236466374,0.0343654749945322,0.054541136264014,6.42614525039865e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41958,0.0271175735365422,0.00313996015883692,0.0209632516252219,0.0332718954478626,6.45991211728514e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42222,0.0400567260012839,0.00464217583270554,0.030958061369181,0.0491553906333868,6.87586265505387e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42174,0.0590994416464149,0.00685316036807043,0.0456672473249968,0.0725316359678329,7.19587756890365e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39575,0.0499974155182662,0.00579904961581663,0.0386312782712656,0.0613635527652668,7.50526133810002e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41771,0.0532458305138467,0.0061783685834784,0.041136228090229,0.0653554329374643,7.57668428308409e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,42124,0.03017753225462,0.00350587113737834,0.0233060248253584,0.0370490396838815,8.26871622490082e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42236,0.0378877458692638,0.00440540953116159,0.029253143188187,0.0465223485503405,8.81181284063307e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42063,0.0395596715385542,0.00459979924866097,0.0305440650111787,0.0485752780659297,8.82140295701873e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39426,0.0288493099300303,0.00335606192951874,0.0222714285481735,0.035427191311887,9.37525759550397e-18
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42111,-0.0190414929826795,0.00221819025434277,-0.0233891458811913,-0.0146938400841676,1.01334320205578e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42048,0.0617543740329927,0.00720079663119336,0.0476408126358538,0.0758679354301317,1.08831489274661e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42063,0.0282362473552816,0.00329912728860731,0.0217699578696113,0.034702536840952,1.26399556881155e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42048,0.0549774049275226,0.00642777526767218,0.0423789654028851,0.0675758444521601,1.3267016837896e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39872,0.0450771248456844,0.00527349352024329,0.0347410775460075,0.0554131721453612,1.41525822551332e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42023,0.0631927983030304,0.00739568166607157,0.0486972622375301,0.0776883343685307,1.42835024225463e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39872,0.0725938417246881,0.00849666611311425,0.0559403761429842,0.089247307306392,1.46562911683123e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,41766,0.0590059691731351,0.00690853579934256,0.0454652390064237,0.0725466993398465,1.47533344671868e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39526,0.0786141298382767,0.00921052188006056,0.060561506953358,0.0966667527231954,1.58343746381355e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42108,0.0233120169962302,0.00273585233328052,0.0179497464230004,0.02867428756946,1.74896625442205e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42187,-0.0554243081239766,0.00650614314253428,-0.0681763486833438,-0.0426722675646094,1.78081099522638e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,42048,-0.0411446951360027,0.00483373152344395,-0.0506188089219529,-0.0316705813500526,1.88930991758648e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,41943,-0.0309527250218886,0.00363673483929551,-0.0380807253069078,-0.0238247247368694,1.90485403674313e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,39575,0.0645840674828346,0.00758594590453281,0.0497156135099503,0.0794525214557189,1.90495782796285e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42056,0.0439958061861791,0.00517758717023547,0.0338477353325176,0.0541438770398407,2.1417864209774e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39597,0.0843305080459277,0.00992670884974391,0.0648741587004296,0.103786857391426,2.22820953458809e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42111,0.0610358130424164,0.00718707937685625,0.0469491374637782,0.0751224886210547,2.23307170586723e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39868,0.0385970768083723,0.00454641218151568,0.0296861089326016,0.047508044684143,2.33365524922176e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,39575,0.0362995378480314,0.00427834740734408,0.027913976929637,0.0446850987664258,2.44509484118281e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39675,0.0628876784396758,0.00741455536406795,0.0483551499261026,0.0774202069532489,2.50208759404651e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39872,0.0615078520896528,0.00725365137680679,0.0472906953911115,0.0757250087881941,2.54166320076966e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42048,0.104557275416379,0.0123374573942366,0.0803758589236749,0.128738691909082,2.5981989026724e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39675,0.0533758030774219,0.00629874734042336,0.0410302582901921,0.0657213478646517,2.67021053902994e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,39597,0.0883098589762625,0.0104220545305001,0.0678826320964822,0.108737085856043,2.68780031651531e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41771,0.058465486511825,0.00690251299175538,0.0449365610479844,0.0719944119756655,2.7080842964654e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,39356,0.0217110552646691,0.00256461909235067,0.0166844018436618,0.0267377086856764,2.87931180877648e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39597,0.0894099339463365,0.0106006904757711,0.0686325806138251,0.110187287278848,3.74669507010361e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42048,0.0453917554324144,0.00538921633772457,0.0348288914104742,0.0559546194543545,4.04911116952727e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39869,0.0766348976817912,0.00913719727799848,0.0587259910169142,0.0945438043466683,5.57403153725109e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,39868,0.0496445591986119,0.00593152875261241,0.0380187628434916,0.0612703555537322,6.46302632582534e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41882,0.032071647385467,0.00384032435390671,0.0245446116518099,0.0395986831191241,7.41668254278865e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42072,0.0337357386751189,0.00404068271014204,0.0258160005632405,0.0416554767869973,7.54967728424518e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,42236,-0.0276114528918671,0.00330738573454596,-0.0340939289315771,-0.021128976852157,7.57934244462481e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,39526,0.037142008510523,0.00445075935623579,0.0284185201723009,0.0458654968487452,7.97217689006416e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,39675,-0.042686802523583,0.00512087023400512,-0.052723708182233,-0.032649896864933,8.60322137118015e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,41766,0.0308466694258159,0.00370437907822279,0.0235860864324993,0.0381072524191326,9.09881675567903e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41771,0.0528973590669941,0.00635250765180256,0.0404464440694611,0.0653482740645271,9.10445063352105e-17
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41766,0.0501426414999871,0.00603037193962157,0.0383231124983289,0.0619621705016454,1.00686178396399e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,39858,0.0201966891141223,0.00243056207140534,0.0154327874541679,0.0249605907740768,1.0714252984709e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42210,0.047170657318219,0.00567924134162984,0.0360393442886245,0.0583019703478135,1.08444672871296e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42108,-0.0251429206039797,0.00302719690435914,-0.0310762265365236,-0.0192096146714358,1.0863183043932e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39575,0.0935014985480095,0.0112565026998761,0.0714387532562524,0.115564243839767,1.10201534067391e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41771,0.0512925231353605,0.00618291620907563,0.0391740073655723,0.0634110389051488,1.18225340787962e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41984,0.04269824808739,0.00515633797403768,0.0325918256582761,0.0528046705165038,1.33959252788028e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39675,0.0609038893134882,0.0073555765656226,0.0464869592448679,0.0753208193821086,1.37367731166641e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,41620,0.0812946709035334,0.00984402361784142,0.0620003846125642,0.100588957194503,1.61966291038263e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,39886,0.0398975373779967,0.00483416612789515,0.0304225717673222,0.0493725029886712,1.71283367245976e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41828,0.0855360597722876,0.0103737439855177,0.0652035215606728,0.105868597983902,1.7998278478218e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39597,0.0498621650332225,0.00605974137864575,0.0379850719310768,0.0617392581353682,2.11068664226654e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41828,0.0512007031387605,0.00624472937283054,0.0389610335680126,0.0634403727095083,2.64537385284119e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,39858,0.0363428796685953,0.00443470474543347,0.0276508583675457,0.0450349009696449,2.77455291504903e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,41668,0.0744165105260547,0.00909194961251396,0.0565962892855274,0.0922367317665821,2.97681724853624e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41766,0.0525003602771353,0.00641731445401924,0.0399224239472576,0.065078296607013,3.07050938981421e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39597,-0.0289901779255062,0.00354847877262416,-0.0359451963198495,-0.0220351595311628,3.42860200368455e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,41924,0.0559525633681389,0.00685875724179314,0.0425093991742244,0.0693957275620535,3.71474894671362e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,41828,0.0501917466094016,0.00615477995059612,0.0381283779062333,0.06225511531257,3.80708317745511e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,39904,-0.0456579579740035,0.00560180318493941,-0.0566374922164848,-0.0346784237315223,4.00319318513207e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42048,0.0903553992471492,0.0111073343755378,0.0685850238710951,0.112125774623203,4.4876860429431e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,39858,0.0555397120511177,0.00682694615142964,0.0421588975943156,0.0689205265079198,4.53796133705336e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42011,0.0177671351526878,0.00218718649541674,0.013480249621671,0.0220540206837046,4.93176239553608e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,41943,0.0536840612636442,0.00661190980345717,0.0407247180488682,0.0666434044784203,5.09778076631274e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,39575,0.0279032170507506,0.00343626564691237,0.0211681363828024,0.0346382977186989,5.15132402947278e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42108,0.0538515315843165,0.00663591069256255,0.0408451466268939,0.0668579165417391,5.26790614306454e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41842,0.0525642735267424,0.00648322532825934,0.0398571518833541,0.0652713951701307,5.60783355541177e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42049,0.0392397111321506,0.00484019131735054,0.0297529361501435,0.0487264861141576,5.63177029054004e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41766,0.0338783495714246,0.00418394837149762,0.0256778107632893,0.0420788883795599,6.11459314903188e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,39917,0.0364252643577979,0.00450576240582518,0.0275939700423805,0.0452565586732152,6.89645432291402e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39904,-0.0291301766307334,0.00360379230467111,-0.0361936095478887,-0.022066743713578,6.95089612493111e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42070,0.0277839695238563,0.00343949596535618,0.0210425574317582,0.0345253816159545,7.14521140623301e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39872,0.0835613990424732,0.0103458846547758,0.0632834651191125,0.103839332965834,7.32666627664333e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39512,0.058798425859999,0.0072876171800879,0.0445146961870267,0.0730821555329713,7.87761662159542e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,42074,0.0547225858453907,0.00679064489215496,0.041412921856767,0.0680322498340144,8.36836788925416e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42164,0.0312179179236347,0.00387820802193587,0.0236166302006404,0.038819205646629,8.99586132461953e-16
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42032,0.0559967459230707,0.00696806198511036,0.0423393444322544,0.069654147413887,1.00360515451006e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41943,0.0636848750955976,0.00793393587687464,0.0481343607769233,0.0792353894142719,1.08288067533965e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39872,0.0527601510210204,0.00657321535222142,0.0398766489306664,0.0656436531113744,1.10204286312407e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,39675,0.0445951729090129,0.00556850246057627,0.0336809080862834,0.0555094377317423,1.27767668357672e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,39512,0.0344931055947879,0.00430764806147417,0.0260501153942985,0.0429360957952773,1.2904729956516e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,42011,0.0729082113370454,0.00911194185756111,0.0550488052962256,0.0907676173778651,1.33071687465813e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42063,0.0230506430263889,0.00288200832551438,0.0174019067083807,0.028699379344397,1.36597795401074e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,42142,0.0879394538243298,0.0110125075333228,0.0663549390590172,0.109523968589642,1.51283901253359e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39869,0.066213377559314,0.0082960273484684,0.0499531639563159,0.0824735911623121,1.58784962869182e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,41828,0.04687580921229,0.0058771296085971,0.0353566351794397,0.0583949832451403,1.63555464308509e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41771,0.03103733917806,0.0038956348849965,0.0234018948034668,0.0386727835526531,1.75572584421947e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42088,0.0610394764019792,0.00767128457995214,0.046003758625273,0.0760751941786854,1.90440133750504e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39869,0.0354010002693892,0.00445027962530866,0.0266784522037843,0.0441235483349942,1.96599524744442e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,42236,-0.013851986955026,0.00174219393214171,-0.0172666870620237,-0.0104372868480282,1.99671225849974e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42063,-0.024745341557643,0.00311482399297459,-0.0308503965838732,-0.0186402865314128,2.10589600912027e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41757,0.0338394833637674,0.0042622293389053,0.025485513859513,0.0421934528680218,2.19586339856773e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,39764,-0.0955541790452269,0.0120355976113132,-0.119143950363401,-0.071964407727053,2.22798577926935e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42048,-0.0454386596160095,0.00573174690526825,-0.0566728835503353,-0.0342044356816837,2.41059669925919e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39869,0.0890759486511015,0.0112354938230205,0.0670543807579813,0.111097516544222,2.43529757189733e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39872,0.0573829877026097,0.00723927689484875,0.0431940049887062,0.0715719704165133,2.46398973071445e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,39675,0.0575806992480102,0.00726960221904999,0.0433322788986722,0.0718291195973482,2.58657270544847e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39895,0.0933681451631601,0.0117935077596345,0.0702528699542765,0.116483420372044,2.66249379363244e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,39597,0.0402608241486767,0.00508904920236953,0.0302862877120324,0.050235360585321,2.79205696138244e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,41766,0.0615292029779724,0.00778946357771028,0.0462618543656603,0.0767965515902846,3.0328972052901e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,41888,0.041160122188713,0.00521407446311528,0.0309405362410071,0.051379708136419,3.15388048714412e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,41995,0.0766693295758464,0.00971440159792557,0.0576291024439122,0.0957095567077805,3.19516783611531e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39872,0.0350365588011375,0.00444558615982955,0.0263232099278716,0.0437499076744034,3.54069620332701e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,39872,-0.0421209037100228,0.00535646240809217,-0.0526195700298835,-0.0316222373901621,4.07366831121907e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42063,-0.034002406396516,0.00432909612669408,-0.0424874348048364,-0.0255173779881956,4.32029233667304e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42108,-0.03270067928796,0.00416791423107783,-0.0408697911808726,-0.0245315673950475,4.62348404822249e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41771,0.0661435517378374,0.00844927492336036,0.0495829728880511,0.0827041305876237,5.32109755378592e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42111,0.0731152078977418,0.00934608969470731,0.0547968720961155,0.0914335436993681,5.53579386871121e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42145,0.0567587245446228,0.00725948841816634,0.0425301272450168,0.0709873218442288,5.73638391546854e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,42095,-0.0315390170050793,0.00404045411140464,-0.0394583070634325,-0.0236197269467262,6.3458463444528e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,39575,0.0632151806394931,0.00811318298139659,0.0473133419959558,0.0791170192830305,7.21004408482138e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42092,0.0646972928491337,0.00830575718364619,0.0484180087691872,0.0809765769290802,7.2197888205793e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,42009,0.0745305322568352,0.00957507396648376,0.0557633872825271,0.0932976772311434,7.55121787111518e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42057,0.0482004787155152,0.00619735493333438,0.0360536630461798,0.0603472943848506,7.92797648676704e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,42092,0.074023096419732,0.0095188903163947,0.0553660713995984,0.0926801214398656,7.99838879682181e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,42236,0.0490440476293643,0.00631027611910395,0.0366759064359206,0.0614121888228081,8.27063344229232e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39675,0.0245565716357428,0.00316294908204816,0.0183571914349284,0.0307559518365572,8.96663466857367e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39917,-0.0207713244627166,0.00267664360942113,-0.026017545937182,-0.0155251029882512,9.20751345490625e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39575,0.0642939803375735,0.00828751110120701,0.0480504585792078,0.0805375020959393,9.39741158863285e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39872,0.0664705874431191,0.00857478786563144,0.0496640032264815,0.0832771716597567,9.83353474844748e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,39512,0.0561017347271586,0.00723729671972784,0.041916633156492,0.0702868362978251,9.86879978928362e-15
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41828,-0.0186529079710606,0.00240984593774412,-0.023376206009039,-0.0139296099330821,1.06368787748793e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42222,0.0564330104220077,0.0072919349168338,0.0421408179850135,0.070725202859002,1.07149339840652e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,39858,0.0279532010188632,0.00362633528734756,0.020845583855662,0.0350608181820644,1.38130854079389e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39872,0.0999831065237817,0.0130095255885185,0.0744844363702854,0.125481776677278,1.65202828004386e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42048,0.0874198514295816,0.011378365286198,0.0651182554686335,0.10972144739053,1.66149158186325e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,42072,-0.026299992047211,0.00342538876754369,-0.0330137540315966,-0.0195862300628253,1.72753576582436e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39590,0.0409253823005584,0.00533047389362492,0.0304776534690536,0.0513731111320633,1.75810682870616e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39868,0.0700728664645347,0.00913170849442294,0.0521747178154658,0.0879710151136037,1.81060062033253e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,39868,0.0604741673329525,0.00789000080455649,0.0450097657560218,0.0759385689098832,1.94024408999853e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,39869,0.0585146847584119,0.00763592402754975,0.0435482736644144,0.0734810958524095,1.96414598247461e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,42222,0.0409934746408408,0.00536289459567173,0.0304822012333242,0.0515047480483574,2.24787903776836e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,41924,0.0576499206353428,0.00754606805834385,0.0428596272409888,0.0724402140296967,2.32506380922191e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39802,-0.0348809091053621,0.00456604410532417,-0.0438303555517975,-0.0259314626589267,2.363884800433e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39575,0.0647413239686266,0.00847614964684491,0.0481280706608105,0.0813545772764426,2.38861838466571e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39927,0.0399950808420856,0.00523928291428697,0.0297260863300831,0.0502640753540881,2.4643978445714e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42092,0.0433796900423335,0.00569535089327343,0.0322168022915176,0.0545425777931495,2.77564064247394e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42048,0.060343729286438,0.00794439406813279,0.0447727169128977,0.0759147416599782,3.2615362298848e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,39673,-0.0257890367857457,0.00339449341939349,-0.0324422438877569,-0.0191358296837344,3.26712131329177e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39895,0.0760453631642706,0.0100159633684946,0.0564140749620211,0.0956766513665201,3.38728949445449e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39597,0.0652620402705711,0.00860079511245468,0.0484044818501599,0.0821195986909822,3.51377591240475e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,42069,0.0872149494317498,0.0115027408421931,0.0646695773810513,0.109760321482448,3.6221329864998e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42111,0.090367064425527,0.0119252175868663,0.0669936379552691,0.113740490895785,3.74261483964905e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,41771,0.0794533518007466,0.0104982333526046,0.0588768144296415,0.100029889171852,4.03358087017678e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,41995,-0.0643867710086299,0.00850837953145495,-0.0810631948902816,-0.0477103471269782,4.05420091355078e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39512,0.0354337656930463,0.00468678173815538,0.0262476734862618,0.0446198578998309,4.34202574976143e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,41943,0.0794115912616164,0.0105239775056152,0.0587845953506106,0.100038587172622,4.78682306479725e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,39868,0.0627394283215679,0.00831587251329367,0.0464403181955123,0.0790385384476235,4.88819451641146e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39675,0.0432533366668161,0.00573302166965718,0.0320166141942881,0.0544900591393442,4.8923528330976e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39869,-0.0250747480933636,0.0033239194853121,-0.0315896302845754,-0.0185598659021519,4.91849565944511e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,39917,0.0176579277142981,0.00234156693159421,0.0130684565283734,0.0222473989002227,5.01763999227763e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,41809,0.0425835453683395,0.00565868587154567,0.03149252106011,0.0536745696765691,5.59821321717708e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,39590,0.0677149063092229,0.00899913347242115,0.0500766047032775,0.0853532079151684,5.70121692517158e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39590,0.0653887356941736,0.00869675593753074,0.0483430940566133,0.0824343773317338,5.9609226449874e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,42072,-0.0312932291329211,0.00416617287205393,-0.0394589279621468,-0.0231275303036954,6.22405522476105e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39917,0.0256107054420239,0.00341461827417709,0.0189180536246368,0.032303357259411,6.84280367939232e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42142,0.0377992550740683,0.00504124081653426,0.0279184230736612,0.0476800870744754,6.8819376767915e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,39895,-0.0228264123043523,0.00305026876030028,-0.0288049390745409,-0.0168478855341637,7.77967904849398e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39575,0.0257517184385723,0.00344123803313499,0.0190068918936277,0.0324965449835169,7.80408558768604e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42092,-0.0641710289546497,0.00857849808977357,-0.0809848852106059,-0.0473571726986935,7.86416336053845e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42056,0.10116414937486,0.0135288960118626,0.0746475131916089,0.12768078555811,8.03498928664102e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41828,0.0594696919276654,0.00795880906485,0.0438704261605594,0.0750689576947714,8.38218822513395e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42063,0.0314810996158764,0.00421539113682686,0.0232189329876957,0.039743266244057,8.63408994527252e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,39872,0.0451429608631194,0.00604612925492872,0.0332925475234591,0.0569933742027797,8.84803855696045e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39827,-0.0222691262931577,0.00298492868830091,-0.0281195865222275,-0.0164186660640879,9.2541095418062e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39895,0.0813216110537974,0.0109042093652057,0.0599493606979943,0.102693861409601,9.44097002927366e-14
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39696,0.0464435693530191,0.00624410292430542,0.0342051276213804,0.0586820110846577,1.0977346811312e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42026,0.0675020056557577,0.00908141954713908,0.0497024233433651,0.0853015879681503,1.12599863932576e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39575,0.0496798125943378,0.00668493087458346,0.0365773480801542,0.0627822771085214,1.15261184272189e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39652,0.0699098275689216,0.00942652186539333,0.0514338447127507,0.0883858104250925,1.29265261788992e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41771,0.0732769986526961,0.00990387856768663,0.0538653966600303,0.0926886006453619,1.45720427725412e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,39590,0.0403837864162404,0.00545768471891718,0.0296867243671627,0.0510808484653181,1.46744467592751e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39927,0.0536704018104408,0.0072627995180827,0.0394353147549987,0.0679054888658829,1.57434132505491e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,41919,0.0371009540842455,0.00502166344524812,0.0272584937315592,0.0469434144369318,1.57709606600655e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,42201,0.0548778581222578,0.00743118823832627,0.0403127291751383,0.0694429870693773,1.6155548635653e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39872,0.061897469160304,0.00838001984799021,0.0454726302582431,0.0783223080623648,1.61607566534822e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39590,0.0588902460954901,0.00798589548081472,0.0432378909530932,0.0745426012378869,1.77124619481671e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42048,0.0771061798152306,0.0104610795054437,0.0566024639845611,0.0976098956459002,1.79550100427676e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,42048,0.0474797308757567,0.00644518627334708,0.0348471657799965,0.060112295971517,1.85093306392589e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39868,0.0272568472931727,0.00370231002050096,0.0200003196529908,0.0345133749333546,1.93624575610918e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,42095,-0.0219349435529626,0.00298403162362511,-0.0277836455352678,-0.0160862415706574,2.08396461292034e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,39590,0.106000552965848,0.0144185342952248,0.0777402257472074,0.134260880184489,2.09631876849813e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,39804,0.076796338673353,0.0104518746230917,0.0563106644120934,0.0972820129346127,2.15804291691008e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39872,0.0857292553775295,0.0116748666834115,0.0628465166780429,0.108611994077016,2.23150897347816e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39675,0.0579169972564776,0.00789965534387619,0.0424336727824802,0.0734003217304749,2.43307126190892e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39872,0.0393565675983173,0.0053687910942565,0.0288337370535745,0.04987939814306,2.44770171886423e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41765,0.0635106335756315,0.00866684860428232,0.0465236103112381,0.0804976568400249,2.47230979817598e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39575,0.0392162333159141,0.00535080067661924,0.0287286639897404,0.0497038026420878,2.48101043102481e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,42236,-0.0212966791388894,0.00291288772211033,-0.0270059390742256,-0.0155874192035531,2.79528568028007e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41842,0.043650740825563,0.00598076641844355,0.0319284386454136,0.0553730430057123,3.07530289901108e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,39429,0.056302878750475,0.00771331465067655,0.0411847820351489,0.071420975465801,3.09226721183669e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39858,0.023098823000471,0.00316813133959681,0.0168892855748613,0.0293083604260807,3.28306673969798e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,39675,0.0433488349769031,0.00594745186992552,0.0316918293118491,0.0550058406419572,3.34420077809879e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,41766,0.040987342677435,0.00562717831503887,0.0299580731799588,0.0520166121749112,3.42952514416591e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,39917,0.0554658542528081,0.00761835648562371,0.0405338755409856,0.0703978329646306,3.54493185537916e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39869,0.116200640591674,0.0159896013943981,0.0848610218586539,0.147540259324695,3.91091046345824e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,39858,0.0291028633052413,0.00401346641233487,0.021236469137065,0.0369692574734177,4.3984822495352e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,42187,0.0877748349315219,0.0121085970166997,0.0640419847787904,0.111507685084253,4.42635150656095e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39917,0.0131001547796408,0.00180801571085549,0.00955644398636407,0.0166438655729176,4.58528304454156e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,41842,0.0350754108500047,0.00484286305947735,0.025583399253429,0.0445674224465803,4.64133871067414e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42046,0.077699337662196,0.0107300344204836,0.0566684701980482,0.0987302051263438,4.68574889509285e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39759,0.0261656169736079,0.00361447143092859,0.0190812529689879,0.0332499809782279,4.81263960729608e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42222,0.0436507993267145,0.00603246210311858,0.0318271736046021,0.0554744250488269,4.86876959904662e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42063,-0.0411349417136225,0.00568540583426158,-0.0522783371487752,-0.0299915462784698,4.90054976500463e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,39895,0.0514092462241034,0.00710709261673719,0.0374793446952985,0.0653391477529083,5.01113778840215e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42236,-0.0193343334667792,0.00267475548916386,-0.0245768542255404,-0.014091812708018,5.14526252824763e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41766,0.0392027354293362,0.00543411402521536,0.0285518719399141,0.0498535989187583,5.72232482019943e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39597,0.0386198462745772,0.0053546377260761,0.028124756331468,0.0491149362176864,5.85832081956344e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39597,0.0437338625659328,0.00606653769316818,0.0318434486873232,0.0556242764445424,6.00482337316636e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39597,0.0460206075303534,0.00638663454893487,0.033502803814441,0.0585384112462657,6.14973656959442e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,39597,0.033491504860553,0.0046597477320582,0.0243583993057189,0.0426246104153871,7.03131840204527e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39512,0.0528516216040187,0.00736923623358394,0.0384079185861942,0.0672953246218432,7.87391091408462e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,39868,0.107684820502565,0.0150229180131522,0.0782399011967871,0.137129739808344,8.0838351989744e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39858,0.0675418648324562,0.0094432439209857,0.0490331067473242,0.0860506229175882,9.05631171255514e-13
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,39839,0.0354607226769352,0.00497281485328627,0.0257140055644941,0.0452074397893763,1.05824531931709e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,41766,0.0530167894973822,0.00744249223242106,0.0384295047218369,0.0676040742729275,1.10668748730398e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39579,0.0662790775031048,0.00931176219984694,0.0480280235914048,0.0845301314148048,1.16525166934598e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42149,0.0455393382973847,0.00640130769951553,0.0329927752063342,0.0580859013884351,1.18329062088042e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,39927,-0.0384364840083853,0.00540253359080142,-0.0490254498463561,-0.0278475181704145,1.19071220298532e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39675,-0.0325178432545521,0.00457994607850266,-0.0414945375684173,-0.0235411489406869,1.32350250641966e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39917,0.0255337324651533,0.00359647279792294,0.0184846457812243,0.0325828191490822,1.32554311213929e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,42072,0.0424201654859134,0.00597620098279813,0.0307068115596291,0.0541335194121977,1.3273538259899e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41771,0.0757317074116549,0.0106857713239939,0.054787595616627,0.0966758192066829,1.43866727622231e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42108,0.055015995894481,0.00776612527590721,0.0397943903537029,0.0702376014352591,1.46883003290267e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,42007,0.0804729034152395,0.0113608702511313,0.0582055977230222,0.102740209107457,1.47740436687045e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,42026,0.0371932569259466,0.00525590734854124,0.0268916785228058,0.0474948353290875,1.55212381483673e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,42111,0.0714723241827754,0.0101143330951899,0.0516482313162032,0.0912964170493475,1.66750871431626e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,39868,0.0485737782127142,0.00688279540001979,0.0350834992286754,0.062064057196753,1.79770157189717e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,42002,0.0297336498088012,0.00421472025539747,0.0214727981082222,0.0379945015093803,1.81446224416663e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39904,-0.0169376253581445,0.00240114806231244,-0.0216438755602769,-0.0122313751560122,1.84042197508565e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39872,0.0513997221230084,0.00730279112835552,0.0370862515114316,0.0657131927345852,2.05800486616467e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41943,0.0615592653839224,0.00876366339685774,0.0443824851260813,0.0787360456417636,2.25447884040411e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39895,0.019592241252717,0.00278995552118879,0.014123928431187,0.0250605540742471,2.30577269550036e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,39927,0.0560992674416677,0.00801241871665676,0.0403949267570205,0.071803608126315,2.67486112921922e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39904,0.0422501565713303,0.00603972778283301,0.0304122901169776,0.054088023025683,2.79495306743958e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39872,0.0410720206725782,0.00587785393818087,0.0295514269537437,0.0525926143914127,2.95424231212082e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42236,0.0548027084838082,0.00784640699148288,0.0394237507805018,0.0701816661871146,2.99260174565905e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42077,-0.0237639048715163,0.00340504435894897,-0.0304377918150563,-0.0170900179279763,3.11121337908977e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39601,0.0300578475857367,0.00430745902138941,0.0216152279038134,0.0385004672676599,3.16421341547998e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,42077,0.030778784088604,0.00441844162899569,0.0221186384957724,0.0394389296814355,3.41253345256509e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39696,0.0379921779789845,0.00546107869760644,0.0272884637316759,0.0486958922262932,3.67428167448784e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39868,0.0235078554214609,0.00338180916987602,0.0168795094485039,0.0301362013944179,3.82023037114522e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41995,0.0157306511793725,0.00226427246479953,0.0112926771483654,0.0201686252103796,3.89455736768833e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42048,0.0287354735495428,0.00413800359097448,0.0206249865112328,0.0368459605878528,3.97852695845523e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42023,0.0514355441451542,0.00741611285907966,0.036899962941358,0.0659711253489503,4.22878056826148e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,39675,0.0445130578551068,0.00641695206003642,0.0319358318174354,0.0570902838927782,4.2347273548764e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39858,0.0268992198980445,0.00387919909515252,0.0192959896715456,0.0345024501245434,4.30833999881376e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42174,0.0350552937791532,0.00506125327892446,0.0251352373524613,0.0449753502058451,4.51730059511855e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39872,0.0581143600854288,0.00839651178880971,0.0416571969793618,0.0745715231914958,4.71971893793744e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,39597,0.0343123547844721,0.00495755246063564,0.0245955519616262,0.0440291576073179,4.72665939049683e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39895,0.036675779860165,0.00530517807707884,0.0262776308290905,0.0470739288912395,4.99370232321756e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,41995,-0.034302023886758,0.00496288335212384,-0.0440292752569208,-0.0245747725165953,5.00504323450523e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39872,0.0471594791440052,0.00684226526103145,0.0337486392323836,0.0605703190556268,5.77956000695732e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39872,0.0441855428594269,0.00641190713010175,0.0316182048844274,0.0567528808344263,5.82865024969952e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42108,-0.0176100798314602,0.00255762754324428,-0.022623029816219,-0.0125971298467014,6.02059399420671e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,39852,0.0733299056677523,0.0106631515110122,0.0524301287061683,0.0942296826293362,6.43899499983333e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42174,0.0467541720333603,0.00680090327510378,0.0334244016141569,0.0600839424525637,6.48345168810969e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42072,0.0605089097168528,0.00880886671157086,0.0432435309621739,0.0777742884715317,6.74477495327156e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,39845,0.0245018245428168,0.00356682273808419,0.0175108519761717,0.0314927971094618,6.78902009912185e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,39858,0.0303236496924072,0.00441464564931414,0.0216709442197515,0.0389763551650629,6.81209966593533e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,39895,0.0407044667329956,0.00592727870398259,0.0290870004731897,0.0523219329928014,6.88570775842808e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41828,0.0280972598235496,0.00410405672004541,0.0200533086522606,0.0361412109948387,7.91743354296056e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,39297,0.0182116272906233,0.00266037480375657,0.0129972926752604,0.0234259619059862,8.03777645899834e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42063,-0.0333962047133875,0.00488551433493371,-0.0429718128098576,-0.0238205966169174,8.50845771807164e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39353,0.0369912208730205,0.00541307561837383,0.0263815926610078,0.0476008490850332,8.72430513818661e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,41747,0.0355431706508524,0.00520261845760896,0.0253460384739388,0.0457403028277659,8.75564720518901e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42222,0.0407880840545098,0.00598173604265336,0.0290638814109092,0.0525122866981104,9.56922496171501e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,39868,0.0513805766507411,0.00753618845355336,0.0366096472817765,0.0661515060197057,9.71385542126699e-12
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42174,0.0481384872180454,0.00707186359752191,0.0342776345669024,0.0619993398691883,1.03808557869041e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42048,0.0541027404235175,0.00794859464478783,0.0385234949197334,0.0696819859273017,1.04183170721784e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39675,0.0297802562308273,0.00437657973132938,0.0212021599574217,0.0383583525042328,1.0666481610073e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,41888,0.0299178540286191,0.00440094831417911,0.0212919953328281,0.0385437127244102,1.10574318160106e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,42111,0.0575710803474893,0.00847485302872776,0.0409603684111829,0.0741817922837957,1.1429087729262e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39904,-0.0202099771495711,0.00297871622983559,-0.0260482609600488,-0.0143716933390933,1.22059897662792e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,39927,0.0161898426281258,0.0023864101183433,0.0115124787961729,0.0208672064600786,1.22563768727348e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41771,0.0385410967320466,0.00569792682278897,0.0273731601593802,0.0497090333047129,1.39847010951013e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41771,0.0422090371669881,0.00624135079598178,0.0299759896068638,0.0544420847271124,1.4105641136108e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,39869,0.0439404299658373,0.00649980364762809,0.0312008148164863,0.0566800451151884,1.44538050211868e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41706,0.0242294339810183,0.0035878405887893,0.0171972664269913,0.0312616015350453,1.50709311905598e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,42063,0.0182849068350518,0.00271241360324659,0.0129685761726885,0.0236012374974152,1.6348980993976e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,41924,0.0589055814547818,0.00874618430469329,0.041763060217583,0.0760481026919807,1.70650487907789e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39868,0.0327047689608679,0.0048597670601117,0.023179625523049,0.0422299123986869,1.78262284773334e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41943,0.0579059128706254,0.0086123883028493,0.0410256317970408,0.07478619394421,1.84551827003064e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42222,0.0258083106087647,0.00384191727897698,0.0182781527419699,0.0333384684755596,1.92127809478836e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,39868,0.0344440171854494,0.00513037475269915,0.024388482670159,0.0444995517007397,1.98809773985932e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,41919,0.0235854543776186,0.00351746386262586,0.0166912252068719,0.0304796835483653,2.09176480398373e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39597,0.0326697769849289,0.00487425138617613,0.0231162442680237,0.0422233097018341,2.14876956806431e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,39675,0.0227045370932396,0.00339442505326517,0.0160514639888399,0.0293576101976393,2.35894001993767e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39597,0.0253384865582341,0.00379305658321989,0.0179040956551231,0.0327728774613451,2.50088528918197e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,41995,0.0405038895048325,0.00606661059531626,0.0286133327380126,0.0523944462716524,2.54312236651608e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,39869,0.0422372164828995,0.00632721303460187,0.0298358789350798,0.0546385540307192,2.57987869946689e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,39597,0.0420339798530585,0.00629661749163964,0.0296926095694448,0.0543753501366722,2.58000697365055e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42174,0.0501756051304881,0.0075196652926947,0.0354370611568065,0.0649141491041697,2.61084654804994e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39869,0.04693546843764,0.0070336085402825,0.0331495956986863,0.0607213411765937,2.62328514762923e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42072,0.0941226033911701,0.0141138025437852,0.0664595504053512,0.121785656376989,2.67898992577394e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,41995,0.0560091094282398,0.00840355132674443,0.0395381488278207,0.0724800700286589,2.7514731832318e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39868,-0.0518114966881317,0.00777272543840784,-0.067046038547411,-0.0365769548288523,2.75503513837713e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39675,0.0312066655708275,0.00468736938467267,0.0220194215768691,0.040393909564786,2.9148309278382e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39512,0.0205607600842011,0.00309016511557808,0.014504036457668,0.0266174837107341,2.9968380714607e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,41980,0.0501918442546231,0.00754784394332725,0.0353980701257017,0.0649856183835445,3.04833692726067e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39872,0.0570967615828404,0.00858709288120023,0.040266059535688,0.0739274636299929,3.08439607507627e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,42236,-0.0176014568105818,0.00264800724937881,-0.0227915510193642,-0.0124113626017993,3.10378492723675e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,39868,0.0678120491475496,0.0102002819990685,0.0478194964293753,0.0878046018657239,3.10709350718856e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39868,0.0496271868362173,0.00746565074122815,0.0349945113834102,0.0642598622890245,3.12086364962442e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39575,-0.0245847446107897,0.00370001127967881,-0.0318367667189601,-0.0173327225026192,3.18644832263768e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41995,0.0846107130044985,0.0127549777245455,0.0596109566643892,0.109610469344608,3.40305591170861e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,42041,0.0293121295474591,0.00442943513971411,0.0206304366736195,0.0379938224212988,3.78973332530941e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,41828,-0.0167747373395768,0.00253651044323659,-0.0217462978083205,-0.0118031768708331,3.90253800075762e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39887,0.0284090527552675,0.0042998342611895,0.0199813776033361,0.0368367279071989,4.09800645343738e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42012,0.0459299766689088,0.00695831399047008,0.0322916812475874,0.0595682720902301,4.24513110149211e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,42108,0.0503726853339849,0.00763799103682365,0.0354022229018105,0.0653431477661592,4.41024665542468e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39590,0.0339421979693927,0.00514898239783018,0.0238501924696456,0.0440342034691399,4.53758558712974e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,42092,0.041910518433794,0.00636505049548351,0.0294350194626463,0.0543860174049417,4.73390126899417e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,41943,-0.018728450412326,0.0028482153846774,-0.0243109525662937,-0.0131459482583583,5.02939990309873e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39869,0.0355931347376237,0.0054133750261554,0.0249829196863592,0.0462033497888883,5.0791442337886e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,39836,0.0632401909803254,0.00962952172963703,0.0443663283902368,0.082114053570414,5.34878897320738e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41828,0.0348528565430909,0.0053080725204687,0.0244490344029723,0.0452566786832096,5.36113377287038e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42048,0.0603545689155669,0.00919591144743802,0.0423305824785884,0.0783785553525455,5.45973072015353e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39868,0.0385213121079007,0.00587426622551491,0.0270077503058915,0.05003487390991,5.70577691992619e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,39597,0.0325664970588935,0.00496752322699435,0.0228301515339846,0.0423028425838025,5.77914246989937e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,42029,0.0474189455346431,0.00723470804782591,0.0332389177609043,0.0615989733083819,5.79181297951955e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41766,0.0461805914156359,0.00704721974046892,0.0323680407243168,0.0599931421069549,5.84829366108908e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41995,0.0644215568895044,0.00984293742680054,0.0451293995329754,0.0837137142460335,6.16807706253995e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,39675,0.0386690642782675,0.00590803982749427,0.0270893062163787,0.0502488223401563,6.20574910004149e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,42187,0.0287546559373218,0.00439495524509813,0.0201405436569294,0.0373687682177141,6.26034262820819e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42063,0.0548671548082151,0.00838726927491373,0.0384281070293842,0.071306202587046,6.30140108434213e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,41671,-0.0654280009542326,0.0100117932717367,-0.0850511157668364,-0.0458048861416287,6.59281569258272e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41771,0.030996876933268,0.00474697942209125,0.0216927972659691,0.0403009566005668,6.82690963488365e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42108,0.039507335822277,0.00605152802871628,0.0276463408859931,0.0513683307585609,6.88103255389955e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41943,0.0410476736858475,0.00629428757793959,0.0287108700330859,0.0533844773386091,7.21553571796249e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42236,-0.0167034260046823,0.00256183579358236,-0.0217246241601037,-0.0116822278492608,7.27344436790026e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,39895,0.0382273441506565,0.0058647438733784,0.0267324461588348,0.0497222421424782,7.42062632966326e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,41995,0.0675213570802607,0.0103704085794199,0.0471953562645977,0.0878473578959237,7.7332449159373e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41771,0.0409757077550404,0.00629617320735773,0.0286352082686193,0.0533162072414616,7.88976306917996e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39575,0.0649737867684293,0.010007379950664,0.0453593220651278,0.0845882514717308,8.80177311714024e-11
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39575,0.0300753076553501,0.00464676262436367,0.0209676529115974,0.0391829623991029,1.0062869510874e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41766,0.0439528071689817,0.00679820095229791,0.0306283333024778,0.0572772810354856,1.04624781273833e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,39575,0.0620543680715088,0.0096067347523893,0.0432251679568258,0.0808835681861918,1.0951890031409e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,39868,0.0158638511754658,0.00245789605948226,0.0110463748988806,0.020681327452051,1.13228389194749e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41828,0.0541291023955902,0.00839276722534093,0.037679278633922,0.0705789261572584,1.16126938879645e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42142,0.0226374094799358,0.00351249692370203,0.0157529155094798,0.0295219034503918,1.19656874837794e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42048,0.0262225120630353,0.00407115055417879,0.0182430569768448,0.0342019671492257,1.2268095512776e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41771,0.0318697664744925,0.00494910474989683,0.0221695211646947,0.0415700117842903,1.24027854168833e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39858,0.0591758593916482,0.00919577859660067,0.0411521333423108,0.0771995854409855,1.28393089830979e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,41682,0.0761859022406465,0.0118499914479038,0.0529599190027551,0.0994118854785379,1.32737334447535e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41828,0.0357768628553771,0.00556548188889168,0.0248685183531494,0.0466852073576048,1.33424804787857e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,41986,0.0390538917052361,0.00607685515205344,0.0271432556072113,0.0509645278032608,1.34855875230436e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,42063,-0.0347149961837584,0.00541905221171168,-0.0453363385187133,-0.0240936538488035,1.5425291773771e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42236,-0.0216555140232627,0.00338313192019803,-0.0282864525868508,-0.0150245754596745,1.59387540124406e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,42011,0.0544013815438888,0.00850367330970632,0.0377341818568645,0.0710685812309132,1.63295600685345e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,42222,0.0443204972446191,0.00693394234098754,0.0307299702562835,0.0579110242329547,1.6926462216459e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,42050,-0.0401609201171002,0.0062840844401792,-0.0524777256198514,-0.027844114614349,1.70356797243844e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39834,0.0318514626062645,0.0049876396095528,0.022075688971541,0.041627236240988,1.7691103187972e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,39846,0.0598664014090527,0.00937531455725408,0.0414907848768347,0.0782420179412707,1.77531732779327e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,41924,-0.0319433813682943,0.00500720471302956,-0.0417575026058322,-0.0221292601307563,1.8355988374525e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,39640,0.0454221475900287,0.00712526582427583,0.031456626574448,0.0593876686056093,1.90510942937874e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,39904,0.0594177535148629,0.00932791660588551,0.0411350369673273,0.0777004700623985,1.96516245385442e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,42063,0.062017765916946,0.00974477270007365,0.0429180114248017,0.0811175204090904,2.02659865126081e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42048,-0.0188745268793762,0.00296893462531647,-0.0246936387449965,-0.013055415013756,2.11907883350175e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,42056,0.0268917785066019,0.00423094739398707,0.0185991216143872,0.0351844353988165,2.13794424648702e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41995,-0.0185684057871769,0.00292155595648449,-0.0242946554618865,-0.0128421561124673,2.14261937684204e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,41842,0.0554380103554016,0.008725320967577,0.0383363812589506,0.0725396394518525,2.17087462944768e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,42063,0.0187479822173829,0.00295245932061656,0.0129611619489744,0.0245348024857913,2.22295740626716e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,42108,0.0372733658834712,0.00587087359249058,0.0257664536421897,0.0487802781247528,2.23851679695973e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42236,0.0248140468624246,0.00390921639342105,0.0171519827313193,0.0324761109935299,2.2565859008756e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,42187,0.0259059241465814,0.00408173841702015,0.0179057168492219,0.0339061314439409,2.26840026925941e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41943,0.0647169748696688,0.0101995095499063,0.0447259361518525,0.0847080135874852,2.29453295364939e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42198,0.0230165872425129,0.00363146123447786,0.0158989232229363,0.0301342512620896,2.3994696993094e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,39590,0.0300161817915436,0.00473715638296115,0.0207313552809398,0.0393010083021475,2.44511359398475e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39872,0.0330673199427358,0.00521882470403741,0.0228384235228225,0.0432962163626492,2.44540846965992e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42111,0.0449186748934069,0.00709563485094238,0.0310112305855598,0.058826119201254,2.52148734840203e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,39869,0.0545142752391343,0.00861660749695335,0.0376257245451057,0.0714028259331628,2.60036779326281e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,39590,0.0317653519897339,0.00502410493875688,0.0219181063097704,0.0416125976696974,2.67194681743065e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39744,0.0388340016154753,0.00615328353726909,0.0267735658824279,0.0508944373485227,2.87575718007311e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39512,0.0459751601438035,0.0072854650738671,0.031695648599024,0.060254671688583,2.88861884236188e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42063,0.0384266846082481,0.00609093561732646,0.0264884507982882,0.050364918418208,2.89950356372275e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41771,0.0308524107101821,0.00489184510658446,0.0212643943012766,0.0404404271190877,2.93766414213405e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39635,-0.0237346405819095,0.00376721847271244,-0.0311183887884259,-0.0163508923753932,3.08368840115905e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPART,Spartin,39675,0.0536103653227014,0.00852319435738508,0.0369049043822266,0.0703158262631761,3.29567924476257e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42063,-0.0194033855346299,0.00309225437912343,-0.0254642041177119,-0.013342566951548,3.6072851470977e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41873,-0.026401735443808,0.00420815820299596,-0.0346497255216801,-0.0181537453659359,3.62957368426567e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39675,0.0719433345682549,0.0114730637037763,0.0494561297088533,0.0944305394276566,3.72985218702039e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39869,0.0442506804375353,0.0070584602150825,0.0304160984159736,0.058085262459097,3.76251840088814e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,42048,0.0453503897539092,0.0072364334090512,0.0311669802721689,0.0595337992356496,3.79417072139078e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39858,0.0358097212057814,0.00571736989345088,0.0246036762146176,0.0470157661969451,3.90606749761126e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41771,0.0414666393535995,0.00663067607217442,0.0284705142521376,0.0544627644550614,4.13078821265391e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41943,-0.0248392294931169,0.00397443601167144,-0.0326291240759929,-0.0170493349102408,4.23621230001311e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39590,0.0298582094475843,0.00478027217701334,0.0204888759806382,0.0392275429145305,4.36294336054464e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42174,0.0207778721043079,0.00333275378559741,0.0142456746845369,0.0273100695240788,4.66808118422349e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39575,0.0427880698532363,0.00686414303417819,0.0293343495062471,0.0562417902002256,4.72684993439443e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42032,0.0232844667429833,0.00374655222808092,0.0159412243759447,0.0306277091100219,5.28739053495113e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,39512,0.0333013267464034,0.00536370766372584,0.0227884597255007,0.043814193767306,5.53881386279647e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39843,0.0308086247867758,0.00496580218456668,0.0210756525050251,0.0405415970685266,5.69239889998738e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41943,0.0535806091989748,0.00864693021574732,0.03663262597611,0.0705285924218395,5.94348665643568e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39872,0.0446714021414878,0.00721032775364909,0.0305391597443356,0.05880364453864,6.01364588943632e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39597,0.0343148959264865,0.0055459041191991,0.0234449238528563,0.0451848680001168,6.33286521013707e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42174,0.034383515066514,0.00556050967631664,0.0234849161009333,0.0452821140320946,6.44856306795756e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,41918,0.0349665100378482,0.00565545126427206,0.0238818255598749,0.0460511945158214,6.48152861672397e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,39917,0.0184168870570944,0.00297939776728811,0.0125772674332097,0.0242565066809791,6.57176233368278e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41995,0.0222402211076921,0.00360754055726922,0.0151694416154444,0.0293110005999398,7.2540857305144e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,42048,0.032210868975478,0.00522748952134802,0.0219649895136359,0.0424567484373201,7.39644431457559e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,42038,0.0445054458350648,0.00722757228922729,0.0303394041481793,0.0586714875219503,7.58969288661766e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,39927,0.0471100712331526,0.00765273186392219,0.0321107167798651,0.0621094256864401,7.71390036641831e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41995,0.0133904727311244,0.00217632879581946,0.00912486829131821,0.0176560771709305,7.83055064885775e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,39696,0.0363340945954161,0.00591369336179049,0.0247432556063067,0.0479249335845255,8.31958526508401e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,39898,0.0251501698734595,0.00409500808252314,0.0171239540317142,0.0331763857152049,8.44056666355336e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,41997,0.0296447438258975,0.00483215262530728,0.0201737246802952,0.0391157629714997,8.76158016502653e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,42174,-0.0194766068252626,0.00317510290315387,-0.0256998085154442,-0.0132534051350811,8.79852046500807e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39895,0.0596482056848175,0.00972910827476947,0.0405791534662693,0.0787172579033657,9.03001970570936e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,42225,-0.02966965703446,0.00484920191178689,-0.0391740927815624,-0.0201652212873577,9.7070994289177e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42070,-0.015971966638895,0.00261210267298108,-0.0210916878779379,-0.010852245399852,9.94743535048903e-10
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,39868,0.056563186328033,0.00926228731708366,0.0384091031865491,0.074717269469517,1.04980492458512e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42048,0.0412252184418261,0.0067537434369487,0.0279878813054066,0.0544625555782455,1.0625475664101e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42201,-0.0254032040233018,0.00416281475607441,-0.0335623209452077,-0.017244087101396,1.07318186938994e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39696,0.0705785804524013,0.0115698402498194,0.0479016935627552,0.0932554673420474,1.09452347915289e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39639,0.0362974520417481,0.00595984438264383,0.0246161570517661,0.04797874703173,1.16425153174479e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39872,0.0265125917215156,0.00435787368055206,0.0179711593076335,0.0350540241353976,1.21148339624699e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39580,0.017852638987828,0.00293676859116829,0.0120965725491381,0.0236087054265178,1.24946392289078e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41842,-0.0261653099089648,0.00430762087180679,-0.0346082468177061,-0.0177223730002235,1.28028778215182e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39597,0.0588918797049533,0.00969600045939529,0.0398877188045385,0.077896040605368,1.29022387334863e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42111,0.0182982175526256,0.00301331347514386,0.0123921231413437,0.0242043119639076,1.2934539620482e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42136,-0.0158777705320896,0.00261916694769389,-0.0210113377495696,-0.0107442033146095,1.37888790816032e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,41842,0.0359378141374422,0.00593668237439609,0.0243019166836259,0.0475737115912585,1.45546854100208e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39868,0.0660905093816326,0.0109216740693209,0.0446840282057636,0.0874969905575016,1.48233057493506e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39927,0.0163688643785179,0.00270685886142505,0.0110634210101248,0.021674307746911,1.52050349889471e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39575,0.0209400344096188,0.00346560985502479,0.0141474390937703,0.0277326297254674,1.56924871374032e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42088,0.0327397595219817,0.0054251418677035,0.0221064814612828,0.0433730375826805,1.63310182738927e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39868,0.025991660637701,0.00430678725917928,0.0175503576097097,0.0344329636656924,1.63914745047713e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39512,0.0796005745954493,0.0131921578927856,0.0537439451255895,0.105457204065309,1.65213035630034e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,41995,-0.0198091472812575,0.00328586402862377,-0.0262494407773601,-0.013368853785155,1.69737606750606e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39575,0.0347897920869891,0.00577652499924288,0.023467803088473,0.0461117810855051,1.77118446372909e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39597,0.024038536156509,0.00399338165942206,0.0162115081040418,0.0318655642089763,1.80434512931634e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,39575,0.0777708377765713,0.0129445714757787,0.0523994776840451,0.103142197869098,1.93799264428058e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39895,0.0589784892357786,0.00982586400705019,0.0397197957819602,0.078237182689597,2.00426710276945e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42016,-0.016998232366068,0.00283676081389994,-0.0225582835613119,-0.0114381811708242,2.12420769704084e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42111,0.0182276874391247,0.00304338951649484,0.0122626439867948,0.0241927308914546,2.1613530537041e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39512,0.0453003270723344,0.00757125208220129,0.0304606729912199,0.0601399811534489,2.25663615313968e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,41995,0.0209567827280667,0.00350646329857875,0.0140841146628523,0.027829450793281,2.33608835394888e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39696,0.0341406616173054,0.00571522279797297,0.0229388249332784,0.0453424983013324,2.39140637557733e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39575,0.041072882371071,0.00687937964059,0.0275892982755146,0.0545564664666274,2.43947596114201e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42236,-0.017625595762007,0.00295635126277526,-0.0234200442370465,-0.0118311472869675,2.5541635223657e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41995,0.0295357615084397,0.00495601612355124,0.0198219699062793,0.0392495531106001,2.59243851559191e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39512,0.0236322657015584,0.00397036145336782,0.0158503572529575,0.0314141741501593,2.727500208516e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39895,0.0194084684181898,0.00326111667933238,0.0130166797266983,0.0258002571096812,2.73619237585629e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41828,0.0239731649037341,0.00402920947250463,0.016075914337625,0.0318704154698431,2.75183861173025e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39904,0.0281439629978473,0.00473205535329318,0.0188691345053926,0.0374187914903019,2.80301700020013e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,42108,-0.0178800635152517,0.00300700691388001,-0.0237737970664566,-0.0119863299640469,2.81328786570239e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39869,0.057825491382949,0.00972703555033161,0.038760501704299,0.0768904810615989,2.84957970134578e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,41771,0.0289058230210456,0.00486301846209676,0.0193743068353359,0.0384373392067553,2.85169296902593e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39675,0.044839760260081,0.0075428666381016,0.0300557416494019,0.0596237788707601,2.85387992574041e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39575,0.0160987856570585,0.00270838776651741,0.0107903456346843,0.0214072256794326,2.86526853353749e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39696,0.02910679888757,0.00489799037893452,0.0195067377448583,0.0387068600302816,2.8896662258035e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39513,-0.0411013323501869,0.00691966015439685,-0.0546638662528047,-0.027538798447569,2.94092195155422e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42072,0.0435704418800004,0.00734692122694066,0.0291704762751967,0.0579704074848041,3.09533938391304e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,41995,0.0381134019054027,0.00645070263306016,0.0254700247446048,0.0507567790662006,3.53810934151385e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39696,0.022270867863225,0.0037716825879337,0.014878369990875,0.0296633657355751,3.63516741991323e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,39698,0.0158079030880812,0.00267872965424824,0.0105575929657546,0.0210582132104077,3.71260946121641e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,39917,-0.0195130802101482,0.00330664557410975,-0.0259941055354033,-0.0130320548848931,3.71273784442886e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41771,0.0543593234688827,0.00921498346259529,0.0362979558821959,0.0724206910555695,3.74653946011918e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,42048,0.0445364898798446,0.00755444229111476,0.0297297829892597,0.0593431967704295,3.82726987749626e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41995,0.0344933159531813,0.00585717818461311,0.0230132467113396,0.045973385195023,3.97691058344566e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,39526,0.0415263204956264,0.00705325382095568,0.0277019430065533,0.0553506979846996,4.03517993240099e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39564,0.0366787328955633,0.00623500770100688,0.0244581178015898,0.0488993479895367,4.15402257498982e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42032,0.0429451182517334,0.00730693595179667,0.0286235237862119,0.0572667127172549,4.26879561087343e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,41995,-0.0178516881897623,0.0030391635138996,-0.0238084486770055,-0.0118949277025191,4.35807242303499e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,39874,0.0207658709852484,0.00353951500036447,0.013828421584534,0.0277033203859627,4.56585925785172e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39597,0.0565448444404009,0.0096410186184515,0.037648447948236,0.0754412409325659,4.61986769019563e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41995,0.0557325998540537,0.00951011140496935,0.0370927815003138,0.0743724182077937,4.72747773522601e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,42236,0.036552697765231,0.00623893207618583,0.0243243908959068,0.0487810046345552,4.76959941089286e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,39869,0.0561445341832302,0.00958247542297398,0.0373628823542012,0.0749261860122592,4.78447351812267e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41995,0.0667310750278317,0.0113965892027985,0.0443937601903466,0.0890683898653168,4.87147037732797e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41771,0.0202325228292545,0.00345747527509915,0.0134558712900602,0.0270091743684488,4.97785535082316e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,41995,0.0855052376966389,0.0146185717533431,0.0568528370600864,0.114157638333191,5.05825613315545e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42070,0.0163690009329358,0.0028020159592714,0.0108770496527639,0.0218609522131078,5.28114349348958e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,39869,0.0661384595870692,0.0113242573809209,0.0439429151204643,0.0883340040536742,5.35068496927814e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,41576,0.0391120078844096,0.00669936740626087,0.0259812477681383,0.0522427680006809,5.40416055297639e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39868,0.0632991880723234,0.0108440900460251,0.0420447715821143,0.0845536045625326,5.4547006239068e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39858,0.0689678190364674,0.0118426006932162,0.0457563216777636,0.0921793163951711,5.9130872936098e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,42063,0.0321885909575812,0.0055280362598831,0.0213536398882104,0.0430235420269521,5.91935207043384e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,39789,0.0628012709107816,0.0107992882343646,0.0416346659714271,0.0839678758501361,6.2175364479597e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,39904,-0.0316510509157967,0.00544361660009647,-0.0423205394519858,-0.0209815623796076,6.2519957685881e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42063,-0.0336688670951229,0.00579254526142051,-0.0450222558075071,-0.0223154783827388,6.29603761617105e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39872,0.0728178980924006,0.0125371558671185,0.0482450725928483,0.0973907235919529,6.48673244409737e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39869,0.0575211082650552,0.00990627903674662,0.0381048013530319,0.0769374151770786,6.55030112515616e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,39917,-0.0173702236688398,0.00299362181832109,-0.0232377224327491,-0.0115027249049304,6.71207776620077e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39675,0.0551953193622726,0.00953198349302216,0.0365126317159492,0.0738780070085961,7.20682830934966e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39575,0.0575676277960445,0.00995209324048555,0.0380615250446928,0.0770737305473962,7.47267871770668e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39575,0.0498280843198112,0.00863295074807851,0.0329075008535774,0.0667486677860451,8.05304068749275e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,39590,0.0433825489247847,0.00751865167811236,0.0286459916356845,0.0581191062138849,8.14176973418349e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41771,0.0411162927284372,0.00713173518855549,0.0271380917588684,0.0550944936980059,8.33616345595107e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,42172,0.0324526844478197,0.00563182055357154,0.0214143161628195,0.04349105273282,8.4737555945144e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42048,0.0383839637620742,0.00666672561807859,0.0253171815506402,0.0514507459735082,8.72111865257619e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41943,0.0350552038408645,0.00610296458487268,0.0230933932545141,0.047017014427215,9.45036019368871e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41749,-0.0285594893918021,0.00497683309925191,-0.0383140822663359,-0.0188048965172684,9.76335450648026e-09
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39597,0.0506559981766425,0.00883672943448855,0.0333360084850449,0.06797598786824,1.01602553587193e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,39675,0.0465713941805912,0.00812699353351665,0.0306424868548985,0.0625003015062838,1.02773127311326e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,42236,-0.0184062805747229,0.00321421051630751,-0.0247061331866856,-0.0121064279627602,1.04666034333341e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39858,0.0348137999511794,0.00608110361285047,0.0228948368699924,0.0467327630323663,1.06131229284989e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42108,-0.0263183439630547,0.00460108653769311,-0.0353364735769332,-0.0173002143491762,1.08764097471301e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39675,-0.0186372761202014,0.003261263296539,-0.0250293521814179,-0.012245200058985,1.12706831295565e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42104,-0.0303678194393533,0.00532433383866184,-0.0408035137631305,-0.0199321251155761,1.19769190813534e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,42222,-0.0057341020431165,0.00100642063717373,-0.00770668649197702,-0.00376151759425598,1.24078268189534e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42236,0.0145189641022538,0.00254880746509007,0.00952330147067728,0.0195146267338304,1.24909374505537e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,39288,0.0772330039780993,0.0135582778265899,0.050658779437983,0.103807228518216,1.25616372396565e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41906,-0.0356014743384428,0.00625088395660399,-0.0478532068933866,-0.0233497417834989,1.25665164473073e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39869,0.0361716052088218,0.0063545344395385,0.0237167177073263,0.0486264927103172,1.28506100174431e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42155,-0.0119525631614453,0.00210158904220708,-0.0160716776841712,-0.00783344863871945,1.31657459679798e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41890,0.0728456460312862,0.0128199474144086,0.0477185490990453,0.0979727429635271,1.35755963944387e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41771,0.0416679972383448,0.00734636582480828,0.0272691202217206,0.056066874254969,1.44176471308915e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42072,0.0511476821746093,0.00902093631756317,0.0334666469921855,0.0688287173570332,1.45826348143657e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42039,0.0166385270856786,0.00293459439021171,0.0108867220808636,0.0223903320904935,1.45917290738157e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,41960,0.0420952943263973,0.0074287096471313,0.02753502341802,0.0566555652347747,1.48695005305793e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,39675,0.0674834953956968,0.0119208145590111,0.0441186988600351,0.0908482919313585,1.54253816332878e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42020,0.0553381752340833,0.00978175924128856,0.0361659271211577,0.0745104233470089,1.56930984745909e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,39652,0.0642599863960508,0.0113669281562262,0.0419808072098474,0.0865391655822541,1.61352937404913e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39597,0.023109823509657,0.0040880360980642,0.0150972727574511,0.0311223742618628,1.61563036590776e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,42029,-0.0386235773019278,0.00683362776734167,-0.0520174877259174,-0.0252296668779381,1.61830096441532e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42174,0.0146253311930968,0.00258828320014546,0.00955229612081171,0.0196983662653819,1.63111546234036e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42030,0.0694869946951934,0.0123019321074402,0.0453752077646106,0.0935987816257762,1.65175073806842e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,42123,0.0182581203679748,0.00323413578981165,0.011919214219944,0.0245970265160057,1.68072512445297e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41828,0.025891723449631,0.00459128910555753,0.0168927968027383,0.0348906500965238,1.74224208917445e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,42072,0.0263904900250431,0.00469016601367329,0.0171977646382434,0.0355832154118427,1.87273146243726e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42111,0.0784093563744184,0.0139569286106325,0.0510537762975787,0.105764936451258,1.97049913259378e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42108,0.0441324638875405,0.00785998522116378,0.0287268928540595,0.0595380349210215,2.00635900352081e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39895,0.0246958724769788,0.00440958596562147,0.0160530839843608,0.0333386609695969,2.18733901672308e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42142,-0.0357747249306755,0.00640065651518209,-0.0483200117004323,-0.0232294381609186,2.32486365331208e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41943,0.0609618357794718,0.0109075857880555,0.0395829676348831,0.0823407039240605,2.32937707986872e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,41879,0.0428274850776861,0.00766323419341734,0.0278075460585881,0.057847424096784,2.33285590994631e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,39680,0.013357376616563,0.00239134668207143,0.00867033711970303,0.018044416113423,2.38232348409856e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,39815,0.0288762758026882,0.00517581149588017,0.0187316852707631,0.0390208663346133,2.47398624735859e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39575,0.0263723752918857,0.00472776296512001,0.0171059598802505,0.0356387907035209,2.48786327950341e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39858,0.0437316018793457,0.00784620285016625,0.0283530442930198,0.0591101594656715,2.5526929567415e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,42048,0.0275234295480739,0.00494413765288196,0.0178329197484252,0.0372139393477225,2.64302931937382e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39872,0.0520345063003295,0.00935035782538308,0.0337078049625786,0.0703612076380803,2.68179554300618e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39869,0.0460512143986692,0.00827675602653913,0.0298287725866525,0.0622736562106859,2.69802626716822e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39868,0.0346522293578545,0.00623648956527835,0.0224287098099089,0.0468757489058,2.81702611434576e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41657,0.0751112446678544,0.013523903755761,0.0486043933065628,0.101618096029146,2.84724219498927e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,39575,0.0313791381848554,0.00565296909329342,0.0202993187620003,0.0424589576077106,2.90785175187879e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42168,0.0554447849232974,0.00999664297036083,0.0358513647013902,0.0750382051452047,2.97165695380262e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAT,Catalase,39765,0.0317536307960839,0.00572833813586518,0.0205260880497881,0.0429811735423796,3.03646141869008e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42044,-0.0293141079608206,0.00529423918209423,-0.0396908167577253,-0.0189373991639159,3.13497694455732e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42048,-0.0300080204828671,0.00542566584650882,-0.0406423255420244,-0.0193737154237098,3.24808559663529e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42029,0.0147519452821213,0.00266820453890297,0.00952226438587143,0.0199816261783711,3.28462804854327e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,42070,0.0178835518268529,0.00323483089796097,0.0115432832668494,0.0242238203868564,3.29110232582802e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39811,0.0379486270997745,0.00687085747182272,0.024481746455002,0.051415507744547,3.40442478323518e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41771,0.0233956469896306,0.00423905421368788,0.0150871007308024,0.0317041932484589,3.47234956614591e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41771,0.031286935953546,0.00568221632149436,0.020149791963417,0.0424240799436749,3.73709073505312e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39889,0.0286593444957046,0.0052154371372844,0.0184370877066271,0.038881601284782,3.9896713394002e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39696,0.0402173535323444,0.00732180500873312,0.0258666157152275,0.0545680913494613,4.04289993571219e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,42048,0.0410323766019569,0.00747334551900924,0.0263846193846988,0.0556801338192151,4.08074715534635e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,41943,-0.0250086651014365,0.00456480650422404,-0.0339556858497156,-0.0160616443531573,4.3651993017886e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39512,0.0262898270918861,0.00480058509209889,0.0168806803113723,0.0356989738724,4.43737853797076e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41771,0.05093383713656,0.00931376580891606,0.0326788561510845,0.0691888181220355,4.61713673817681e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42050,0.0235953425311904,0.00431625914485368,0.0151354746072772,0.0320552104551036,4.66878812482648e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41766,0.0408479767534348,0.00747316269614242,0.0262005778689956,0.0554953756378739,4.68801437582243e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41924,0.0579084798896531,0.0106057507218313,0.0371212084748637,0.0786957513044425,4.843854760939e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39858,0.0346415927711563,0.00635675763891409,0.0221823477988847,0.0471008377434279,5.15557170288216e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSG,Basigin,42210,0.0123926070979615,0.00227489828906393,0.0079338064513962,0.0168514077445268,5.19577061350812e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39869,0.0524669914718821,0.00963461038085365,0.0335831551254089,0.0713508278183552,5.26915091082037e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39675,0.0495559034923504,0.00910874878409443,0.0317027558755253,0.0674090511091754,5.42701002923648e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,42072,0.0271448319197389,0.0049950424249699,0.0173545487667979,0.0369351150726799,5.59515138794729e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,42222,0.036305718001881,0.0066810019363422,0.0232109542066503,0.0494004817971117,5.59978971901817e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39500,0.0298821583088659,0.00549834919255797,0.0191053938914522,0.0406589227262795,5.60548274948754e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39590,0.0392394746746604,0.00723462112425177,0.0250596172711269,0.0534193320781939,5.95660850762639e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39869,0.0297961017669405,0.00549594573621941,0.0190240481239505,0.0405681554099305,6.03304079727171e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39869,0.0617361730000546,0.0114021243824982,0.039388009210358,0.0840843367897511,6.27408982809985e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39734,-0.00483292619844226,0.000893947829571865,-0.00658506394440312,-0.00308078845248141,6.56785345661256e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39597,0.0199397169452527,0.00370267403087596,0.0126824758447358,0.0271969580457696,7.38459195746593e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,42222,0.0208722750078254,0.00388348695739735,0.0132606405713266,0.0284839094443242,7.80075229987573e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,41766,0.0212887660924404,0.00396096447976217,0.0135252757121065,0.0290522564727742,7.80430270612128e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42174,0.0329462208905279,0.00613639633434055,0.0209188840752204,0.0449735577058353,8.0484453309407e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39868,0.0277900272249636,0.00518749315741805,0.0176225406364243,0.037957513813503,8.62234248843142e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42048,0.0140291900828233,0.00262040607344316,0.00889319417887473,0.0191651859867719,8.75304877244888e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,42063,-0.0184397002800985,0.00344472367104236,-0.0251913586753415,-0.0116880418848554,8.79139016431821e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39872,0.034926492593296,0.00652588937711062,0.0221357494141592,0.0477172357724328,8.86980793447453e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39895,0.0578240220130245,0.0108108713852522,0.0366347140979302,0.0790133299281188,9.03214772676398e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42048,0.0240412380251796,0.0044985784052542,0.0152240243508814,0.0328584516994778,9.23067510811314e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39526,0.0581240070969737,0.0108757148278262,0.0368076060344344,0.079440408159513,9.25500849546862e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39576,0.0336553427473255,0.00630701118333038,0.021293600827998,0.0460170846666531,9.6815423669184e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41828,0.0282839800712771,0.00530199079898288,0.0178920781052707,0.0386758820372836,9.73352751229023e-08
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41814,0.0232278730215264,0.00436462149735885,0.014673214886703,0.0317825311563497,1.04394294645035e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39590,0.0390600997596477,0.00735021550669937,0.0246536773665169,0.0534665221527785,1.0925675399922e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39512,0.0409413713143413,0.00772158110791869,0.0258070723428207,0.0560756702858619,1.16650009381128e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39597,0.0525002750374492,0.00990694051962008,0.0330826716189939,0.0719178784559046,1.18467954799994e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39895,0.0158849051927942,0.0029986842647118,0.0100074840339591,0.0217623263516294,1.19742263941646e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42051,0.0540552325900248,0.0102197645286453,0.03402449411388,0.0740859710661695,1.24720958375691e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39512,0.0380778057253158,0.00720255038288174,0.0239608069748676,0.052194804475764,1.26939822502151e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42072,0.0380981827077054,0.00721233350695366,0.0239620090340763,0.0522343563813346,1.29511770306901e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39696,0.0426057454405079,0.0080811277022095,0.0267667351441772,0.0584447557368385,1.37291281816393e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39872,-0.0148052542196502,0.0028158646919568,-0.0203243490158856,-0.00928615942341491,1.48455869874089e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42108,0.0195760515666203,0.00372482849161007,0.0122753877230646,0.0268767154101761,1.49822900596879e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42108,0.0196613428976963,0.00374142918091865,0.0123281417030957,0.0269945440922968,1.50247928369818e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41766,0.063846586814693,0.0122000846563033,0.0399344208883386,0.0877587527410474,1.69077126804669e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41943,0.0136499693012375,0.00261257424758512,0.00852932377597065,0.0187706148265043,1.77045875685707e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,41766,0.0350892434304942,0.00671609579853,0.0219256956653754,0.048252791195613,1.77149336575449e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,42108,0.0350185249140694,0.00670307629594799,0.0218804953740114,0.0481565544541275,1.7746603421107e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39696,0.0425597267150647,0.00814694436126445,0.0265917157669864,0.058527737663143,1.78261986837193e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,41748,-0.0673295750608894,0.0129081643804324,-0.092629577246537,-0.0420295728752419,1.85559347203602e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42093,0.0680260926411191,0.0130568966231588,0.0424345752597278,0.0936176100225104,1.91649247720765e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39895,0.0415169732088009,0.00796815260241921,0.0258993941080592,0.0571345523095425,1.91792275099614e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,39858,0.0274808283704485,0.00527581049468419,0.0171402398008675,0.0378214169400295,1.93385826222405e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42072,0.0163420614765197,0.0031412529581096,0.0101852056786249,0.0224989172744145,1.99615015790065e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,42010,0.0456846420601568,0.00878702099518831,0.0284620809095878,0.0629072032107259,2.03194965545428e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39675,0.0478839438503784,0.00920935994383796,0.029833598360456,0.0659342893403008,2.03402894624306e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDK,Midkine,42056,0.0290879535017813,0.00559827346220045,0.0181153375158684,0.0400605694876942,2.06732628131198e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,42187,0.0139396013693752,0.00268366125605471,0.00867962530750803,0.0191995774312425,2.08521010658481e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,42236,0.0499681908058221,0.00962062278354132,0.0311117701500811,0.0688246114615631,2.08941677252885e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41771,0.0431405687687919,0.00832058912435744,0.0268322140850513,0.0594489234525325,2.19452817185853e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39675,0.0232552804011998,0.00448990125827101,0.0144550739349886,0.0320554868674109,2.26433229376407e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39675,0.0679799493391341,0.0131273701914373,0.042250303763917,0.0937095949143512,2.27615659449186e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39526,0.0428582235667663,0.00827856370952387,0.0266322386960995,0.0590842084374331,2.29474897798604e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42108,0.0389257497596977,0.00752089209304957,0.0241848012573206,0.0536666982620749,2.30335934328103e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41995,-0.0389185615657731,0.00752665452454633,-0.0536708044338839,-0.0241663186976623,2.36497075435578e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39868,0.0256865367695966,0.00496938529056983,0.0159465416000798,0.0354265319391135,2.39435959375613e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42111,0.0140306343186034,0.00271600754596007,0.00870725952852165,0.0193540091086851,2.4268523919602e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,41828,0.0475312136287383,0.00922797402607722,0.0294443845376269,0.0656180427198496,2.63141825369572e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39590,0.0364315253349339,0.00707409169593997,0.0225663056108915,0.0502967450589762,2.65005379824224e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,39863,0.0175148714165725,0.00340372768309606,0.0108435651577042,0.0241861776754408,2.70880862942454e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,41759,0.061003768397215,0.0118736241440256,0.0377314650749249,0.0842760717195051,2.8201889859888e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41842,0.0369590665625951,0.00720086635775481,0.0228453685013957,0.0510727646237945,2.89835565100213e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,42063,0.0356484695226128,0.00695663389735779,0.0220134670837915,0.049283471961434,3.02642955417702e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42063,0.016862120293925,0.00329223897967422,0.0104093318937635,0.0233149086940865,3.06848120712623e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42236,0.023723559778432,0.0046460098537673,0.0146173804650481,0.0328297390918159,3.33092880077595e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39590,0.0342406500322961,0.00671468423609777,0.0210798689295445,0.0474014311350478,3.46465577605838e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,39904,-0.0141890944464284,0.00279164101286652,-0.0196607108316468,-0.00871747806121006,3.78041917431277e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41842,0.0208587503498034,0.00411279741960922,0.0127976674073693,0.0289198332922374,3.99672190948528e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,41771,0.021431531155529,0.00422727027446053,0.0131460814175863,0.0297169808934716,4.0358175391292e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,39675,-0.0289761610406427,0.00571748744462905,-0.0401824364321157,-0.0177698856491698,4.0852985987174e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41800,0.0261771234317606,0.00517537404076641,0.0160333903118584,0.0363208565516627,4.29328072097444e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39869,0.0168193534654673,0.00332587284087537,0.0103006426973515,0.023338064233583,4.32318960749915e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,39836,0.0512198492611597,0.010154368282468,0.0313172874275224,0.071122411094797,4.62729133760993e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39512,0.0310037346487699,0.0061469639291996,0.0189556853475387,0.0430517839500011,4.6384129471563e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42048,0.0429766723209817,0.00852914274881377,0.0262595525333067,0.0596937921086567,4.7453277521912e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39512,0.0686773529539735,0.0136283653369944,0.0419657568934645,0.0953889490144825,4.7473689796723e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39536,0.0229772580980542,0.00456085451717207,0.014037983244397,0.0319165329517115,4.78113714132182e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41842,0.0510298746889593,0.0101331622083757,0.0311688767605429,0.0708908726173757,4.81795194078235e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42008,0.0173916362464811,0.0034563310314595,0.0106172274248205,0.0241660450681417,4.9213668190961e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39868,-0.0168222425578548,0.00335072378149398,-0.023389661169583,-0.0102548239461266,5.23305589212145e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41828,0.0282736034642133,0.00563660753548027,0.017225852694672,0.0393213542337546,5.34237938546343e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,42099,-0.0143307209044123,0.00285771730601064,-0.0199318468241931,-0.00872959498463143,5.37782100858817e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39597,0.0466711108789327,0.00932361837026644,0.0283968188732105,0.064945402884655,5.65255648227201e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39696,0.0376160105751145,0.00751567427856554,0.022885288989126,0.0523467321611029,5.67167927425679e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39872,0.0257098819082962,0.00514279091404298,0.015630011716772,0.0357897520998204,5.84317669490042e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,41943,0.0178644056920413,0.00357574378209858,0.0108559478791281,0.0248728635049546,5.92734356311407e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41995,0.0317375441592772,0.00635348448123787,0.019284714576051,0.0441903737425034,5.94854787503142e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,39868,0.0208592758150095,0.004177865572542,0.0126706592928272,0.0290478923371918,6.03986542364782e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41771,0.0285342377920132,0.00571639529932799,0.0173301030053303,0.039738372578696,6.0631178072111e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LXN,Latexin,41889,-0.037314093897928,0.00747705786342012,-0.0519691273102314,-0.0226590604856246,6.09922470911713e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,39904,-0.0175273125467498,0.00351802941829695,-0.0244226502066118,-0.0106319748868878,6.38155054111185e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,42016,0.0360148444954719,0.0072297290623312,0.0218445755333028,0.0501851134576411,6.3880973065766e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39597,-0.0142126909622211,0.00285700541383065,-0.0198124215733292,-0.008612960351113,6.63434232365289e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,41808,0.0197643855205156,0.00397469757959442,0.0119739782645105,0.0275547927765207,6.69073937930652e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42108,0.0454891827987419,0.00915223976440765,0.0275507928605029,0.0634275727369809,6.76760440009785e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,41842,0.0260567163974835,0.00524459864462399,0.0157773030540204,0.0363361297409465,6.83871013500294e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,41842,0.04407814213543,0.00887603701292787,0.0266811095900914,0.0614751746807687,6.92099561739534e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39868,0.0166123100166464,0.0033450823382348,0.0100559486337062,0.0231686713995866,6.92824428962904e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,39927,0.0503520866537915,0.0101406658862894,0.0304763815166643,0.0702277917909187,6.95719773498288e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39575,0.0312100515924998,0.00628553670907401,0.0188903996427147,0.0435297035422848,6.9599635545711e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,39850,0.0351451271902808,0.00708651011918941,0.0212555673566696,0.0490346870238921,7.17289207776571e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42048,0.0197102763048905,0.00398064018082834,0.011908221550467,0.0275123310593141,7.45238642708002e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,41771,0.0431248615940834,0.00872837236670544,0.0260172517553407,0.0602324714328261,7.87713547083902e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,41766,-0.0402877783626267,0.00816621687831591,-0.0562935634441259,-0.0242819932811276,8.17688297605721e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41828,0.0191956771303049,0.00389627572154031,0.0115589767160858,0.0268323775445239,8.46531774613951e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42174,0.0273369782054981,0.0055522248874609,0.0164546174260748,0.0382193389849215,8.59619590464844e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39872,0.0359198161959234,0.00729520265619896,0.0216212189897735,0.0502184134020734,8.61009255418869e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39858,0.0511537181650255,0.0103945758252809,0.030780349547475,0.0715270867825761,8.72363415952061e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42174,-0.0150032224279194,0.00304966932689585,-0.0209805743086353,-0.00902587054720358,8.77275195776875e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42108,-0.0153659382082029,0.00312356516300761,-0.0214881259276978,-0.00924375048870797,8.78505893305132e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39895,0.0144360938188012,0.00294041784689683,0.00867287483888343,0.020199312798719,9.25680152814074e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,42174,-0.0161215317520123,0.00328564151273159,-0.0225613891169662,-0.00968167438705835,9.37143356168702e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,42072,-0.0379231835710193,0.00773182553120287,-0.0530775616121769,-0.0227688055298616,9.46064256811567e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,42033,0.0489954136210227,0.009993151761905,0.0294088361676889,0.0685819910743565,9.55363972928161e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,39597,0.0263167755673565,0.00537070298868708,0.0157901977095298,0.0368433534251831,9.71729274007378e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41828,0.0325835447027527,0.00665568779967623,0.0195383966153873,0.0456286927901182,9.91660677822721e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,42048,-0.0236617705336801,0.00483348495301067,-0.033135401041581,-0.0141881400257791,9.92521786509684e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39575,0.0394542430210349,0.00805905484372319,0.0236584955273374,0.0552499905147323,9.93809035575307e-07
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,41995,0.0401722329466935,0.00821522742694785,0.0240703871898757,0.0562740787035113,1.02020475020431e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41828,0.027466857374641,0.00562054757477267,0.0164505841280866,0.0384831306211955,1.03655219831269e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,39575,0.0275287617452347,0.00564219361407437,0.0164700622616489,0.0385874612288205,1.08075152123822e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,39863,0.0136631315945258,0.00280322624155075,0.00816880816108637,0.0191574550279653,1.10811110519602e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41828,0.0186913190366878,0.00383992599134897,0.0111650640936438,0.0262175739797318,1.14251383203339e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,39575,0.0156619941159444,0.00321757921228699,0.00935553885986187,0.0219684493720269,1.14515909133147e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41943,-0.027194138878072,0.00558980333868365,-0.038150153421892,-0.016238124334252,1.1579053676188e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,41886,0.0230794509747227,0.00474554481768866,0.0137781831320529,0.0323807188173925,1.16712017123296e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39696,0.0381378337654334,0.00784671698238862,0.0227582684799518,0.0535173990509151,1.18779869557343e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41929,0.0248968310536653,0.0051285376802982,0.0148448972002808,0.0349487649070497,1.22017839859869e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,41774,0.0297666346520671,0.00613683793274582,0.0177384323038853,0.0417948370002489,1.2456881922367e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41995,0.0182579273326362,0.00376833116706733,0.0108719982451843,0.0256438564200882,1.27967266133664e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42048,0.0525932873215966,0.010857723910538,0.0313121484569421,0.0738744261862511,1.28759883746151e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,39872,0.0408692497290135,0.00844489496876563,0.0243172555902329,0.0574212438677942,1.31877708160332e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39872,0.025437709268294,0.00525708015116986,0.0151338321720011,0.0357415863645869,1.32387825708213e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41981,0.0331760335562226,0.00685945343939414,0.01973150481501,0.0466205622974351,1.33588254783336e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42051,0.0153954301025757,0.00318370750408645,0.00915536339456622,0.0216354968105851,1.34151341584133e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAX,Protein max,41766,0.0561398715920355,0.0116126118682705,0.0333791523302254,0.0789005908538457,1.35064446032561e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,42063,-0.0129673301928529,0.00268331833333765,-0.0182266341261947,-0.00770802625951109,1.362665712149e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42072,0.0185362194454114,0.00384407389935704,0.0110018346026716,0.0260706042881511,1.43661435345135e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39872,-0.0235826918054239,0.00489202810348656,-0.0331710668882575,-0.0139943167225902,1.44969224969012e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41849,0.015121735960526,0.00313806080748879,0.00897113677784792,0.021272335143204,1.46013909422325e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,42092,-0.0111111883246735,0.00230645510168546,-0.015631840323977,-0.00659053632537,1.46999444023638e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,39883,0.0251709106660044,0.00522965470374384,0.0149207874466665,0.0354210338853424,1.50525316546822e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42063,0.0162743067970334,0.00338195198491259,0.00964568090660472,0.0229029326874621,1.50969532974537e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,39526,0.0288071767394439,0.00599161789317981,0.0170636056688114,0.0405507478100763,1.54548345708106e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41995,0.0297910253974838,0.00620893079393226,0.0176215210413766,0.0419605297535911,1.61910911282713e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42222,-0.0145880970202749,0.00304146056867302,-0.020549359734874,-0.00862683430567574,1.63243462527808e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41842,0.022288338441167,0.00465611678379643,0.0131623495449259,0.031414327337408,1.71213094496736e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42063,0.0222478173330764,0.00465670633804722,0.0131206729105039,0.031374961755649,1.79283834436645e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39904,0.0438551405403983,0.00919849930038587,0.025826081911642,0.0618841991691546,1.88721341832534e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,39500,0.0291405050207516,0.00611633324175648,0.0171524918669089,0.0411285181745943,1.91885096964939e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,39575,-0.0224216885561125,0.00470733600380748,-0.0316480671235752,-0.0131953099886498,1.9304674675186e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,41919,-0.0171214984409935,0.00359829269359975,-0.024174152120449,-0.010068844761538,1.97350283536038e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39675,0.0455745197193259,0.00958579327797161,0.0267863648945015,0.0643626745441503,2.01562732396404e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,39872,0.0152575161581729,0.00321485580918147,0.00895639877217725,0.0215586335441686,2.10090595281574e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39696,0.03859434077141,0.00813371409428394,0.0226522611466134,0.0545364203962065,2.11125500371486e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,39597,0.0637873869798007,0.0134744348282202,0.0373774947164891,0.0901972792431123,2.22933012496257e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,42048,0.0446872169669326,0.00944145956678983,0.0261819562160245,0.0631924777178407,2.23387618631167e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,42141,0.0303099018536103,0.00640578174059557,0.017754569642043,0.0428652340651776,2.24955712503584e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39858,0.0271103983953537,0.00573626810100213,0.0158673129173895,0.0383534838733179,2.31601015749634e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,42055,0.0162045745514118,0.00342956605385889,0.00948262508584834,0.0229265240169752,2.32485092079988e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39597,0.022989470231994,0.0048685400705016,0.0134471316938109,0.0325318087701771,2.36369573164942e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39675,0.0307315879290808,0.00652431973405328,0.0179439212503363,0.0435192546078252,2.50342976104946e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39575,0.026527705137587,0.00565091353803011,0.015451914603048,0.037603495672126,2.70614385738102e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,42149,0.0356395007193492,0.0076001601723277,0.0207431867815869,0.0505358146571115,2.7680367298913e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39597,0.0290498721476648,0.00620661124248955,0.0168849141123853,0.0412148301829443,2.89633523424961e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,41681,0.0384837342479976,0.00823877826318421,0.0223357288521565,0.0546317396438386,3.02649616738975e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41943,-0.0573727319537064,0.0122913484745175,-0.0814637749637608,-0.033281688943652,3.07505765244536e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,41817,0.028748363787715,0.00615894704640949,0.0166768275767524,0.0408198999986776,3.07523488859064e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,39927,0.038261487810845,0.00819756868681369,0.0221942531846902,0.0543287224369998,3.08505674819344e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39512,0.0225769000523937,0.00484251026646534,0.0130855799301216,0.0320682201746657,3.16509537064383e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39868,0.0546997148260048,0.0117388551914667,0.0316915586507301,0.0777078710012794,3.20276324840423e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39500,0.0185546736049775,0.00398733095964601,0.0107395049240713,0.0263698422858836,3.30342728863278e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,41766,0.0241895991885788,0.00520767451041407,0.0139825571481672,0.0343966412289904,3.43384463322572e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39927,-0.0309167281839784,0.00665593238047066,-0.0439623556497009,-0.017871100718256,3.43925154746156e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,41686,-0.0355172041597036,0.00765837850805285,-0.0505276260354872,-0.02050678228392,3.55731652457469e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39904,0.0241489966538704,0.00521850553422564,0.0139207258067881,0.0343772675009526,3.74096723571637e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42222,0.0238714970136367,0.00515931618666112,0.0137592372877809,0.0339837567394925,3.74650664096445e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,39895,0.0365581862513342,0.00790129586029267,0.0210716463651605,0.0520447261375078,3.75381563805349e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42187,-0.026867519131786,0.00581119550335304,-0.0382574623183579,-0.015477575945214,3.80966922697686e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42050,0.027224998742352,0.00588957854202967,0.0156814247999738,0.0387685726847301,3.82537141156731e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39895,0.0173478965628807,0.00375262542892635,0.00999275072218503,0.0247030424035763,3.82664140931837e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39868,0.0195888482658439,0.00424270300926235,0.0112731503676897,0.0279045461639981,3.93504046363321e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41924,0.0375683992593038,0.00813943870329327,0.0216150994008489,0.0535216991177586,3.95618865248449e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41766,0.0363888223700611,0.00788601315131028,0.020932236593493,0.0518454081466293,3.98049584079107e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39895,0.0311523346262728,0.00675403996216983,0.0179144163004199,0.0443902529521256,4.02420311437589e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,42048,-0.0328479325797671,0.00713674746010344,-0.0468359576015699,-0.0188599075579644,4.20970667603765e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42128,0.0572672756933139,0.0124430528020475,0.0328788922013008,0.0816556591853269,4.21550263209566e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41828,0.0561950001969585,0.012217812143832,0.0322480883950478,0.0801419119988691,4.27573923727088e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42072,0.029046568937827,0.00631658332043986,0.0166660656297649,0.0414270722458891,4.29494726396505e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,39907,-0.0178677823174656,0.00388541034612796,-0.0254831865958764,-0.0102523780390548,4.29778226761306e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,39927,0.0136077594722417,0.00296350755782879,0.00779928465889728,0.0194162342855861,4.44226198947433e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42142,-0.0179767718201733,0.0039175743361937,-0.025655217519113,-0.0102983261212337,4.4991110661453e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39869,0.0246820520273131,0.00537883773903116,0.014139530058812,0.0352245739958142,4.50759513862326e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42048,-0.0285263911892263,0.0062180468935362,-0.0407137631005573,-0.0163390192778954,4.5225489914464e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42142,-0.0163793308749353,0.00358015238644685,-0.0233964295523711,-0.00936223219749944,4.80362026798411e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39868,0.0239052741332082,0.00524323336808219,0.0136285367317671,0.0341820115346493,5.1874557340166e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,41771,0.0283381432586085,0.00624826993516394,0.0160915341856872,0.0405847523315298,5.80134236517617e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42187,0.02006318127027,0.00443214093305115,0.0113761850414898,0.0287501774990503,6.04073557443904e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42072,-0.0159437139289318,0.00352404705418675,-0.0228508461551378,-0.00903658170272577,6.11246099448628e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42108,-0.013618304094687,0.00302047461643874,-0.019538434342907,-0.00769817384646711,6.57861515388051e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,42069,0.0177636694645612,0.00394326444351078,0.01003487115528,0.0254924677738423,6.69901202371032e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,42072,0.0335063075062081,0.00744020615244838,0.0189235034474092,0.0480891115650069,6.74329760370277e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,42092,0.0281934288990944,0.00626538263811575,0.0159132789283875,0.0404735788698013,6.85624452322927e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39597,0.0184267001339799,0.00409997575108621,0.0103907476618509,0.0264626526061089,7.04978507231417e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39519,0.0273816007206403,0.00611533860417606,0.0153955370564552,0.0393676643848253,7.6278225706259e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41943,0.0283852121549015,0.00634445917471343,0.0159500721724632,0.0408203521373398,7.73988090473568e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39895,0.0158980314417997,0.00355657045388435,0.00892715335218638,0.022868909531413,7.89648218725934e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39512,0.0340065709426741,0.00762251544004182,0.0190664406801922,0.0489467012051561,8.22671489585853e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,39808,0.0158290685493439,0.00355438537441946,0.0088624732154818,0.0227956638832061,8.53425711649168e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39850,0.0196274152731608,0.00441236558215318,0.0109791787321405,0.028275651814181,8.73936169705354e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,41842,0.0553448284875322,0.0124520214696902,0.0309388664069395,0.0797507905681249,8.87519941621178e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41990,0.0220652351292334,0.00496824065085627,0.0123274834535551,0.0318029868049116,9.01513009530181e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,42114,0.0175077888994806,0.00394220326192022,0.00978107050611697,0.0252345072928442,9.02031119753589e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39872,0.0488316229101844,0.0109960343110672,0.0272793956604927,0.070383850159876,9.0461630522172e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39512,0.0353020933040186,0.00796941542532951,0.0196820390703728,0.0509221475376645,9.52848253667303e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39696,0.034496607846418,0.00778786655935642,0.0192323893900794,0.0497608263027566,9.5341976575862e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,42063,0.035275129616537,0.00796998303198013,0.0196539628738559,0.050896296359218,9.67522729597338e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39575,0.0226263814245992,0.00511552913852154,0.012599944313097,0.0326528185361014,9.82417513905434e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42163,-0.0121593880483512,0.00274952676854627,-0.0175484605147018,-0.00677031558200047,9.83897718991864e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42034,0.0529868939953032,0.0119895050488119,0.0294874640996318,0.0764863238909745,9.97325864680884e-06
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39652,-0.0236809203465857,0.00538113656093358,-0.0342279480060156,-0.0131338926871559,1.08899802344402e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39872,0.0317691429404964,0.00722406198958187,0.0176099814409159,0.0459283044400768,1.10415264557359e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41771,0.0278701834029509,0.00635184025314013,0.0154205765067962,0.0403197902991055,1.15428498442995e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39869,0.0254567013892947,0.00580715124061317,0.0140746849576929,0.0368387178208966,1.17747592344443e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39597,0.0309302025329292,0.00705761991940361,0.0170972674908981,0.0447631375749603,1.18399330105131e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39590,0.0299947118900043,0.006846393527693,0.016575780575726,0.0434136432042825,1.19178106734058e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41766,0.0303892172834111,0.00693836386227299,0.0167900241133561,0.0439884104534662,1.19660743268575e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41967,-0.0104040421094351,0.00237549290396629,-0.015060008201209,-0.00574807601766114,1.19724780219789e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39512,-0.0223811976106278,0.00511036500210613,-0.0323975130147558,-0.0123648822064998,1.20022877448976e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,41766,0.0391769995920775,0.00895646942254719,0.021622319523885,0.05673167966027,1.22839899246975e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,42111,0.0182775258740356,0.00418116111159584,0.0100824500953077,0.0264726016527634,1.24375052297979e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41882,-0.0285995051605577,0.00654976419113708,-0.0414370429751864,-0.015761967345929,1.27212397780887e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,42187,-0.0286732319287407,0.00657357349370248,-0.0415574359763975,-0.0157890278810838,1.29891312172829e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39675,0.045754044115296,0.0105018337179378,0.0251704500281378,0.0663376382024542,1.33186138872653e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39575,-0.0103109225421037,0.00236779441767525,-0.0149517996007472,-0.00567004548346026,1.34486830312955e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39575,0.0485742313563402,0.0111720421267982,0.0266770287878157,0.0704714339248647,1.38725516185182e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,42149,0.0339994241127735,0.0078287528510932,0.0186550685246308,0.0493437797009162,1.41641421851037e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41771,0.027413331016349,0.00632181529987768,0.0150225730285888,0.0398040890041093,1.45973565448455e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39590,0.0186753722438353,0.00431071040563167,0.0102263798487973,0.0271243646388734,1.48857367826603e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,39858,0.0405671780169704,0.00936579728933996,0.0222102153298641,0.0589241407040767,1.49435772612167e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,42063,0.0576479452290745,0.0133185752760773,0.0315435376879629,0.083752352770186,1.51290013822145e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39869,-0.0342196674299223,0.00792180047433493,-0.0497463963596188,-0.0186929385002259,1.57591612923193e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39512,0.0279244161753353,0.0064698621513766,0.0152434863586372,0.0406053459920334,1.60227763409325e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41995,-0.0185475173226981,0.00430169619043551,-0.0269788418559517,-0.0101161927894445,1.63180737422764e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,42046,-0.0316732263615198,0.00735171140913143,-0.0460825807234174,-0.0172638719996222,1.65697949685831e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39500,0.03169159619262,0.00736090548442519,0.0172642214431466,0.0461189709420933,1.68146449253139e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41766,0.0202979507954317,0.00471677030080939,0.0110530810058453,0.0295428205850181,1.6944361881152e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42051,0.0281032278941187,0.00653817650279767,0.0152884019486353,0.0409180538396022,1.73302212891211e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42048,0.0430085946139481,0.0100083621162848,0.02339220486603,0.0626249843618662,1.74133488578567e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39675,-0.015147952341222,0.00352799979752938,-0.0220628319443796,-0.00823307273806444,1.77266086576746e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,39869,0.0172281274512422,0.00402344431120598,0.00934217660127845,0.0251140783012059,1.86809361370074e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_E,,42048,0.01372646036708,0.00320594180580787,0.00744281442769654,0.0200101063064634,1.86867127860805e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,42222,0.027383560118904,0.0063963876248375,0.0148466403742225,0.0399204798635855,1.87246180803777e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39868,0.0157176922016789,0.0036715921243781,0.00852137163789781,0.02291401276546,1.87685286640084e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42187,0.0250966796349926,0.00586563600555629,0.0136000330641022,0.0365933262058829,1.89364199910126e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,39897,-0.0180369997336761,0.00421677367144205,-0.0263018761297025,-0.00977212333764964,1.90609706430148e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42048,-0.0207279848143237,0.00484716347643866,-0.0302284252281434,-0.0112275444005039,1.91325984315934e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,42050,0.0127665953490853,0.00298614201773674,0.00691375699432132,0.0186194337038493,1.92212666674585e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41766,0.0172845645146219,0.00404324187749112,0.00935981043473928,0.0252093185945045,1.92546011366507e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39872,0.040495411722646,0.00949633558840388,0.0218825939693744,0.0591082294759176,2.02146238587201e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39868,0.0106631255630749,0.00250200371892494,0.00575919827398201,0.0155670528521678,2.04404984824627e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39895,0.0332043589733194,0.00779670949486507,0.0179228083633839,0.0484859095832549,2.07222324953968e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,41943,-0.015786676450208,0.00371457469696422,-0.0230672428562579,-0.00850611004415813,2.15291560337191e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,41995,0.0383414159510182,0.00902641644061396,0.0206496397274149,0.0560331921746216,2.1744491137883e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42048,0.03839144153164,0.00905323986300133,0.0206470914001574,0.0561357916631227,2.24383027828992e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,41995,0.0144106690913441,0.0034008204446281,0.00774506101987303,0.0210762771628152,2.27626408737712e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,41766,0.033475677281914,0.00791208076309552,0.0179679989862468,0.0489833555775812,2.34273651934967e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39675,0.0585798268470537,0.0138471958994528,0.0314393228841263,0.0857203308099811,2.35104131252515e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39512,0.0174558992059121,0.00413228051856872,0.00935662938951742,0.0255551690223068,2.41655442966315e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,42222,0.0365493210517541,0.00866488393117782,0.0195661485466455,0.0535324935568626,2.47965795327979e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,42063,-0.0120557645282021,0.00285894514082619,-0.0176592970042214,-0.00645223205218276,2.49349209195475e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39821,0.0225925112884373,0.00535896877432947,0.0120889324907515,0.0330960900861231,2.50809472349768e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41967,-0.0153682322261851,0.00364883829135037,-0.0225199552772318,-0.00821650917513835,2.54986664124196e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39872,-0.0193970782595551,0.00460533646112607,-0.0284235377233622,-0.010370618795748,2.55234134386316e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39696,0.0342628480233288,0.00814453999689867,0.0182995496294074,0.0502261464172502,2.6099207354818e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42236,-0.0187341426937691,0.00445387215279107,-0.0274637321132396,-0.0100045532742986,2.61291034708852e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40452,-0.0143183808639699,0.0034041734603729,-0.0209905608463008,-0.00764620088163902,2.6169639288421e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,42048,-0.0284838227679816,0.00678252149580842,-0.0417775648997661,-0.0151900806361971,2.69118622997985e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42111,0.0404674699205524,0.00964136546644761,0.0215703936063151,0.0593645462347897,2.71873019905232e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42174,0.0358190143730236,0.00853530136318164,0.0190898237011876,0.0525482050448597,2.72708614250189e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39904,0.0281453513362749,0.00671874674244091,0.0149766077210907,0.0413140949514591,2.82217295746176e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,42174,0.0516998666565362,0.0123574941723328,0.0274791780787639,0.0759205552343085,2.88624948133312e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42043,0.0424779444935418,0.0101578789688589,0.0225685017145784,0.0623873872725052,2.91078275508483e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41828,0.0423641034827261,0.0101330411471978,0.0225033428342185,0.0622248641312337,2.92369716915248e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,39758,0.0276025279406063,0.00661813283741168,0.0146309875792794,0.0405740683019332,3.05905498058944e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,39512,-0.0142234002998079,0.00341096208559388,-0.0209088859875719,-0.00753791461204386,3.07077225068419e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39590,0.0269248144548187,0.00647637292997082,0.0142311235120759,0.0396185053975615,3.24345208555836e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41736,0.0343523703495514,0.00826742581449364,0.0181482157531439,0.0505565249459589,3.27136731851784e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,42222,0.0392678907613073,0.00945763879570619,0.0207309187217232,0.0578048628008915,3.31623269598763e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,39648,0.0233708979615843,0.00563355836903447,0.0123291235582768,0.0344126723648919,3.37145015321136e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41842,0.0196007494051362,0.00473469298783544,0.0103207511489787,0.0288807476612937,3.49739922338773e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,39575,0.0134930065961294,0.0032641850063261,0.00709520398373019,0.0198908092085285,3.59697361019957e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42063,0.0131253035757653,0.0031769596481643,0.00689846266536331,0.0193521444861674,3.62733748972588e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,42187,0.0183561737332319,0.00444429407723781,0.00964535734184582,0.027066990124618,3.64491311497591e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42072,0.030443666380319,0.00739736372948572,0.015944833470527,0.044942499290111,3.88682546104218e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39872,0.0352121206088207,0.00855869976759091,0.0184370690643425,0.0519871721532989,3.91302577651706e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42236,0.0145908354039037,0.00355590349985333,0.00762126454419122,0.0215604062636163,4.09718322679092e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42072,0.014912070748258,0.00363500019454841,0.00778747036694314,0.0220366711295729,4.11366397472553e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39869,0.0239920770846578,0.00584973600915442,0.0125265945067152,0.0354575596626005,4.13552755434992e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42072,-0.0153059166604029,0.00373999913373107,-0.0226363149625158,-0.00797551835829004,4.29248590435491e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,41766,0.0185510410849047,0.0045333581405029,0.00966565912951896,0.0274364230402903,4.29996956650336e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42108,0.0122352594399073,0.00299257067579465,0.00636982091534977,0.0181006979644648,4.36600989416689e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,42164,0.0271167936044601,0.00663535724953205,0.0141114933953773,0.0401220938135429,4.40048351356364e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,39863,-0.0214449497710826,0.00525955782781425,-0.0317536831135986,-0.0111362164285667,4.58691193775037e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42149,-0.0156932700956167,0.0038493675681379,-0.023238030529167,-0.00814850966206643,4.59118115028839e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,39868,0.0127868972184421,0.00314357066839502,0.00662549870838785,0.0189482957284963,4.78161668526564e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39858,0.0195950586489404,0.00481795472782593,0.0101518673824016,0.0290382499154792,4.79280237087364e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,42063,0.0337294864897701,0.00830457242527943,0.0174525245362224,0.0500064484433178,4.90228577669037e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41741,0.0325343132030728,0.00801061066584686,0.016833516298013,0.0482351101081326,4.90618909684202e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39872,0.0568437791883153,0.0140397250200181,0.0293259181490799,0.0843616402275507,5.18293222208768e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42111,0.0531935891489564,0.0131577787157468,0.0274043428660926,0.0789828354318202,5.31212884546844e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,41995,0.0245530844423279,0.0060885534572763,0.0126195196660664,0.0364866492185895,5.54539341034226e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39675,0.014570543424079,0.00361361503787991,0.00748785794983432,0.0216532288983236,5.56454758002699e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39510,0.0450007934026712,0.0111630850377519,0.0231211467286775,0.0668804400766649,5.58664928019785e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39869,-0.0222203274306387,0.00551306434735685,-0.0330259335514582,-0.0114147213098193,5.60277229306577e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,41943,0.0172916409109319,0.00429086061542909,0.00888155410469092,0.025701727717173,5.61156663763974e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39904,0.0226485535157303,0.00562755739730612,0.0116185410170103,0.0336785660144503,5.744924132497e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,42048,0.0151083401055164,0.00375662487501681,0.00774535535048344,0.0224713248605493,5.80741545397236e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42108,-0.0108758813830202,0.00270465003851987,-0.0161769954585192,-0.00557476730752128,5.82224083875101e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41995,0.0303837348456359,0.00757531010957994,0.0155361270308592,0.0452313426604126,6.08187030454099e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,42032,0.0125474853611451,0.00313317007009117,0.00640647202376641,0.0186884986985238,6.24237821584817e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39854,0.0384526169330435,0.00962044763518912,0.0195965395680728,0.0573086942980142,6.45683776066683e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39858,-0.0168785742299047,0.00422381602558006,-0.0251572536400416,-0.00859989481976774,6.48188793933533e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39858,0.0314019109853731,0.0078666367432782,0.0159833029685478,0.0468205190021984,6.59943543541705e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,39512,-0.0305781518283953,0.00766601263257425,-0.0456035365882408,-0.0155527670685497,6.68433869993636e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42048,0.0523036835805845,0.0131288707134469,0.0265710969822285,0.0780362701789404,6.81599886727207e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39927,-0.0633217510699888,0.0158983564388433,-0.0944825296901217,-0.0321609724498559,6.85017692425068e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FST,Follistatin,42092,-0.0212108001931568,0.00532724366215479,-0.0316521977709802,-0.0107694026153334,6.88200501942508e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,42041,-0.0320095461049034,0.00804652699236745,-0.0477807390099436,-0.0162383531998632,6.98449696664196e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41842,0.0313493696054617,0.00788589690348366,0.0158930116746337,0.0468057275362896,7.06425777140794e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39575,0.0337027547276615,0.00847906816473326,0.0170837811247843,0.0503217283305387,7.08841704427919e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,41828,0.0193683689464721,0.00487317646013783,0.00981694308460193,0.0289197948083422,7.09061373834234e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42221,0.0121198982124861,0.00305334686224175,0.00613533836249228,0.0181044580624799,7.24292766254778e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41771,0.0188719569222164,0.00475885509273021,0.00954460094046518,0.0281993129039676,7.35831157751589e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,42226,0.014701576825645,0.00370932625521762,0.00743129736541849,0.0219718562858716,7.42639502135225e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41943,0.0250740001653189,0.00632880390070505,0.012669544519937,0.0374784558107008,7.47468189493308e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41719,0.0251244617495345,0.00635390101696124,0.0126708157562905,0.0375781077427785,7.72012425712362e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,39512,0.0170272199998115,0.00430967989034288,0.00858024741473949,0.0254741925848836,7.83400727541704e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42047,0.0315765357893781,0.00800707302464272,0.0158826726610784,0.0472703989176778,8.06812061637529e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42236,-0.00693298703119328,0.00176107943498741,-0.0103847027237686,-0.00348127133861796,8.29916488531356e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,39597,0.0139205490881343,0.0035369352247339,0.00698815604765589,0.0208529421286128,8.34424424002625e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39696,0.0203682281857406,0.00518113857920369,0.0102131965705014,0.0305232598009799,8.50271769738907e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39895,0.023434094337771,0.0059616610489714,0.0117492386817871,0.0351189499937549,8.51689735843217e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42027,-0.00746629687020232,0.00190153419826734,-0.0111933038988063,-0.00373928984159833,8.66361324588259e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,39895,0.0117029102552539,0.00298091281234199,0.00586032114306362,0.0175454993674442,8.6901638541058e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,41995,0.0128594719933116,0.00327752918548361,0.0064355147897637,0.0192834291968594,8.76980246051967e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42069,0.026676877809879,0.00680720526339769,0.0133347554936195,0.0400190001261384,8.9387248663372e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,42198,0.0122269253949006,0.003120348971917,0.00611104140994324,0.0183428093798579,8.95572025678181e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,42070,0.0139483638395495,0.00356342399389864,0.00696405281150814,0.0209326748675908,9.11074889169074e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42048,0.0519943082853478,0.0132873439391764,0.0259511141645621,0.0780375024061336,9.1578823997771e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,39869,0.0149580904170371,0.00382500516255081,0.00746108029843753,0.0224551005356367,9.26045329828647e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,39696,0.0123701485542839,0.00317347030983307,0.00615014674701105,0.0185901503615567,9.75659950252999e-05
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39872,0.0116397900822706,0.00299159170090309,0.00577627034850056,0.0175033098160407,0.000100474377082517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41828,0.0378279037508329,0.00972304007920146,0.0187707451955981,0.0568850623060678,0.000100510149253067
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42222,0.0116868875050406,0.0030070686318407,0.00579303298663282,0.0175807420234484,0.000102193591128067
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39872,0.0158893571628781,0.00409009700987583,0.00787276702352151,0.0239059473022348,0.000102984404477406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39675,-0.00904681966828176,0.00233098599965508,-0.0136155522276057,-0.0044780871089578,0.000104582555099739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41766,0.0176519421568031,0.00455432213297159,0.00872547077617877,0.0265784135374274,0.000106761616239341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39590,-0.0133761153118688,0.00345669865657192,-0.0201512446787497,-0.0066009859449878,0.000109634370904465
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,42048,0.0273072468225857,0.00706222489812446,0.0134652860222617,0.0411492076229096,0.000110853889493401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,39590,0.0277230405825284,0.00717295248516715,0.0136640537116008,0.0417820274534561,0.000111755077568083
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,39597,0.0216159383599882,0.00559316870154257,0.0106533277049648,0.0325785490150116,0.0001118634927243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,42048,0.0237240725113706,0.00614628885316258,0.011677346359172,0.0357707986635693,0.000113962940416688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39575,0.0222124937644266,0.00576191915958479,0.0109191322116404,0.0335058553172128,0.000116365442738802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,42072,0.0157648467191452,0.00409807036515011,0.007732628803451,0.0237970646348394,0.000120175469863086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42083,0.0403066448872069,0.0104834212249663,0.019759139286273,0.0608541504881408,0.000121205853409133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41771,0.0238421668974973,0.0062023663658853,0.0116855288203621,0.0359988049746324,0.000121592401007665
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41995,0.0393912782179202,0.0102496175549029,0.0193020278103105,0.0594805286255298,0.000122003800165597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,41771,0.0275932207955503,0.00718098976863351,0.0135184808490287,0.041667960742072,0.000122340499556839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39512,0.0147154688111341,0.00382982114951459,0.00720901935808549,0.0222219182641827,0.000122558225344378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,39512,0.0246727751091167,0.00643195037816291,0.0120661523679174,0.037279397850316,0.000125773448586108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39512,0.0255670269906707,0.00666829456610143,0.0124971696411119,0.0386368843402295,0.0001267240529717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39872,0.0164468035687459,0.00429352346500038,0.00803149757734512,0.0248621095601466,0.000128520332842081
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,42072,0.0161992613795416,0.00423075425057762,0.00790698304840944,0.0244915397106737,0.000129284412449775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42072,0.0365361545881291,0.00956899680069941,0.0177809208587583,0.0552913883175,0.00013504199070479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39581,0.015105326585102,0.00396869176508236,0.00732669072554062,0.0228839624446635,0.000141929491987265
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39927,0.0111405643404648,0.00292837533796252,0.00540094867805822,0.0168801800028713,0.000142924611860659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C3,Complement C3,39383,0.01919961027893,0.00504768948592228,0.00930613888652235,0.0290930816713377,0.000143370429844528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39858,0.0156162645919586,0.0041060876702766,0.00756833275821647,0.0236641964257007,0.000143594810822945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,42187,0.00918901026395999,0.00241919635700006,0.00444738540423988,0.0139306351236801,0.00014628341191838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,42048,0.0132142064174857,0.00348277142471772,0.00638797442503897,0.0200404384099324,0.000148790897524879
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39575,0.015038901562707,0.00396894298673221,0.00725977330871191,0.0228180298167022,0.000151974500588357
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39575,0.0254228888173393,0.00670957409939946,0.0122721235825164,0.0385736540521623,0.000152034801616428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39869,0.0400149668523045,0.0105774771146904,0.0192831117075112,0.0607468219970977,0.000155729146696959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42187,-0.0109753155917423,0.00290304972882685,-0.0166652930602429,-0.00528533812324166,0.000157110446363441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42048,0.0342082534485728,0.00904940605223674,0.0164714175861888,0.0519450893109568,0.000157401430419729
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42039,0.0098568628571318,0.00260785522525138,0.00474546661563909,0.0149682590986245,0.00015770771365138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39500,0.0315126733515744,0.00834213947990336,0.0151620799709638,0.047863266732185,0.000159234747931679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39869,0.0208236456164787,0.00552599675795033,0.00999269197089607,0.0316545992620614,0.000165197234679837
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,41828,0.0204714215341755,0.00543633373840647,0.00981620740689884,0.0311266356614522,0.000166824533857997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39597,0.0227625494111057,0.00606848131543812,0.010868326032847,0.0346567727893644,0.000177072750496612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42187,0.025520507891651,0.00681287729364878,0.0121672683960994,0.0388737473872026,0.000180475250649272
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,39858,-0.0430518400630954,0.0114954002096846,-0.0655828244740772,-0.0205208556521137,0.000181194867146799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41943,0.0137871366422307,0.00368388833793788,0.00656671549987248,0.021007557784589,0.000182926358273779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39575,0.0200799365572633,0.00536810922959407,0.00955844246725889,0.0306014306472676,0.00018451795609553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39904,0.0116469727792822,0.00311405061320681,0.00554343357739684,0.0177505119811675,0.00018482944009614
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2,Complement C2,42124,0.00924736166253699,0.00247275038856739,0.0044007709009449,0.0140939524241291,0.000184995272281095
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39675,0.0462904017016037,0.0123852268315544,0.0220153571117571,0.0705654462914502,0.000186757007841738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,41828,0.0297192211544141,0.00796314431369393,0.014111458299574,0.0453269840092542,0.000190688002902552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42221,0.00951437128866165,0.00254975626980208,0.00451684899984958,0.0145118935774737,0.000191129655641105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39917,-0.00788373757864724,0.00211511069215179,-0.0120293545352647,-0.00373812062202972,0.00019445376764724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,41766,0.0299296723442735,0.008030165790776,0.0141905473943525,0.0456687972941944,0.000194464016126096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,42108,-0.0124965256845526,0.00335450471296698,-0.0190713549219679,-0.00592169644713732,0.000195879965325766
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,38447,0.0435630358855032,0.0116975834224903,0.0206357723774222,0.0664902993935841,0.000197103048374137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42187,0.0135777398705607,0.00366382189355265,0.00639664895919748,0.0207588307819239,0.000211481615711041
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39904,0.0260710791122158,0.00704551355320941,0.0122618725479254,0.0398802856765063,0.000216298376705206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCT,Secretin,39590,0.0195236220182384,0.00528236678033974,0.00917018312877255,0.0298770609077043,0.000220088382439045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,42174,0.0262933538189519,0.00711918502544928,0.0123397511690713,0.0402469564688325,0.000222222706727882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,39575,0.00939616140303803,0.00254659037934596,0.00440484425951996,0.0143874785465561,0.000225601977346493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39868,0.0279062933483291,0.00757517103226527,0.0130589581250891,0.042753628571569,0.000230753380035202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41924,0.0289886671649973,0.00786948854859981,0.0135644696097416,0.0444128647202529,0.000230801848815914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39526,-0.0251174439890329,0.00681997867877786,-0.0384846021994375,-0.0117502857786283,0.00023168875683199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,39512,0.025391914811722,0.00691330630039563,0.0118418344629466,0.0389419951604974,0.000240955513675283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,42174,0.010932533037484,0.00298371445154341,0.00508445271245887,0.0167806133625091,0.000249185905258708
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,39590,0.0198528341569698,0.00542024152109367,0.00922916077562621,0.0304765075383134,0.000250722309068261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42048,-0.0177780425864045,0.0048668279069994,-0.0273170252841233,-0.00823905988868564,0.000260278985393518
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,42063,0.0179521207460475,0.00491457516274612,0.00831955342706506,0.0275846880650299,0.000260347534633571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,41828,0.0186860283838793,0.00511832149563863,0.00865411825242755,0.028717938515331,0.000262420387053907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41747,0.0266484575625819,0.00730572174766131,0.0123292429371657,0.040967672187998,0.000265709387905224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,39512,0.0240121970708365,0.00658759261936132,0.0111005155368883,0.0369238786047847,0.000268567280381858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,39526,0.0167197666820888,0.00459075269469647,0.00772189140048371,0.0257176419636939,0.000271723088319787
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39869,0.0395112400175361,0.0108507015699351,0.0182438649404632,0.0607786150946089,0.000272423930657087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,41741,0.036605881008866,0.0100556195916058,0.0168968666093187,0.0563148954084133,0.000273322673082757
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41771,0.029448406728968,0.00812791902216529,0.013517685445524,0.0453791280124119,0.000292168433822192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,42041,0.0347729765756381,0.00963086303223142,0.0158964850324646,0.0536494681188117,0.000306627831186164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,42172,-0.0120744838633099,0.00334524898356696,-0.0186311718711011,-0.00551779585551866,0.000307960300644051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,41995,0.0168181049769761,0.00466095740143804,0.00768262847015752,0.0259535814837947,0.000309339773352507
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39927,-0.0255391723482874,0.00708470214636745,-0.0394251885551676,-0.0116531561414072,0.00031369401557106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,41995,-0.00594544686121727,0.00165176076758938,-0.00918289796569245,-0.00270799575674209,0.00032002961678108
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,42063,-0.0092189370085044,0.00256769467317867,-0.0142516185679346,-0.00418625544907422,0.000331401816931116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39575,0.0345259748195639,0.00963167435866327,0.0156478930765839,0.053404056562544,0.000339022890396772
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39500,0.0143085538036649,0.00400309186010462,0.00646249375785987,0.02215461384947,0.000352582032564102
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39895,0.0112887845465424,0.00315852341579687,0.00509807865158051,0.0174794904415043,0.000352940017827069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41842,0.0253733696563713,0.00711506125178043,0.0114278496028816,0.0393188897098609,0.000363542684034107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42048,0.0134520294423729,0.00377348056733534,0.00605600753039568,0.0208480513543502,0.000365276106377178
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41842,0.0146595337450927,0.00411272269344721,0.00659859726593617,0.0227204702242492,0.000365923953642419
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,39872,0.027114801944318,0.00760941095174396,0.0122003564788999,0.0420292474097362,0.000367700030969414
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42236,0.0120975655274208,0.00340011282319034,0.00543334439396777,0.0187617866608739,0.00037497306823711
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,39512,-0.013520389431694,0.00380137783801615,-0.0209710899942057,-0.00606968886918235,0.000377123242419448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42054,0.0121274708105279,0.00341468352564046,0.00543469110027262,0.0188202505207832,0.000384256103688734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,39927,-0.00940669698840142,0.00264848317729928,-0.014597724015908,-0.00421566996089483,0.000384261682878531
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39869,0.016778711252064,0.00473161906608491,0.0075047378825376,0.0260526846215905,0.000392590515582083
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,39417,0.0153500460339982,0.00434238617927732,0.00683896912261466,0.0238611229453818,0.000409582091382978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42063,0.0146571668402389,0.00415073841533215,0.00652171954618794,0.0227926141342899,0.000415031733046197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42069,-0.0147317780424162,0.00417598157140195,-0.0229167019223641,-0.0065468541624684,0.000420518637246513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,39426,0.0321941487499211,0.00912677973121298,0.0143056604767437,0.0500826370230985,0.000421340027939188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41828,0.010512528036131,0.00300693746560272,0.00461893060354965,0.0164061254687123,0.000473674530107714
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,39652,-0.0110857136393526,0.00317116077022064,-0.0173011887489851,-0.00487023852972017,0.000474513698158698
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,39858,0.0172223185157791,0.00493166793505433,0.00755624936307263,0.0268883876684856,0.000480916090825811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42139,0.0318812788712868,0.00914482791156227,0.0139574161646247,0.0498051415779488,0.000491370601528065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39512,-0.014160428872571,0.00407473627870645,-0.0221469119788357,-0.00617394576630636,0.000512500772582449
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42174,-0.0170681153501086,0.0049124041773965,-0.0266964275378057,-0.00743980316241142,0.000513416562234847
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42174,0.0107363562561244,0.00309079360177173,0.00467840079665184,0.016794311715597,0.000515018198449994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39575,0.0097386729321319,0.0028035976444702,0.0042436215489703,0.0152337243152935,0.000515440983207009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,42030,0.0189659133826312,0.00546125592174464,0.00826185177601169,0.0296699749892507,0.000516658354208109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39597,0.0157427065345641,0.00453643865527389,0.00685128677022726,0.0246341262989009,0.00052191287949921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42050,0.0111303994856718,0.00321420812606448,0.00483055155858544,0.0174302474127582,0.000536100011948984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,39869,0.0166140642361305,0.00479987193359852,0.00720631524627739,0.0260218132259836,0.0005394546845435
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41997,0.0101704046189459,0.00293922224499675,0.00440952901875224,0.0159312802191395,0.000541381517652207
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,39597,-0.0113250519306223,0.00328518334679247,-0.0177640112903355,-0.00488609257090903,0.000568313065078988
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39512,0.0191897679209176,0.00557267065952028,0.00826733342825787,0.0301122024135774,0.000576287623302234
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39512,0.0174130303372975,0.00505881832391703,0.00749774642242013,0.0273283142521749,0.00057935104640674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,39597,0.016419519442394,0.00478937327796775,0.00703234781757718,0.0258066910672108,0.00060954834168186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39872,0.0136494600978884,0.00398442798601208,0.00583998124530471,0.0214589389504721,0.000615401159265463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39869,-0.0163751008912943,0.00478394129380229,-0.0257516258271468,-0.00699857595544183,0.000621701179965687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41771,0.0199607057171846,0.00584117511125995,0.0085120024991151,0.0314094089352541,0.000634504127845817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42124,-0.0103201242955976,0.00302865934562919,-0.0162562966130309,-0.00438395197816443,0.000657544908421256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41771,0.0110837058557537,0.00325718025166269,0.0046996325624948,0.0174677791490126,0.000668846140014388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41771,0.0276271371746608,0.00812100771465673,0.0117099620539337,0.043544312295388,0.000671095997245673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,42108,0.00823336259217502,0.00242081869245096,0.00348855795497113,0.0129781672293789,0.000673181955838935
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,39904,0.00966234580785542,0.00284379346008094,0.00408851062609678,0.0152361809896141,0.000681902567281336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,42187,-0.0232673188027837,0.00684835648025942,-0.0366900975040922,-0.00984454010147526,0.000681986428490902
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,41943,-0.00451787703473829,0.00133058695891167,-0.00712582747420518,-0.00190992659527141,0.000687277124127939
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,42111,0.0133645746178102,0.0039686012795947,0.00558611610980461,0.0211430331258158,0.000760432149709405
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39512,0.0360972259549478,0.0107187825351012,0.0150884121861494,0.0571060397237461,0.000760708196210382
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39675,0.0257494635069594,0.00768353131473232,0.010689742130084,0.0408091848838347,0.000807156184914689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,41771,0.0225625804508017,0.00673830265572412,0.0093555072455824,0.035769653656021,0.000815053661482135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39858,0.0146233393885362,0.00437950117952734,0.00603951707666264,0.0232071617004098,0.000843406786312674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39575,0.0119937142740554,0.00359920270022612,0.00493927698161217,0.0190481515664986,0.000864081687635551
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42072,-0.0143038968389795,0.00429415589566703,-0.0227204423944869,-0.00588735128347215,0.000867626048069174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41943,0.0382386160940979,0.0114802342489794,0.0157373569660982,0.0607398752220976,0.000868249374643396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42072,0.0223636811285615,0.00673424348948439,0.00916456388917209,0.0355627983679509,0.000899694298808655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41771,0.0175448657985362,0.0052832295448835,0.00718973589056454,0.0278999957065079,0.000899845050588001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,42048,0.0201129557160398,0.00606057667681098,0.00823422542949029,0.0319916860025893,0.000906927473251969
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,41828,0.0416270105871961,0.0125488886507059,0.0170311888318125,0.0662228323425798,0.000911738562676514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,41842,0.0255604236991205,0.0077396980096183,0.0103906156002687,0.0407302317979724,0.000960777987566379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,42039,0.00863181547416093,0.00261705619502567,0.00350238533191063,0.0137612456164112,0.000975276346519323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39696,0.0143108060495197,0.00434436875552337,0.0057958432886939,0.0228257688103455,0.000990449325887315
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39858,0.0175063711920897,0.00531474327296768,0.00708947437707303,0.0279232680071063,0.000991034344943609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,39639,0.0160399023595076,0.00487425774752261,0.00648635717436325,0.0255934475446519,0.00100238553871505
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,41842,0.0276314700421328,0.00840053034055141,0.011166430574652,0.0440965095096135,0.00100715840823339
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41842,0.0213952602470729,0.006510715524715,0.00863425781863148,0.0341562626755143,0.0010182704648353
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,39512,0.0202583808056273,0.00616842065665852,0.00816827631857658,0.032348485292678,0.00102591283843485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42210,0.018624914849842,0.00567447205239233,0.00750294962715304,0.029746880072531,0.00103249509893735
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,39590,0.0134755640257995,0.00411113994747711,0.00541772972874433,0.0215333983228546,0.00104938044233386
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41771,0.0164893108569273,0.00505959560061915,0.00657250347971379,0.0264061182341409,0.00112082256625517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42072,0.0176209465347874,0.00540880931701352,0.00701968027344086,0.0282222127961339,0.0011254813731329
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,42048,0.013776400359015,0.00423208994069314,0.0054815040752565,0.0220712966427736,0.0011358318743732
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39858,0.0160037305285011,0.00491852286755109,0.00636342570810095,0.0256440353489012,0.00114221295288866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,39869,0.0233141087454321,0.00717243026029652,0.00925614543525093,0.0373720720556133,0.0011553343713758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,39512,-0.014893721508566,0.00458380795336394,-0.0238779850971593,-0.00590945791997264,0.00116079301751024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39868,0.0129957509022385,0.00400106777764119,0.00515365805806177,0.0208378437464152,0.0011653059476731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,39792,0.01530688237691,0.00471294391872832,0.00606951229620244,0.0245442524576175,0.00116627796336193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,39858,0.0142409041061637,0.004387067809418,0.00564225119970447,0.022839557012623,0.00117335757930362
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,42070,-0.0117900940640465,0.00363698620582066,-0.018918587027455,-0.00466160110063804,0.0011909918577688
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42236,-0.0223599103301255,0.00691959084050764,-0.0359223083775205,-0.00879751228273058,0.00123481260931384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39597,0.00988243969338745,0.00306475040018591,0.00387552890902306,0.0158893504777518,0.00126539486157874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,39590,0.0174228695228402,0.00540391942924653,0.00683118744151697,0.0280145516041634,0.00126730776795906
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41766,0.0135154141944603,0.0041923877087868,0.00529833428523815,0.0217324941036824,0.00126810559098777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42108,-0.0104552676164987,0.00324450241447001,-0.01681449234886,-0.00409604288413753,0.00127397921997748
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41766,0.0259559876274408,0.00806299295128494,0.0101525214429223,0.0417594538119592,0.00128882655850718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39869,0.0273601385614493,0.00852028891809752,0.0106603722819782,0.0440599048409205,0.00132564432385287
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,39897,0.00789611847679727,0.00246035355697352,0.00307382550512918,0.0127184114484654,0.00133410356959161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42111,0.00945241761926613,0.0029690049062547,0.00363316800300692,0.0152716672355253,0.00145735901634197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39869,0.0140235710125165,0.00440644037070085,0.00538694788594284,0.0226601941390902,0.00146397429837498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39869,0.0294093787708712,0.00924201637514752,0.0112950266755821,0.0475237308661604,0.00146588532263003
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42048,-0.0168315152492007,0.00529606066422428,-0.0272117941510803,-0.00645123634732109,0.00148569018704621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39742,0.0195072285907889,0.00614672199991135,0.00745965347096262,0.0315548037106151,0.00150970967100706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,41741,0.0126613619384533,0.00400314434135814,0.00481519902939134,0.0205075248475153,0.00156586085200519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39675,0.0150439129661791,0.00475660491073664,0.00572096734113528,0.0243668585912229,0.00156712925940591
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,39696,-0.0573404999301029,0.0182290300389973,-0.0930693988065376,-0.0216116010536683,0.00166207328170221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39696,0.0121915346887612,0.00388072812551255,0.00458530756275658,0.0197977618147658,0.00168493045304635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42048,-0.0210084482931691,0.00670027332362548,-0.034140984007475,-0.00787591257886315,0.0017195355354377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,39500,-0.0137147274420593,0.00438581626460154,-0.0223109273206783,-0.00511852756344029,0.00177026196352809
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41771,0.0161867879343604,0.00518533926530798,0.00602352297435677,0.0263500528943641,0.00180232823975496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42142,0.0106972986900264,0.00342807328435653,0.00397827505268761,0.0174163223273652,0.00180924420166951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41943,0.0102705051859987,0.00329289498865364,0.00381643100823753,0.0167245793637598,0.00181858734101363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39512,0.0131985934803882,0.00423163788233377,0.00490458323101399,0.0214926037297624,0.00181921693700904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,42074,0.0321853535198374,0.0103397784437298,0.011919387770127,0.0524513192695478,0.00185728213991856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39858,0.021302566555596,0.00684862749940963,0.00787925665675309,0.0347258764544388,0.00187245794542026
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,39597,0.0217559838981227,0.00700219727343814,0.00803167724218398,0.0354802905540615,0.00189463465234569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42072,0.00596165051576217,0.00191947735242412,0.0021994749050109,0.00972382612651344,0.00190112872551549
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39895,-0.0136029784957264,0.00440198644670603,-0.0222308719312702,-0.00497508506018258,0.00200514168603187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41771,0.0241790712993886,0.00782968356375573,0.00883289151442738,0.0395252510843498,0.00201840014733314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42072,-0.0372574545399249,0.0120907413202968,-0.0609553075277066,-0.0135596015521433,0.00206385360708779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,41686,0.0247885687527144,0.00804692276226188,0.0090166001386811,0.0405605373667477,0.00207079982184113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39696,0.0294253337994964,0.00956984505360888,0.010668437494423,0.0481822301045698,0.0021115748788656
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42056,0.0194339782861801,0.00632359955904794,0.00703972315044614,0.0318282334219141,0.00212167148144941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,41842,-0.0156531207743068,0.00510156348527363,-0.0256521852054431,-0.00565405634317046,0.00215716179729786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39904,-0.0137043498556832,0.00447063725643407,-0.022466798878294,-0.00494190083307245,0.00217882226743413
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,39895,0.0332632112743548,0.0108521149975186,0.0119930658792183,0.0545333566694912,0.00218084222499888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42175,0.0104275582432551,0.00340387506606453,0.00375596311376862,0.0170991533727416,0.0021923863630513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,39590,0.0152482812680016,0.00498075154925519,0.00548600823146142,0.0250105543045418,0.00220805606016838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42187,-0.0111057570145645,0.00363626800832202,-0.0182328423108756,-0.00397867171825331,0.00226125923868119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,39917,-0.0110836579566725,0.00363402690243339,-0.0182063506854419,-0.00396096522790305,0.00229396664637217
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,41766,0.0163734415063783,0.00537261161037946,0.00584312275003457,0.026903760262722,0.00231152506880706
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39850,0.0234352012734126,0.00769513109916473,0.00835274431904968,0.0385176582277754,0.00232863511674931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41943,0.0204585973744533,0.00672019092261972,0.00728702316611868,0.033630171582788,0.00233639772867296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,41766,-0.0107415095942754,0.00353045625383255,-0.0176612038517872,-0.00382181533676359,0.00235062675740808
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39872,-0.0153056963977436,0.00504106964283346,-0.0251861928976972,-0.00542519989778999,0.00240127402115652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41995,0.0177091099239056,0.00583779490920139,0.00626703190187089,0.0291511879459403,0.00242175855408241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,42072,0.00810557280872068,0.00267876643930089,0.00285519058769093,0.0133559550297504,0.00248394697954449
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39858,0.00958634111029,0.00317435206373033,0.00336461106537855,0.0158080711552014,0.00253394687606513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,39512,0.024928952554119,0.00827016161445383,0.00871943578978945,0.0411384693184485,0.00258143720234803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39895,0.0247673043535389,0.00821730114453472,0.00866139411025083,0.0408732145968269,0.00258362701476678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,39895,0.0218940639617526,0.00726472715694023,0.00765519873414975,0.0361329291893554,0.00258613563716058
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39791,0.0222907284067715,0.007401642003811,0.0077835100793019,0.036797946734241,0.0026046160470661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39575,-0.0131609113683743,0.00438632540480534,-0.0217581091617928,-0.00456371357495582,0.00270194346384931
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41967,0.00931439868423635,0.00310592171395246,0.00322679212488954,0.0154020052435832,0.00271440577251286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39675,0.0293469886453926,0.00978930370008443,0.0101599533932271,0.0485340238975581,0.00272483369937687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39887,0.00753156134810121,0.00251381212197701,0.00260448958902628,0.0124586331071761,0.00274076238245678
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39895,-0.0116797464211359,0.0039013877771944,-0.0193264664644369,-0.00403302637783488,0.00276175884340242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39869,0.0143233607293426,0.00480216053954355,0.00491112607183723,0.023735595386848,0.00286337991152271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,39660,0.0189207201888993,0.00636011021007188,0.00645490417715842,0.0313865362006402,0.00293712983993019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39869,0.039117286101493,0.0131643300144668,0.0133151992731381,0.0649193729298479,0.00297012817332863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,39868,-0.0292857324158337,0.00985812519491444,-0.048607657797866,-0.00996380703380137,0.00297729029539289
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39575,0.0108999945498329,0.00368450234989595,0.00367836994403684,0.018121619155629,0.00309964981727756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39917,-0.00498687694811183,0.00168727645682111,-0.00829393880348121,-0.00167981509274244,0.00312727342200324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,39869,0.0202169750809287,0.00684814299573503,0.00679461480928807,0.0336393353525694,0.0031618590065243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39895,-0.0124627321671785,0.00422852801664154,-0.0207506470797959,-0.00417481725456104,0.00321219586323065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42187,-0.019804226645873,0.00672697452085114,-0.0329890967067412,-0.00661935658500473,0.00324546322874941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39575,0.0172134477349772,0.00585415997752048,0.00573929417903709,0.0286876012909174,0.00328495213508661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39831,0.0146690195294731,0.00498960367010854,0.00488939633606036,0.0244486427228858,0.00328969397823331
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,39732,0.0105358752066179,0.00358730120597498,0.00350476484290693,0.0175669855703288,0.003320914438501
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,42008,-0.00920226800218339,0.0031350285193413,-0.0153469239000923,-0.00305761210427445,0.00333784380512469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39597,-0.0136570840004785,0.00466013519465404,-0.0227909489820005,-0.00452321901895661,0.00338982576730257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,39825,0.00914991699884526,0.00312419954409591,0.00302648589241727,0.0152733481052733,0.0034104126454044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41903,0.00942483639526674,0.00323508833669344,0.0030840632553476,0.0157656095351859,0.00358207043462457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42142,-0.00865918014107482,0.00297895756667755,-0.0144979369717628,-0.00282042331038683,0.0036575977380981
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42111,0.00909911966632723,0.0031342105954036,0.00295606689933617,0.0152421724333183,0.00370013733839139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,39895,0.0122360482346596,0.00421825124274999,0.00396827579886959,0.0205038206704495,0.00373001551510596
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39675,-0.00897822522879775,0.00309765629986736,-0.0150496315765378,-0.00290681888105773,0.0037581631894556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39895,-0.00983506748542944,0.00339702562360443,-0.0164932377076941,-0.00317689726316475,0.00379643554686009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39858,0.0137055933259117,0.00474136921179228,0.00441250967079885,0.0229986769810246,0.00385192735391899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42108,-0.0144375530185063,0.00500075686309017,-0.024239036470163,-0.00463606956684952,0.00389459992192152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42174,-0.00894762760378233,0.00310672576993382,-0.0150368101128526,-0.00285844509471205,0.00398192670254331
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,39512,-0.0183927089089917,0.00639022641756464,-0.0309175526874184,-0.00586786513056503,0.00400656717158611
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39597,0.0127566046640956,0.00444299261159114,0.00404833914537698,0.0214648701828142,0.0040973137713947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,39895,0.0167656549889777,0.00585831529727214,0.00528335700632434,0.0282479529716311,0.00421942060909891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39696,0.0221207045360768,0.00774653986027884,0.00693748640993029,0.0373039226622233,0.00430408074087119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42236,0.00712899991011528,0.00249900373256269,0.00223095259429242,0.0120270472259382,0.00434097137287339
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,41766,0.0140077474593022,0.00491173521937311,0.00438074642933088,0.0236347484892735,0.00435272550868407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39675,0.0116800548217859,0.00409640642933437,0.00365109822029055,0.0197090114232813,0.00436223438250673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39590,0.0124951643987687,0.00438244796845291,0.00390556638060099,0.0210847624169364,0.00436379433838305
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39575,0.0135786949279422,0.00476837359592743,0.00423268267992448,0.02292470717596,0.00441240935244324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41771,0.0165030493849043,0.00583611742154869,0.00506425923866892,0.0279418395311398,0.00469479179042152
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,42003,0.00776129656995777,0.00274568216013727,0.00237975953608871,0.0131428336038268,0.00470958886838831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39858,0.0201865450020203,0.00714312664245889,0.00618601678280088,0.0341870732212397,0.00472148543579786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41842,0.0111367126459046,0.0039484582777049,0.00339773442160298,0.0188756908702062,0.00480169033058823
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,42048,0.0106371906388389,0.00377141340133764,0.00324522037221708,0.0180291609054606,0.00480222784715568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39872,0.00902011420405489,0.00319962663320044,0.00274884600298202,0.0152913824051278,0.00482402876464782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39575,0.0119522977573547,0.00424463156924389,0.00363281988163668,0.0202717756330727,0.00487332779272649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,42187,0.00976884077914792,0.00347128567493554,0.00296512085627427,0.0165725607020216,0.00489713340689517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,42072,0.0108760448127994,0.00386644778414965,0.00329780715586609,0.0184542824697327,0.00491634724921233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39590,0.01664555535432,0.00592082738211715,0.00504073368537035,0.0282503770232696,0.00494204761713293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,41766,0.0212009368373904,0.00755014519272857,0.00640265225964246,0.0359992214151384,0.00499209355954194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,42111,-0.0204308869749289,0.00728185512130433,-0.0347033230126854,-0.00615845093717245,0.0050275212824952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,41911,-0.0107316252640093,0.00383427590236446,-0.0182468060326436,-0.00321644449537495,0.00513561518468231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42072,-0.00865863254756167,0.00309726567886246,-0.0147292732781321,-0.00258799181699126,0.0051881111075042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,42048,0.0155585189128535,0.00556762323166086,0.00464597737879817,0.0264710604469087,0.00520595390656896
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39858,0.0107671242901295,0.00386013186590521,0.00320126583295532,0.0183329827473038,0.00529083818487015
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39500,-0.014766950938498,0.00529701607073037,-0.0251491024371295,-0.00438479943986646,0.00531613833131159
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41943,0.0140403752390908,0.00505543525101982,0.004131722147092,0.0239490283310897,0.00548918981542958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41771,0.0144042216396669,0.0051950224491034,0.0042219776394242,0.0245864656399095,0.00556720393987044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41771,0.0159047969417868,0.0057528879934403,0.00462913647464376,0.0271804574089298,0.00570608681641941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39872,0.0180863810643427,0.00654407739237143,0.00525998937529475,0.0309127727533907,0.00572290419580364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,39872,0.00773284531434969,0.00280039446077145,0.00224407217123764,0.0132216184574617,0.00576576060566477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,39526,-0.0141771664012722,0.0051420460556822,-0.0242555766704093,-0.00409875613213504,0.0058412247216165
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42050,-0.00704697429105742,0.00256167440273599,-0.01206785612042,-0.00202609246169487,0.00595067347339022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,39512,-0.0101963069118263,0.00370931434274229,-0.0174665630236012,-0.00292605080005137,0.00599051553574573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41932,0.0305972983577569,0.0111483957387785,0.00874644270975095,0.0524481540057628,0.00606755349283566
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39675,0.0191959047163666,0.00701300891326137,0.00545040724637432,0.0329414021863589,0.00620662634741461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39904,0.0189065625269324,0.00691592916211516,0.00535134136918666,0.0324617836846781,0.00627111350100811
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39512,-0.0062471340263628,0.00228811084610651,-0.0107318312847315,-0.00176243676799405,0.00633862488065652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39500,-0.0093095064120566,0.00342063217412679,-0.0160139454733451,-0.00260506735076811,0.00650748715584296
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42172,0.0201397341977666,0.00740468405491202,0.00562655345013909,0.0346529149453942,0.00653918708927819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,41842,0.0147403319910467,0.00542081692825009,0.00411553081167652,0.0253651331704169,0.00655236092282084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,41998,0.0197514707833241,0.00728339464742361,0.00547601727437381,0.0340269242922744,0.00669942958020303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,39673,-0.0113843254854841,0.00421244438930258,-0.0196407164885172,-0.00312793448245108,0.00689155363349363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41828,-0.0101785747790015,0.00377429522218984,-0.0175761934144936,-0.00278095614350938,0.00700948802556683
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39858,0.0117412101544498,0.00435653840015504,0.00320239489014593,0.0202800254187537,0.00704766726620565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39868,0.00803715399358062,0.00299916699554843,0.0021587866823057,0.0139155213048555,0.00737742435983927
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39556,0.0109736936715488,0.00411152496053884,0.00291510474889265,0.0190322825942049,0.00761876994132317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39590,0.00983475556721103,0.00368805048877686,0.00260617660920838,0.0170633345252137,0.00767226194046051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41995,0.0246511221612948,0.00931735021525966,0.00638911573938586,0.0429131285832037,0.00816118907400957
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41771,-0.00870509854347476,0.00330043380418104,-0.0151739487996696,-0.00223624828727992,0.0083602478213983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,42071,0.0157211381056015,0.00598476042222655,0.00399100767803744,0.0274512685331655,0.00862739030905751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,42063,-0.0127668957668345,0.00489108332268527,-0.0223534190792976,-0.00318037245437136,0.00905792192881838
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,42072,0.0217168645379484,0.00835521180175051,0.0053406494065174,0.0380930796693794,0.00935432384098286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39500,-0.0226099198256462,0.00873047842006263,-0.0397216575289689,-0.00549818212232344,0.00961681759355115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42236,0.00777185805682779,0.00301016596809185,0.00187193275936777,0.0136717833542878,0.00983698548581282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,39904,-0.0135336706720028,0.00524873858737905,-0.0238211983032657,-0.00324614304073984,0.00993666553892398
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41967,-0.0114792779790246,0.00445618551433529,-0.0202134015871218,-0.00274515437092745,0.0100047659351515
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39500,0.017398848249468,0.00676671777306952,0.00413608141425171,0.0306616150846842,0.010146676928548
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41747,0.0114867773847239,0.00446894525272532,0.00272764468938231,0.0202459100800656,0.0101703311628203
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39696,-0.00982285923850671,0.00382218627044647,-0.0173143443285818,-0.00233137414843163,0.0101840077801788
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42039,0.0121013218427723,0.00472330111069636,0.00284365166580739,0.0213589920197371,0.0104165120701815
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39597,-0.012035357549806,0.00470145930289661,-0.0212502177834834,-0.00282049731612865,0.0104828853209107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,39904,0.0235169881408073,0.00921508664216601,0.00545541832216196,0.0415785579594527,0.0107233994832987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,39868,0.0274047756391713,0.0107484110449326,0.00633788999110344,0.0484716612872392,0.0107959791480324
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,41837,0.0204080448341413,0.00802349669361644,0.00468199131465306,0.0361340983536295,0.0109849791802292
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,39675,0.0101971819433797,0.00400915248184081,0.0023392430789717,0.0180551208077877,0.0109890449637942
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41865,0.00666533600127997,0.00262624241547507,0.00151790086694884,0.0118127711356111,0.0111609560448557
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39512,0.0101920127032951,0.00401813334775219,0.00231647134170079,0.0180675540648894,0.0112103530179007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39868,0.01547471517746,0.00610697016223011,0.00350505365948895,0.027444376695431,0.011292134121293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,39512,-0.0112079541926484,0.00442715332823744,-0.0198851747159938,-0.00253073366930298,0.0113669956744482
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,41828,0.0217692215911587,0.00860464638587835,0.0049041146748371,0.0386343285074802,0.0114197768480022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39575,0.00881541553692782,0.00349871596329467,0.00195793224887026,0.0156728988249854,0.011762420226038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39575,0.0120748578368664,0.00479511696620543,0.00267642858310377,0.0214732870906291,0.0118111769274802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42055,0.0261388437726637,0.0104310034409612,0.00569407702837981,0.0465836105169476,0.0122264142236929
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42236,-0.0082020213535075,0.00327313710713308,-0.0146173700834883,-0.00178667262352666,0.0122269739670086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41842,-0.0110578889612393,0.0044163938789769,-0.019714020964034,-0.00240175695844456,0.0122977211548371
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41874,-0.00762324108333585,0.0030579260672784,-0.0136167761752015,-0.00162970599147018,0.0126809401873038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,39590,0.00859983955118823,0.00345162646076478,0.00183465168808926,0.0153650274142872,0.0127339626943383
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,39526,0.0223335103381119,0.00899464869192037,0.00470399890194802,0.0399630217742759,0.0130438238784498
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39896,-0.00535179697405199,0.00216137878019905,-0.00958809938324212,-0.00111549456486186,0.0132970586845681
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,41828,-0.0140673791935168,0.0056879349793564,-0.0252157317530553,-0.00291902663397822,0.0134035275897641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,39512,-0.0107187328909471,0.0043407192139853,-0.0192265425503583,-0.00221092323153589,0.0135512620140733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39868,-0.0160143963923603,0.00650015692996336,-0.0287547039750884,-0.00327408880963207,0.0137661805499654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39869,-0.00966504079555545,0.00392935512378517,-0.0173665768381744,-0.00196350475293652,0.0139201674990013
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,41943,-0.0128984569168638,0.00524646646418879,-0.0231815311866738,-0.00261538264705374,0.0139643460421595
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41842,-0.0164538886410369,0.00669406590642371,-0.0295742578176273,-0.00333351946444642,0.0139847610851492
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41771,-0.0102285518744742,0.00416175403510822,-0.0183855897832863,-0.00207151396566213,0.0139938255630392
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41995,0.0120852928712145,0.00491901020254215,0.00244403287423184,0.0217265528681971,0.0140285289651872
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,39917,-0.0060771981856559,0.00247470704504689,-0.0109276239939478,-0.001226772377364,0.0140750223418237
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,41766,0.00791252948085553,0.00322243667116848,0.0015965536053653,0.0142285053563458,0.0140836970213416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39869,-0.0146378400253199,0.00596318762339904,-0.026325687767182,-0.00294999228345781,0.0141152064734821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41747,0.0130048871439743,0.00530274571868696,0.00261150553534781,0.0233982687526007,0.0142003596504542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,41766,0.0133865174070031,0.00546034963637814,0.00268423211970197,0.0240888026943043,0.0142357138373366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39575,0.0108009747761937,0.00441514904961792,0.00214728263894256,0.0194546669134448,0.0144468948886363
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39500,0.00795071995258488,0.00325023506597384,0.00158025922327616,0.0143211806818936,0.014452845751253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39512,-0.022520175990089,0.00920814306728513,-0.0405681364019679,-0.00447221557821016,0.0144735935803283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39705,0.0106561588182005,0.00436191932950456,0.00210679693237152,0.0192055207040294,0.0145813012684585
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42111,-0.00575489379157478,0.00235985263653873,-0.0103802049591907,-0.00112958262395886,0.0147543506107012
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,39590,-0.0101464567741165,0.00416095176929874,-0.018301922241942,-0.00199099130629097,0.0147643214404532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39512,-0.00705225437079029,0.00290360418868929,-0.0127433185806213,-0.00136119016095927,0.015165209420316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41943,0.00968394007927701,0.0039939646890862,0.00185576928866807,0.0175121108698859,0.0153366215431563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39677,-0.0140705467532316,0.00580865423138902,-0.025455509046754,-0.00268558445970909,0.0154367702029147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,39858,0.018714344741882,0.00773020143033372,0.00356314993842793,0.0338655395453361,0.0154961923396544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,41895,0.0279374101289089,0.0115459684652994,0.00530731193692215,0.0505675083208957,0.0155480087533477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,42063,-0.00526562655958797,0.00217635095485997,-0.00953127443111352,-0.000999978688062424,0.0155560940036529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42063,0.00976071803797189,0.00403482502539863,0.00185246098819057,0.0176689750877532,0.0155713580241311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,42236,-0.0195778591942183,0.00809487471595174,-0.0354438136374838,-0.00371190475095293,0.0155955143793163
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39696,-0.0209677167386913,0.00866955164537412,-0.0379600379636246,-0.00397539551375805,0.0155986282454902
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,39869,0.00896712388293203,0.00370958739916288,0.00169633258057277,0.0162379151852913,0.0156526085022439
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,39500,-0.00904113571334881,0.00375475876380734,-0.0164004628904112,-0.00168180853628642,0.0160604671222316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42236,0.00779491788706178,0.00324780376931043,0.00142922249921335,0.0141606132749102,0.01640579109939
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39479,0.0227676395623628,0.00949378134279071,0.00415982813049297,0.0413754509942325,0.0164942506272761
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42187,0.00877281118914575,0.00366409079047536,0.00159119323981403,0.0159544291384775,0.0166670966229188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39868,0.00736803163071857,0.00307961327694242,0.00133198960791142,0.0134040736535257,0.0167494646151096
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42048,0.0127408699070263,0.00532687457328608,0.0023001957433856,0.023181544070667,0.0167791873522312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41771,0.0122996075936615,0.00514311392036561,0.00221910430974485,0.0223801108775781,0.0167949559933447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39597,0.0117066087453378,0.00489590351386722,0.00211063785815803,0.0213025796325175,0.0168145570140048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41842,-0.00949739656389658,0.00397220256104378,-0.0172829135835424,-0.00171187954425077,0.0168180418732864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,39696,-0.0108699277510422,0.00454695932455866,-0.0197819680271772,-0.00195788747490723,0.0168377733987007
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,42187,0.0122175871042985,0.00511139856328733,0.00219924592025531,0.0222359282883417,0.0168498476066486
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39927,0.0191949576959738,0.00804918739869375,0.00341855039453404,0.0349713649974135,0.017109058314645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42048,0.0179029025256193,0.00750778527557327,0.00318764338549567,0.0326181616657429,0.0171124808411064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39526,0.00830880459969078,0.00348537481960975,0.00147746995325567,0.0151401392461259,0.0171469660897839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,42236,0.00805428293781754,0.00338121315339296,0.00142710515716733,0.0146814607184677,0.0172293015707155
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39500,0.0219041596275959,0.00919705654105346,0.00387792880713115,0.0399303904480607,0.0172523804979859
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42063,0.0108647296278092,0.00456348983743194,0.00192028954644257,0.0198091697091758,0.017289191431427
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,39575,0.00809343823540463,0.00340168024668191,0.00142614495190809,0.0147607315189012,0.0173650308325542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,41924,0.00927477892512757,0.00389856301190044,0.0016335954218027,0.0169159624284524,0.0173724990294004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42149,0.00788590093158428,0.00331772916055904,0.00138315177688856,0.01438865008628,0.017472761158186
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41542,0.0083799116488718,0.00354010515145858,0.00144130555201299,0.0153185177457306,0.0179409539694656
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41766,0.0130438120962968,0.00551137231218431,0.00224152236441558,0.0238461018281781,0.0179614449075947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39904,-0.00698330291688319,0.00295973175488368,-0.0127843771564552,-0.00118222867731117,0.0183195558088053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,39512,-0.0167267403489802,0.00709431535323745,-0.0306315984413256,-0.00282188225663482,0.0184027934232491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,41812,0.0228185954148528,0.00970891771977236,0.00378911668409902,0.0418480741456067,0.0187743328906636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39872,0.00808383969981753,0.00344470629435244,0.00133221536288675,0.0148354640367483,0.0189555384827775
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,41730,-0.0123388539959416,0.00526029363092819,-0.0226490295125609,-0.00202867847932238,0.019008284796029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41828,-0.00870440500965176,0.00371687333295147,-0.0159894767422366,-0.00141933327706688,0.0192025556913897
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,42034,0.0102987077059722,0.00440064680400309,0.00167343997012616,0.0189239754418183,0.0192842898563703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41842,0.009471436028624,0.00404716814525392,0.00153898646392632,0.0174038855933217,0.0192849561964148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39512,0.0224130742931383,0.00958590242487105,0.00362470554039107,0.0412014430458856,0.0193985365294697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,39872,-0.00889412371123517,0.00380985223558947,-0.0163614340929905,-0.00142681332947982,0.0195866996448941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42102,0.0129663770174279,0.00558185279185987,0.00202594554538254,0.0239068084894732,0.0201965045750804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42050,0.0759420316545358,0.0327174435539455,0.0118158422888027,0.140068221020269,0.0202937231495859
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39675,0.0189939876488327,0.00820727473990561,0.0029077291586177,0.0350802461390477,0.0206701990368347
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39526,-0.0189749806540154,0.00821837159193285,-0.0350829889742038,-0.002866972333827,0.0209705189404194
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39597,0.0268977682922961,0.0116506004235926,0.00406259146205458,0.0497329451225377,0.020978556454779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41771,-0.00802201625026576,0.00347684794221461,-0.0148366382170064,-0.00120739428352512,0.0210553750243328
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39597,-0.00868554985887221,0.0037655412399548,-0.0160660106891836,-0.0013050890285608,0.0210963303504294
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42222,0.0166431478140861,0.00721944612932655,0.00249303340060605,0.0307932622275661,0.0211635005975449
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39590,0.0216155375505893,0.00938997455980224,0.00321118741337688,0.0400198876878017,0.0213548817244945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,39868,-0.0100965035635757,0.00439218842486056,-0.0187051928763024,-0.00148781425084899,0.021537864354364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,39696,-0.00843036632532987,0.00367052059455499,-0.0156245866906577,-0.00123614596000209,0.0216500454264242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PI3,Elafin,41894,0.0141145776570512,0.00615386519397109,0.00205300187686787,0.0261761534372345,0.021828335064779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,39872,0.00757439255966314,0.00331271390325576,0.00108147330928186,0.0140673118100444,0.0222457374537323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,41995,0.011304028117697,0.00494924267268827,0.00160351247922798,0.021004543756166,0.0223876074544331
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39526,0.0120463810668686,0.0052940234620574,0.00167009508123613,0.0224226670525011,0.022897146169891
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,39872,0.015174057338506,0.00667086939149803,0.00209915333116985,0.0282489613458421,0.0229441571947146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39597,0.00948810564647598,0.00417391583281402,0.00130723061416051,0.0176689806787914,0.0230339054501195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,42072,0.0167417696779946,0.00736617581004718,0.00230406509030208,0.031179474265687,0.0230545260313442
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,41771,0.0077852320802483,0.00343055186105391,0.00106135043258263,0.014509113727914,0.0232612135784835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,41676,-0.0166861804100798,0.0073688855260896,-0.0311291960412154,-0.00224316477894422,0.0235651926002848
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,39814,-0.018106512036497,0.0080001686150928,-0.0337868425220789,-0.00242618155091511,0.023638311636702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,39917,-0.0050069275582364,0.00221575524785983,-0.00934980784404167,-0.000664047272431129,0.0238592178416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42222,0.0181801090279263,0.00805261587955195,0.00239698190400447,0.0339632361518481,0.0239823162463771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39696,0.0141701171334324,0.00628257757290885,0.00185626509053104,0.0264839691763337,0.0241237214264623
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41995,0.00527071043731654,0.00234423703073488,0.000676005857076178,0.00986541501755689,0.0245688451042098
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,42072,0.0085979374356244,0.0038345933940035,0.00108213438337754,0.0161137404878713,0.0249644478441468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39597,0.00893320424122603,0.00398559721455556,0.00112143370069713,0.0167449747817549,0.025021884649028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41360,0.0102726276587895,0.00458998322825305,0.00127626053141349,0.0192689947861654,0.025234753584273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41842,0.00767157834898341,0.00343493126076692,0.000939113077880239,0.0144040436200866,0.0255391599974607
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39500,0.0232454832956944,0.0104221534450043,0.00281806254348605,0.0436729040479028,0.0257417331256269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42063,0.00598687320040646,0.00268432338758639,0.000725599360737128,0.0112481470400758,0.0257432883866753
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39917,-0.0044657511454898,0.00200993537641194,-0.0084052244832572,-0.000526277807722395,0.026313944480379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41771,0.00972896966436769,0.0043967487134762,0.00111134218595434,0.018346597142781,0.0269309669208959
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,39858,0.0128495385659088,0.0058100614161003,0.00146181819035222,0.0242372589414654,0.0270142460192976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41995,0.00887574351808483,0.00401731055087653,0.00100181483836683,0.0167496721978028,0.0271654585011928
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,42009,0.00848760659792025,0.00384234695679321,0.000956606562605552,0.0160186066332349,0.02719398119406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39868,0.0113868061948458,0.00515930494924325,0.00127456849432899,0.0214990438953625,0.0273311629303517
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39512,-0.0159137256607063,0.00723101120188992,-0.0300865076164105,-0.00174094370500208,0.027773835848001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,41943,-0.0251605013390194,0.0114406357453749,-0.0475841473999542,-0.00273685527808456,0.0278792127337443
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39364,0.0260222029451333,0.0118861915274563,0.00272526755131903,0.0493191383389475,0.0285978835847317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,42048,0.00955681925786066,0.004378834611881,0.000974303418573892,0.0181393350971474,0.0290896772812237
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42174,0.0112638365400439,0.00517074137537761,0.00112918344430381,0.021398489635784,0.0293949497062837
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42063,-0.00844452498071003,0.00387803417045752,-0.0160454719548068,-0.000843578006613286,0.0294585565146835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41842,0.0156015142701254,0.00717043399392655,0.00154746364202931,0.0296555648982214,0.0295869639069323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39696,0.0107826151210918,0.00496142342574259,0.00105822520663631,0.0205070050355472,0.0297795295154565
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41771,0.00858321373821094,0.00395394208819911,0.00083348724534069,0.0163329402310812,0.0299641668903468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39512,-0.0136626140605475,0.0063036490778343,-0.0260177662531027,-0.00130746186799223,0.030224895249996
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41766,0.0353059107943217,0.0162934660298906,0.00337071737573613,0.0672411042129072,0.0302622301573461
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,41599,0.00866997295679322,0.00400589933040991,0.000818410269189801,0.0165215356443966,0.0304593842666312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39847,0.00860277986801791,0.00398213191069652,0.000797801323052742,0.0164077584129831,0.0307670034349109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39872,0.0279141820488236,0.0129247434992911,0.00258168479021294,0.0532466793074342,0.0308132424907541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39682,-0.0127079083236735,0.00588863944703677,-0.0242496416398656,-0.00116617500748143,0.0309462818238276
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,39479,-0.00972885812116549,0.00451903550808681,-0.0185861677170156,-0.00087154852531535,0.0313514725604536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39872,0.00709452848233291,0.00329774388388595,0.000630950469916439,0.0135581064947494,0.0314715092175433
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,39512,-0.0108124009096417,0.00503057604182203,-0.0206723299516129,-0.000952471867670503,0.0316296539174802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,39597,-0.0130980016219526,0.00610345564357299,-0.0250607746833557,-0.00113522856054958,0.0318949834172767
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39526,-0.0198645799502542,0.00927987032246391,-0.0380531257822834,-0.00167603411822493,0.0323275990525467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39597,-0.0106418542797943,0.00497185706569468,-0.0203866941285559,-0.000897014431032725,0.0323429002098328
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39696,0.0147816663345308,0.00693511101395265,0.00118884874718356,0.0283744839218779,0.0330760878143817
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39597,0.00726964757503385,0.00341230184740816,0.000581535954113856,0.0139577591959538,0.0331588049096835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39675,-0.00858449486140967,0.00403193527596585,-0.0164870880023027,-0.00068190172051661,0.0332659039547912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39526,-0.0134389734449712,0.00631322671343195,-0.0258128978032979,-0.00106504908664461,0.033301293507756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41863,-0.0392396131004532,0.0184534215349141,-0.0754083193088848,-0.00307090689202158,0.0334872194788281
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41995,0.012368656786604,0.00582356895501214,0.000954461634780236,0.0237828519384278,0.033697084514652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39597,0.0136470599582395,0.00642745160286087,0.00104925481663221,0.0262448650998468,0.0337555248731713
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,39500,0.0165628610223789,0.0078034743259631,0.0012680513434912,0.0318576707012666,0.0338183973402124
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,41771,0.0170399526320484,0.00803229699448666,0.00129665052285454,0.0327832547412422,0.0339042893028089
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,39512,0.0259855021152722,0.0122542573541311,0.00196715770117534,0.0500038465293691,0.0339839962016274
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42149,0.0158811626235627,0.00749615531233045,0.00118869821139506,0.0305736270357304,0.0341446013527664
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39590,-0.015931594709358,0.00752203684498747,-0.0306747869255334,-0.00118840249318257,0.0341983474149738
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42089,0.0118475220755337,0.00561083058805388,0.000850294122948063,0.0228447500281193,0.0347438233611128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39500,-0.0108215145736923,0.00513460651189465,-0.0208853433370058,-0.00075768581037877,0.0350914502550555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41995,0.00945190290081164,0.00448959646114888,0.000652293836959826,0.0182515119646634,0.0352846345682384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41842,0.0266711892645197,0.0126696040440594,0.00183876533816329,0.051503613190876,0.0352986036506999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39869,0.0111175881764019,0.00528767787258865,0.000753739546128177,0.0214814368066757,0.0355275627907444
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42070,0.00798793237955061,0.00380277975762934,0.00053448405459711,0.0154413807045041,0.0356989503732415
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,39664,-0.00482909642116659,0.00230057315607415,-0.00933821980707192,-0.000319973035261265,0.0358320932449675
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39512,-0.00839535381590911,0.00400857024481074,-0.0162521514957382,-0.000538556136080061,0.0362517159978369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42207,0.0118959947520754,0.00569523142825497,0.000733341152695704,0.0230586483514552,0.0367475033420466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42063,-0.00815358692190493,0.0039067238967933,-0.0158107657596198,-0.000496408084190068,0.0369010158381153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39872,-0.00869433233676307,0.00417605888170779,-0.0168794077449103,-0.000509256928615795,0.0373698344622212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41900,-0.00560215410537299,0.00269334981935172,-0.0108811197513024,-0.000323188459443624,0.0375450954760889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,39897,0.0032885560487433,0.0015822278311426,0.00018738949970381,0.00638972259778279,0.037691926042884
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39512,0.00972102113283125,0.00468039164103684,0.000547453516399047,0.0188945887492634,0.0378279031527971
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,42048,-0.0134422068160029,0.00652095579924533,-0.0262232801825237,-0.000661133449482022,0.0392854088603827
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42048,0.0336950784998777,0.0163903538584069,0.00156998493740017,0.0658201720623552,0.039822300728972
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_DRA,,41989,-0.00817812725711031,0.00398318115097719,-0.0159851623130256,-0.000371092201195006,0.0400759848798926
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39904,0.0052183644082934,0.00254177211340122,0.000236491066027016,0.0102002377505598,0.0400914873345111
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39696,-0.0162769702448514,0.00793132759220695,-0.031822372325577,-0.000731568164125762,0.0401699673848396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39512,-0.0087267336419196,0.00425309767837707,-0.0170628050915387,-0.000390662192300552,0.0402077067291703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39512,-0.0152439088484475,0.00745693917714341,-0.0298595096356486,-0.000628308061246422,0.0409520001016794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41547,0.00852400850393409,0.00417171546504864,0.000347446192438745,0.0167005708154294,0.0410443193393466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41943,-0.0155479400385269,0.00761081051044859,-0.0304651286390062,-0.000630751438047689,0.0410843497363613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,39853,-0.00550855027288,0.00269687870282011,-0.0107944325304074,-0.000222668015352577,0.0411187657525145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,41942,0.0131662532543893,0.0064564924518554,0.00051152804875269,0.0258209784600258,0.0414470485762131
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,41766,0.00860101797745012,0.00421952639921982,0.000330746234979272,0.016871289719921,0.041531416360477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,39526,0.0237633194139995,0.0116603092393896,0.000909113304795893,0.0466175255232032,0.0415773199708502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41859,0.00757611917409063,0.00372004477513382,0.000284831414828338,0.0148674069333529,0.0417133130877182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39500,-0.00581976694206148,0.00286175604056974,-0.0114288087815782,-0.000210725102544785,0.042012592028467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,42174,0.00667989917057734,0.00328968633613345,0.000232113951755774,0.0131276843893989,0.0423192978293326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39512,-0.00953488639374778,0.00469650423058976,-0.0187400346857037,-0.000329738101791845,0.0423594790526856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,39675,0.00767702019354458,0.00379950983605586,0.000229980914875087,0.0151240594722141,0.0433525556938266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39858,-0.00904886202535222,0.00447974585111928,-0.017829163893546,-0.00026856015715843,0.0434122286982035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,41842,0.0106142017265494,0.00526295926929558,0.000298801558730067,0.0209296018943688,0.0437392024504061
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39597,0.0142045263504673,0.00704942468841538,0.000387653961173197,0.0280213987397615,0.0439298951006947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39526,-0.0184009727110509,0.0091570434464051,-0.0363487778660049,-0.000453167556096888,0.0445099056628921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39590,-0.0131389508259359,0.00654493969008123,-0.0259670326184951,-0.000310869033376696,0.0447211393747221
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,39917,-0.00659303371619084,0.00328436515584547,-0.013030389421648,-0.000155678010733721,0.0447308486574852
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41771,-0.0113768240827922,0.00567384554372029,-0.022497561348484,-0.000256086817100444,0.0449690810995071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,41943,0.0123299885046968,0.00614925351859904,0.000277451608242689,0.0243825254011509,0.0449704268636436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41771,0.0110012914218071,0.00548809146592351,0.000244632148596987,0.0217579506950172,0.0450289233765257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,39597,0.00919625022376661,0.00459032042885635,0.000199222183208158,0.0181932782643251,0.0451588088279808
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39481,-0.00583697312277511,0.00291760946024444,-0.0115554876648542,-0.000118458580696001,0.0454601795515654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41995,0.0075726683400293,0.00378565993993718,0.000152774857752423,0.0149925618223062,0.0454819632916841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42063,0.00966507770355191,0.00485212947660155,0.000154903929412883,0.0191752514776909,0.0463994593560009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39834,0.00585091311051323,0.00297070418702591,2.83329039424398e-05,0.011673493317084,0.0489159399079861
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,42174,0.00792062904969733,0.00402582370755037,3.00145828986062e-05,0.0158112435164961,0.0491510502091137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,42142,0.0100269735970569,0.00510036309882296,3.0261923363941e-05,0.02002368527075,0.0493267158722905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39512,0.0141104139337905,0.00718508869154923,2.7640098354027e-05,0.028193187769227,0.0495732023346858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,39858,0.0112358712016494,0.00572251136937344,1.97489176774705e-05,0.0224519934856214,0.0496183586585882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,41759,0.0183934985219419,0.00938120825290199,6.33034625397919e-06,0.0367806666976298,0.0499380353786721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,39526,-0.0113372696838341,0.00578402675730589,-0.0226739621281537,-5.77239514581648e-07,0.0500095048185027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,42236,-0.00894430228576669,0.00456650453148669,-0.0178946511674806,6.04659594722647e-06,0.0501711096312919
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,41945,0.0150054888197255,0.0076881807347646,-6.33454204130753e-05,0.0300743230598641,0.050987513041151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41842,-0.010220094142524,0.0052386065652637,-0.0204877630104409,4.7574725392836e-05,0.051087810285923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41995,0.00698110900009293,0.00358202683747524,-3.9663601358539e-05,0.0140018816015444,0.0513249838900697
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39597,0.0223768183556752,0.0114836731819027,-0.000131181080854081,0.0448848177922046,0.0513713914719214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41766,0.0142645246939528,0.00732174396513031,-8.60934777026229e-05,0.0286151428656082,0.0514073040261031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,39597,-0.0116818490174483,0.00599864933082617,-0.0234392017058676,7.55036709709535e-05,0.051510630959534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,42072,-0.00826477518373547,0.00425992268153142,-0.016614223639537,8.46732720661131e-05,0.0523855493830987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39861,0.004253719050991,0.00219629268362203,-5.10146089081846e-05,0.00855845271089019,0.0527981544585312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,41771,-0.00801741570102973,0.00414794171757275,-0.0161473814674723,0.00011255006541286,0.0532741122710161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39512,0.00851340720790822,0.00441359300746421,-0.000137235086721643,0.0171640495025381,0.0537684039143759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,39512,0.00823436147997644,0.00427701049910055,-0.00014857909826063,0.0166173020582135,0.0542226749118358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,42072,0.0143415079826224,0.00746122346269585,-0.000282490004261516,0.0289655059695062,0.0546093456451052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,39858,0.00841098730336249,0.00437810986071819,-0.00017010802364517,0.0169920826303701,0.0547385535272803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42156,-0.0047013469819197,0.00244876911460339,-0.00950093444654234,9.8240482702943e-05,0.0548938076309256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39500,0.0079460871941843,0.00413908843151332,-0.000166526131581806,0.0160587005199504,0.0549133535091782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERVV_1,,39512,-0.00918439792500137,0.00478972020023448,-0.018572249517461,0.000203453667458213,0.055197618046779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,42015,0.0151888003069955,0.00793324777972447,-0.000360365341264499,0.0307379659552554,0.0555679339780381
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,39500,-0.0162513997366832,0.00853916594229219,-0.0329881649835759,0.000485365510209466,0.0570459787950771
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39597,-0.0182459841198319,0.00959570750419961,-0.0370535708280631,0.000561602588399376,0.0572661229289188
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,41741,0.0126514907943755,0.00666541277118772,-0.000412718237152478,0.0257156998259034,0.05770735411912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39725,0.00277930872913801,0.00146588202412189,-9.3820038140889e-05,0.0056524374964169,0.0579862558886243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,39869,0.0250827746173157,0.0132302244712242,-0.000848465346283751,0.0510140145809152,0.0580029058667639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,42070,0.00495767155362206,0.00261823427448457,-0.000174067624367696,0.0100894107316118,0.0583105365616021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39868,-0.00784136105935539,0.00414173108765257,-0.0159591539911544,0.000276431872443647,0.0583493076529278
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39597,0.00845343854067212,0.00446712461560941,-0.00030212570592233,0.0172090027872666,0.0584683599599416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39868,0.0115823147853948,0.00613569740543209,-0.000443652129252046,0.0236082817000417,0.0590928117913532
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42027,0.0098417607164175,0.00521554782277042,-0.000380713016212519,0.0200642344490475,0.0591813118929791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFP,Properdin,39917,0.00489020315758916,0.00259298779149704,-0.000192052913745031,0.00997245922892335,0.0593294703944335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,39858,0.00927506566442944,0.0049317845073646,-0.000391231970005176,0.0189413632988641,0.0600424347978456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39872,-0.00748460911293444,0.00398015585718896,-0.0152857145930248,0.000316496367155928,0.0600682586484336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39512,-0.00955186832133345,0.00508139543889073,-0.0195114033815593,0.000407666738892372,0.0601656865993607
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39500,-0.00627455667968291,0.00333928912492175,-0.0128195633645295,0.000270450005163713,0.0602698289056248
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42072,-0.00585683806203282,0.00311806112278406,-0.0119682378626896,0.000254561738623925,0.0603536534528908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,39512,-0.00717871243130708,0.00382779083539499,-0.0146811824686813,0.000323757606067106,0.060761756591824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,39512,-0.0104786664835269,0.00559173812097709,-0.021438473200642,0.000481140233588164,0.0609633071815045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39500,-0.0140242617802341,0.00748593362392433,-0.0286966916831258,0.000648168122657585,0.0610378114125561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39869,0.0233871042842758,0.0125821951363521,-0.00127399818297427,0.0480482067515258,0.0630892081591358
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41995,0.0076390952730242,0.00411716606842428,-0.000430550221087401,0.0157087407671358,0.0635574281341846
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39500,0.0296865326094305,0.0160726550354395,-0.00181587126003085,0.0611889364788918,0.0647711702498606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39500,-0.0165141321684825,0.00895951755046258,-0.0340747865673891,0.00104652223042416,0.0653277717008061
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,41942,0.0101960011630939,0.00553246949599853,-0.000647639049063184,0.0210396413752511,0.0653601561277202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,42174,0.0148174367139535,0.00805985912276724,-0.000979887166670277,0.0306147605945773,0.066021818444787
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41747,0.00945033886290758,0.0051433350715095,-0.000630597877251048,0.0195312756030662,0.0661741389954795
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39696,-0.0153929019405763,0.00837816939489915,-0.0318141139545786,0.00102831007342607,0.0661977822598468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39869,-0.00879679001370945,0.00480202460463333,-0.0182087582387908,0.000615178211371872,0.0669939056583424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,39696,-0.00772022393110767,0.00424050396640798,-0.0160316117052673,0.000591163843051972,0.0686959541600699
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39512,0.0118010490375027,0.00649886617754809,-0.000936728670491523,0.024538826745497,0.0694188596609153
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39526,-0.0111319135296728,0.00613044715220339,-0.0231475899479915,0.000883762888645792,0.0694222567963768
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42013,0.0380997996577504,0.0210216800697471,-0.00310269327895402,0.0793022925944547,0.0699459780926342
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39895,-0.00556609458227308,0.00307188899079142,-0.0115869970042243,0.000454807839678094,0.0700212056383293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39590,0.0100310489342447,0.00553734837252709,-0.000822153875908414,0.0208842517443978,0.070086799450364
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42219,0.0119093283210647,0.00657650041607421,-0.000980612494440753,0.0247992691365701,0.0701796822666464
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41771,0.0155779274648496,0.00860869850081616,-0.00129512159675004,0.0324509765264493,0.0703873567272379
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,41468,0.00558889251062886,0.00309861398408029,-0.000484390898168514,0.0116621759194262,0.0713056528947715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39525,-0.00679194731910904,0.00378160994484234,-0.014203902811,0.000620008172781942,0.0725147409890799
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39512,-0.00614378749897509,0.00343131081850374,-0.0128691567032424,0.000581581705292235,0.0734000861113717
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,39904,-0.0223798398334597,0.0125233481274332,-0.0469256021632287,0.00216592249630939,0.0739563149245116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41766,0.00541671927731757,0.00304748796905504,-0.000556357142030308,0.0113897956966654,0.0755193706174342
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39500,0.0115829258737314,0.00652745131887354,-0.00121087871126068,0.0243767304587236,0.0760093119113459
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39858,-0.0081954561227417,0.00463257147123818,-0.0172752962063685,0.000884383960885127,0.0769051965840249
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41828,-0.00569835190521332,0.00322188248636979,-0.0120132415784981,0.000616537768071457,0.0769769267523828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42108,-0.0153380639570612,0.00870102771680891,-0.0323920782820067,0.00171595036788424,0.0779589254034495
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,39526,0.00833412246865606,0.00473951743659684,-0.000955331707073749,0.0176235766443859,0.0787019055876773
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39526,-0.0112220847261702,0.00639663138009229,-0.0237594822311511,0.0013153127788107,0.079394448497438
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39575,-0.0109276506167469,0.00623127144274059,-0.0231409426445185,0.00128564141102462,0.0795134168916232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,39500,-0.0101518327988639,0.00578910259559655,-0.0214984738862332,0.00119480828850531,0.0795253244043765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39868,0.0463486517833284,0.0264594631336343,-0.00551189595859487,0.0982091995252516,0.0798551445165851
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41943,-0.00551018019569435,0.00314822295511568,-0.0116806971877211,0.000660336796332382,0.0800980050846146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39675,0.00472132295261562,0.00269825519598544,-0.000567257231515834,0.0100099031367471,0.0801858979606807
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41766,0.00643898917395008,0.00368219835602888,-0.00077811960386652,0.0136560979517667,0.080369532918264
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',39512,0.00825462239828347,0.00472767218617433,-0.00101161508661822,0.0175208598831852,0.0808351687249174
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,41842,-0.00555388776463479,0.00318282656539479,-0.0117922278328086,0.000684452303538994,0.0810159739741555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42142,0.00822813161071639,0.00472012381140988,-0.00102331105964698,0.0174795742810798,0.0813209448826269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,39526,-0.00928194905136648,0.00532527526993385,-0.0197194885804368,0.00115559047770387,0.0813619341958009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39872,-0.00946024478048018,0.0054292772767524,-0.0201016282429149,0.00118113868195453,0.081456986360903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,39590,0.0174132427595859,0.010006925318074,-0.00220033086383919,0.0370268163830109,0.0818660832416453
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39512,0.0120257579334615,0.00691609008088807,-0.00152977862507912,0.0255812944920021,0.0820966121480206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41828,0.0159323503639743,0.00916447496546612,-0.00203002056833931,0.0338947212962879,0.0821477339563437
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,39597,-0.00726375619853024,0.00418452691218946,-0.0154654289464216,0.000937916549361094,0.0826164612545313
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39872,0.00872766895516352,0.00503186733463093,-0.00113479102071311,0.0185901289310401,0.0828604399005487
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39590,0.01041200892692,0.00600318604904007,-0.00135423572919852,0.0221782535830385,0.0828727214069598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,39500,-0.0101505745363437,0.00585387201113012,-0.0216241636781587,0.00132301460547134,0.0829475553961505
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,42114,0.00859230872053253,0.00496815006257397,-0.00114526540211244,0.0183298828431775,0.083746325793395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,39868,0.0132124181661262,0.0076425922369034,-0.00176706261820443,0.0281918989504569,0.0838745201448454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,39696,0.0132912039025246,0.00772624116269195,-0.00185222877635161,0.0284346365814009,0.0854116552056378
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41771,0.00876320854919288,0.00509744756235321,-0.00122778867301941,0.0187542057714052,0.0856130025432008
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39526,-0.0133442669444008,0.00778507323035741,-0.0286030104759013,0.00191447658709974,0.0865417213524975
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39858,0.00977621310822307,0.00570602476375872,-0.00140759542874403,0.0209600216451902,0.0866822872486923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39575,0.00518605174788217,0.0030273794927329,-0.000747612057874307,0.0111197155536387,0.0867316265177167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,39590,0.0145435045497946,0.00851462977127363,-0.00214516980190174,0.0312321789014909,0.0876533190444005
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,42008,0.0203727647836185,0.0119310098521619,-0.00301201452661872,0.0437575440938558,0.08774350701223
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39869,0.00554637967691747,0.00324938427703615,-0.000822413506073371,0.0119151728599083,0.0878678664403297
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,39869,0.00575919183563004,0.00337692767257359,-0.000859586402614197,0.0123779700738743,0.0881375074334033
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41842,-0.0119035734001982,0.00698615481948106,-0.025596436846381,0.0017892900459847,0.0884268650098752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39868,-0.00758745912629444,0.00445568654126845,-0.0163206047471806,0.00114568649459172,0.0886198023310752
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39895,0.0143666637047965,0.00845948448961973,-0.00221392589485813,0.0309472533044512,0.0894804550069656
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39590,-0.00583298969946445,0.00343609003306374,-0.0125677261642694,0.000901746765340485,0.0896180118986377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,39917,0.00564254481011975,0.00333363029976071,-0.000891370577411232,0.0121764601976507,0.0905567473450692
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41995,-0.00386413192647717,0.00228308378577422,-0.00833897614659464,0.000610712293640298,0.0905728830507449
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,39629,0.0158144437195041,0.00935679681619641,-0.00252487804024086,0.0341537654792491,0.0910264257045469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39526,-0.0114028745917107,0.00676070105790489,-0.0246538486652043,0.00184809948178287,0.0917009798240349
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,39872,0.00676952430538735,0.004020491127262,-0.00111063830404617,0.0146496869148209,0.0922566070352826
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41919,0.00745319759925709,0.00442992674535609,-0.00122945882164085,0.016135854020155,0.0925021068219588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39512,-0.00485887522603045,0.00289024782550426,-0.0105237609640188,0.000806010511957895,0.0927667616399457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39674,-0.00931359120807267,0.00554539358257119,-0.0201825626299122,0.00155538021376686,0.0930792419042734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,41954,0.00851003088305633,0.00507472875516214,-0.00143643747706146,0.0184564992431741,0.0935770326012047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39590,0.00939542245981087,0.00560957731468732,-0.00159934907697628,0.020390193996598,0.0939843540037024
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41945,0.010720099934194,0.00642253938214874,-0.00186807725481753,0.0233082771232055,0.0951136321778441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42003,0.00802660005312103,0.00481099369509592,-0.00140294758926698,0.017456147695509,0.0952622557442499
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39590,0.0150190951310134,0.00901827122824676,-0.00265671647635024,0.0326949067383771,0.0958600174677161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,39590,-0.0122512063910928,0.00736759996017339,-0.0266917023130326,0.00218928953084707,0.0963711761705705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42072,0.00837966709545607,0.00504135972136841,-0.00150139795842602,0.0182607321493382,0.0964991664835222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,39597,-0.0104533006668686,0.00630183492044586,-0.0228048971109425,0.00189829577720528,0.0971904746938012
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,41989,0.00582133296937167,0.00352426976661124,-0.00108623577318635,0.0127289017119297,0.0986020091884299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39526,-0.00534050990900236,0.0032335693465587,-0.0116783058282574,0.000997286010252682,0.0986482147192145
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,42072,-0.00467055096050816,0.00282904846112548,-0.0102154859443141,0.00087438402329779,0.0987769008030346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39526,0.0106604258610082,0.00645813187556089,-0.00199751261509118,0.0233183643371075,0.0988289819700537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39512,-0.0057437734141683,0.00348849312993315,-0.0125812199488373,0.00109367312050068,0.0996914567986689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41828,0.0101337819977609,0.00615571353844593,-0.00193141653759311,0.0221989805331149,0.0997381080357983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39845,0.00689430012754963,0.00420014027462013,-0.00133797481070582,0.0151265750658051,0.100732996797277
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41828,-0.00565541310899177,0.00344563043012502,-0.0124088487520368,0.00109802253405326,0.100752914745746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,39590,0.0132556210845461,0.00809476829113522,-0.00261012476607894,0.0291213669351711,0.101543371855833
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39512,-0.00925686321721789,0.00567379879161773,-0.0203775088487886,0.00186378241435285,0.102811469143705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TTN,Titin,39512,0.0123690731411566,0.00758618709322983,-0.00249985356157388,0.0272379998438871,0.103030430318902
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,39597,0.00783600929289796,0.00480897854381716,-0.00158958865298367,0.0172616072387796,0.103245587968047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,39526,-0.00743037255732126,0.00457849038398759,-0.0164042137099369,0.00154346859529442,0.104642411439094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,39500,-0.00539885678469961,0.00333003436291574,-0.0119257241360145,0.00112801056661523,0.104990474263187
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,41227,-0.00888233257697344,0.00548162099484721,-0.019626309726874,0.0018616445729271,0.105174721661586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,39675,-0.0172197355709818,0.0106371532390627,-0.0380685559195446,0.00362908477758113,0.105512465745279
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39575,0.0170879398782132,0.0105611437937756,-0.00361190195758701,0.0377877817140134,0.105691146022702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39597,-0.00527748284495975,0.00327263732147839,-0.0116918519950574,0.00113688630513789,0.106858279762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,42222,0.00751317577994388,0.00466011671592764,-0.00162065298327429,0.016647004543162,0.106935261045987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39512,-0.0187200845832309,0.0116321751614988,-0.0415191478997685,0.00407897873330672,0.107571699307049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,42133,0.0197138669067179,0.0122521696597949,-0.00430038562648008,0.0437281194399159,0.107637419666559
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,42190,0.00362475038432818,0.00225351295702968,-0.000792135011449994,0.00804163578010635,0.107751392684258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,39798,-0.0053847700716347,0.00335512624621827,-0.0119608175142225,0.0011912773709531,0.108535618444436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39512,0.0162907834312383,0.0101532685222457,-0.00360962287236327,0.0361911897348399,0.108635772064074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,39872,0.00922407541512173,0.00576230888080512,-0.0020700499912563,0.0205182008214998,0.109458038492253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39512,0.00579308113426107,0.00362062826789216,-0.00130335027080757,0.0128895125393297,0.109622882231958
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,42004,0.0103009498713185,0.00644535071969759,-0.00233193753928878,0.0229338372819258,0.110022377530484
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39590,0.0109035336421774,0.00683008590820191,-0.00248343473789838,0.0242905020222531,0.110428774321745
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39526,0.00780956367748921,0.00489252940144061,-0.00177979394933439,0.0173989213043128,0.110468130114255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,42063,0.00751470544348129,0.00472423664015658,-0.0017447983712256,0.0167742092581882,0.111707152949886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41990,-0.00513870227686001,0.00324324660528893,-0.0114954656232263,0.00121806106950629,0.11311916025914
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,41794,0.0129139674408988,0.00815225048734494,-0.00306444351429727,0.0288923783960949,0.113195281502973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39590,-0.00709983127031147,0.00448328339732338,-0.0158870667290653,0.00168740418844235,0.113308281630826
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,39869,0.0108270325881202,0.00684384113099639,-0.00258689602863271,0.0242409612048731,0.113675101606224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39597,0.0149923799623469,0.00948312902702664,-0.00359455293062536,0.0335793128553191,0.113917575460795
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,41766,0.0114139333870328,0.00724471342066746,-0.00278570491747543,0.025613571691541,0.115168689955978
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,41842,-0.00469208937559555,0.00298271555348939,-0.0105382118604347,0.00115403310924365,0.115721143709803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39512,-0.0082734581533879,0.00526233195966499,-0.0185876287943313,0.00204071248755548,0.115932293633635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,42187,-0.0079173239684686,0.00504308766794937,-0.0178017757976494,0.00196712786071217,0.116453329493045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42114,-0.00591242840388883,0.00376656757463099,-0.0132949008501656,0.00147004404238791,0.11650541147921
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,42108,-0.00575518479917599,0.00367457036338565,-0.0129573427114119,0.00144697311305988,0.117320597067628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42187,-0.00708979080059171,0.00453613322742558,-0.0159806119263458,0.00180103032516243,0.118085499830222
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39512,-0.00609765891598302,0.00391779841160126,-0.0137765438027215,0.00158122597075546,0.119642159271662
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39500,-0.00449204206599407,0.00288676637211929,-0.0101501041553479,0.00116602002335975,0.11971788442241
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,42236,-0.00334327285871433,0.00215006750434509,-0.0075574051672307,0.000870859449802051,0.119978372321336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39872,-0.0133473655914334,0.0085892121944955,-0.0301822214926446,0.00348749030977775,0.120219993899327
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,39500,-0.00794846167182945,0.00512791173516666,-0.0179991686727561,0.00210224532909721,0.121161258320374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,39597,0.00790984100217662,0.00510337702291409,-0.002092777962735,0.0179124599670882,0.121188794544094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42087,0.003857080099033,0.00249534652487253,-0.00103379908971716,0.00874795928778317,0.122198275102885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39872,0.00835536523388427,0.00540684946045708,-0.00224205970861162,0.0189527901763802,0.122294599839004
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,39590,0.00379434833688816,0.00245647320550845,-0.0010203391459084,0.00860903581968473,0.122463974339899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,39597,-0.0171536887732753,0.0111181542187384,-0.0389452710420026,0.00463789349545207,0.122894976185139
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39858,0.0081424912630005,0.00528841318877225,-0.00222279858699311,0.0185077811129941,0.123665222611983
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39500,0.00958208471773852,0.00623833616065381,-0.00264505415714295,0.02180922359262,0.12456739054504
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,42174,-0.00539717181004533,0.00351458957191987,-0.0122857673710083,0.00149142375091762,0.124648086445535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,41771,-0.00910694817347906,0.00595095415577436,-0.0207708183187968,0.00255692197183868,0.125958063291632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39526,-0.00822906117101395,0.00537767456965878,-0.0187693033275452,0.00231118098551725,0.125989576548212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39696,0.00878814883090241,0.00576194513145559,-0.00250526362675054,0.0200815612885554,0.127236417712905
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,39512,-0.00974475614917798,0.00639336292395543,-0.0222757474801306,0.00278623518177466,0.127488035203618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,39500,-0.00505090546047601,0.00332161660043428,-0.0115612739973272,0.00145946307637518,0.128385075635858
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,42049,-0.0214071464415924,0.0140922796590627,-0.0490280145733554,0.00621372169017051,0.128768612578485
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,39526,0.00812783555531433,0.00539214176037236,-0.0024407622950155,0.0186964334056442,0.131750322397953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42063,-0.00602439829419819,0.00400029741887155,-0.0138649812351864,0.00181618464679005,0.132093818802564
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42236,0.00538030173987222,0.00358134359750013,-0.00163913171122802,0.0123997351909725,0.133039254785726
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39590,-0.00597361485159286,0.00397825277173848,-0.0137709902842003,0.00182376058101456,0.133237585627206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,39500,0.0123481310173885,0.00822808631939243,-0.00377891816862069,0.0284751802033976,0.133454531063359
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39500,0.00719017391440464,0.00479172202167481,-0.00220160124807798,0.0165819490768873,0.133503363212556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41842,-0.00567886455289021,0.00378969197496186,-0.0131066608238155,0.00174893171803504,0.134026467399653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39858,-0.0124361678632913,0.00831042254220516,-0.0287245960460134,0.00385226031943083,0.134563331069692
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39597,0.00725115695899446,0.00485579738525797,-0.00226620591611117,0.0167685198341001,0.135387648783546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,39744,-0.00584102434509449,0.00391157642963099,-0.0135077141471712,0.00182566545698226,0.135395864987478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39858,-0.0146187351186962,0.00979647517872606,-0.0338198264689993,0.00458235623160685,0.135663110212537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,39917,-0.0034449911214199,0.00231082196561752,-0.00797420217403023,0.00108421993119043,0.136039866740172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39590,-0.010999806471465,0.00739651401703514,-0.0254969739448539,0.00349736100192385,0.137001007550888
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,39696,-0.0054820425980611,0.00368877942878859,-0.0127120502784867,0.00174796508236454,0.13727050952621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39526,0.012292405110813,0.00827262148046446,-0.00392193299089731,0.0285067432125234,0.137330689310794
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39696,-0.00446031167322414,0.00300490603583459,-0.0103499275034599,0.00142930415701165,0.137746315195618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,39500,-0.00761888164311907,0.00514147755321966,-0.0176961776474296,0.00245841436119146,0.13840999230478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,41903,0.0105400854036435,0.00711964999068867,-0.00341442857810631,0.0244945993853933,0.138784384447525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41919,-0.00764340529304428,0.00516507413243773,-0.0177669505926222,0.00248014000653367,0.13894363427913
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,39696,0.0139996930864382,0.00948013770408381,-0.00458137681356603,0.0325807629864425,0.139773878908782
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,39526,-0.0150262684636995,0.0101897195872774,-0.0349981188547632,0.00494558192736422,0.140335517762326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39590,0.0124757356926612,0.00847550885918445,-0.00413626167134029,0.0290877330566627,0.14105630960694
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39575,-0.00624783976693485,0.00424514489520459,-0.0145683237615358,0.00207264422766614,0.141114033125776
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,39575,0.0118183992977814,0.00803981024471444,-0.00393962878185889,0.0275764273774217,0.141594521391896
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42174,0.00469165308607382,0.00319569467264687,-0.00157190847231405,0.0109552146444617,0.142095665635937
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41842,-0.0102483693667491,0.00698416859528219,-0.0239373398135022,0.00344060108000398,0.142298794970948
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,39597,-0.00474391503904106,0.00323923281618564,-0.0110928113587649,0.0016049812806828,0.143081031081786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41771,-0.00867320001246495,0.00593198948308799,-0.0202998993993174,0.0029534993743875,0.143735903429774
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42053,-0.00355388171753239,0.00243112910386155,-0.00831889476110102,0.00121113132603624,0.143812933077952
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,42065,0.00653324396627024,0.00447065607198722,-0.0022292419348247,0.0152957298673652,0.143939638196034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,41937,-0.00785453586860195,0.00538176638351776,-0.0184027979802968,0.00269372624309286,0.144458869247167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,42048,0.010825529575722,0.00742426383049051,-0.00372602753203936,0.0253770866834834,0.144828520715406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,42037,0.00466919063932101,0.00322651350556963,-0.00165477583159546,0.0109931571102375,0.147883311449609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,39675,0.00623802467827538,0.00431514220389113,-0.00221965404135124,0.014695703397902,0.148314138020703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39526,0.00720801444308623,0.00498801016548245,-0.00256848548125937,0.0169845143674318,0.148467432640195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39500,0.00909355570978771,0.00629789005191383,-0.00325030879196339,0.0214374202115388,0.148794406067673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39526,-0.00525894405813202,0.00365314628362869,-0.0124191107740443,0.00190122265778022,0.150018960693889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,39500,-0.0184154068586255,0.0128294923557453,-0.0435612118758862,0.00673039815863527,0.151202871296183
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41886,-0.00475944417586523,0.00332824470987053,-0.0112828038072115,0.00176391545548101,0.152735856681539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39858,-0.00691727475715413,0.00483792837168599,-0.0163996143656587,0.00256506485135041,0.152801895554185
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42005,0.00552482259765326,0.00387183429802917,-0.00206397262648391,0.0131136178217904,0.153624399761019
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42222,0.00549085696944274,0.00384920935815971,-0.0020535933725503,0.0130353073114358,0.153749995741317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,42072,0.0178522448581707,0.0125452443072973,-0.00673643398413198,0.0424409237004734,0.154750941251189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,39675,-0.00706918274538285,0.00497773703898362,-0.0168255473417907,0.00268718185102503,0.155589271750268
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41592,-0.00756685372685836,0.00534745092287324,-0.0180478575356899,0.00291415008197319,0.157080912807237
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,39597,0.00614955292543169,0.00436386391262471,-0.00240362034331274,0.0147027261941761,0.158804591359132
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,39590,0.00555089019607334,0.00394476928396378,-0.00218085760049568,0.0132826379926424,0.159410585358613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39500,-0.0103372630636971,0.00736697635507617,-0.0247765367196464,0.0041020105922522,0.160588855103506
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39512,-0.00522792159522662,0.00373830607035081,-0.0125550014931142,0.00209915830266096,0.161999374149406
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,39696,-0.00860507038482633,0.00617048594321949,-0.0206992228335365,0.00348908206388387,0.163178560525894
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42047,-0.00897607001078839,0.00644163857127267,-0.0216016816104828,0.00364954158890604,0.163508251614271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42048,0.0129447316431202,0.00931436829656591,-0.00531143021814903,0.0312008935043893,0.164624931514863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39868,-0.0066583722743668,0.00479186336621177,-0.0160504244721419,0.00273367992340827,0.16470326081115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,39917,0.0022600827186147,0.00162979967831446,-0.000934324650881644,0.00545449008811104,0.165553180392749
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39597,0.00754938960106293,0.00545542912337207,-0.00314325148074632,0.0182420306828722,0.166438425184537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39858,0.00819239663610412,0.00592647782422336,-0.00342349989937366,0.0198082931715819,0.166895307144868
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42175,-0.00522048557214111,0.00378435347385953,-0.0126378183809058,0.00219684723662357,0.167765815508117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41895,0.00646074689977027,0.00469027858262592,-0.00273219912217654,0.0156536929217171,0.168388270323889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39872,0.00410296513468309,0.00298444166656595,-0.00174654053178618,0.00995247080115235,0.169225488958537
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39512,0.00576186543635528,0.00419631088268868,-0.00246290389371453,0.0139866347664251,0.169756070209806
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39895,0.00453690954370639,0.00330856098837087,-0.00194786999350053,0.0110216890809133,0.170320012723086
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39526,-0.00473966163519406,0.00346123230857596,-0.011523676960003,0.00204435368961482,0.170915948927146
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39597,0.00543736957671078,0.00398257366971573,-0.00236847481593205,0.0132432139693536,0.172189724185519
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,41771,-0.0131418104511253,0.00969210272111454,-0.0321383317845098,0.00585471088225919,0.175144765895166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42164,0.00453283178851002,0.00334767969592527,-0.0020286204155035,0.0110942839925235,0.175751933146451
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39590,-0.00622619552543663,0.0046055488159365,-0.0152530712046722,0.0028006801537989,0.176438318543987
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41409,-0.00441753242745229,0.0032747644047233,-0.0108360706607099,0.00200100580580538,0.177373048775377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,42072,0.012256229816481,0.0090932029135662,-0.00556644789410873,0.0300789075270708,0.177730843220793
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39597,0.00826755684074375,0.00613450073765631,-0.00375606460506262,0.0202911782865501,0.177777924169995
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,39696,-0.00784883956238814,0.00584682485096424,-0.0193086162702781,0.00361093714550178,0.17949036822859
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BSND,Barttin,39500,0.00494054039380545,0.00368342875511024,-0.00227897996621062,0.0121600607538215,0.179854768731873
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39872,-0.00509614131531611,0.00380607002497278,-0.0125560385642627,0.00236375593363053,0.180613621521618
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41842,0.00814546787988937,0.00610569932895439,-0.00382170280486122,0.02011263856464,0.182201842116463
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39858,0.0146441950726534,0.0109950768776008,-0.00690615560744422,0.0361945457527511,0.182924432508606
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39512,-0.00743091562573627,0.00558261524483314,-0.0183728415056092,0.00351101025413669,0.183190019561773
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39864,-0.00895709902897986,0.00673229840007938,-0.0221524038931354,0.00423820583517574,0.183391475596054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39512,-0.00897512521306254,0.00676378248097001,-0.0222321388757638,0.00428188844963868,0.184556702898627
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39904,-0.00497619018381769,0.00375134113734409,-0.0123288188130121,0.00237643844537672,0.184697741870258
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,41766,-0.00673659004684131,0.00508991736605411,-0.0167128280843074,0.00323964799062474,0.185686625969641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39500,-0.00581712852275449,0.00439691460357277,-0.0144350811457571,0.00280082410024813,0.185862336456941
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39675,0.0121198767880319,0.00917188992937155,-0.00585702747353631,0.0300967810496002,0.186390184349151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41995,-0.00374571403844216,0.00283820643048535,-0.00930859864219345,0.00181717056530913,0.186942101824534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39597,0.0089907651993097,0.00682795614946008,-0.00439202885363206,0.0223735592522515,0.187947228289705
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,41842,-0.0073294940874333,0.00558185426060561,-0.0182699284382203,0.0036109402633537,0.189174345766508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,42032,-0.0100276369210993,0.00763788032799695,-0.0249978823639733,0.00494260852177476,0.189245084483589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39597,-0.00602387416967853,0.00459606650487005,-0.0150321645192238,0.00298441617986676,0.190000496455408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,41842,-0.00693042212655921,0.00530140909826106,-0.0173211839591509,0.00346033970603246,0.191140585916113
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42149,0.0058567424094183,0.00449343132541666,-0.00295038298839835,0.014663867807235,0.192460078536896
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,42108,0.00608065873670093,0.00466780532777548,-0.00306823970573901,0.0152295571791409,0.192706087365269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41842,0.00813001806480235,0.00624936625466602,-0.00411873979434306,0.0203787759239478,0.193303408264639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39696,0.00572208428648645,0.0044133891721242,-0.00292815849087698,0.0143723270638499,0.194820473558034
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39927,-0.0037403682624164,0.00289279445349445,-0.00941024539126553,0.00192950886643272,0.196039219461601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41943,0.00567364819730703,0.00440802104953651,-0.00296607305978453,0.0143133694543986,0.198075097434982
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39858,0.00489833213707156,0.00380584524038333,-0.00256112453407977,0.0123577888082229,0.198101580679866
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42050,-0.00559686524888493,0.00435078169388685,-0.0141243973689032,0.0029306668711333,0.198324063007189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42063,-0.00830655953775139,0.00646065229117562,-0.0209694380284556,0.00435631895295282,0.198564551294689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,41903,0.00784123205894312,0.0061013874128865,-0.00411748727031441,0.0197999513882007,0.198760297709508
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,39590,0.0086733046360559,0.00676334432881744,-0.00458285024842628,0.0219294595205381,0.199729833884377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39575,0.00879845008838513,0.00688305051191125,-0.00469232891496093,0.0222892290917312,0.20117855474116
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,39575,-0.00573881448111712,0.00450193642673892,-0.0145626098775254,0.00308498091529116,0.202427009300601
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39696,-0.00922105540666397,0.00724883127128974,-0.0234287646983919,0.00498665388506392,0.203373211104462
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39512,-0.00677433815816344,0.0053584620030621,-0.0172769236841652,0.00372824736783827,0.206173836991711
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,39858,0.0107566558837255,0.00852977930247954,-0.00596171154913442,0.0274750233165854,0.207309460063243
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39597,-0.00952421530812944,0.00759199060205587,-0.024404516888159,0.00535608627190006,0.209683969089252
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39904,-0.00506487816303389,0.00404119749708548,-0.0129856252573214,0.00285586893125365,0.210118389050965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39526,-0.00418095794549793,0.00333644344187691,-0.0107203870915767,0.00235847120058081,0.210189515640581
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,39597,0.00448746127643987,0.00361635007340244,-0.0026005848674289,0.0115755074203086,0.214676062480039
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,41828,0.00658815341340067,0.00532408895456019,-0.00384706093753729,0.0170233677643386,0.215951819992075
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39526,0.008382422127138,0.0067819424895441,-0.00491018515236844,0.0216750294066444,0.216488357296976
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,41809,-0.00764359852099588,0.00621347102977048,-0.019822001739346,0.00453480469735427,0.21865699439042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,39696,0.00583674938423426,0.00475330160797697,-0.0034797217674006,0.0151532205358691,0.219497102459743
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,39590,-0.00864466615420544,0.00710335996459807,-0.0225672516848177,0.00527791937640678,0.223636932787271
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39512,-0.00460249876048208,0.00378403321949301,-0.0120192038706884,0.00281420634972421,0.223899068148257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,41766,-0.00704242283242421,0.00579154778030469,-0.0183938564818214,0.00430901081697297,0.224013252452447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39512,-0.00998224401569258,0.00821192621198502,-0.0260776193911832,0.00611313135979807,0.224171683894672
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41766,0.00781530806706349,0.00643351980152032,-0.00479439074391633,0.0204250068780433,0.224471981265107
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39526,-0.0096337043067493,0.00793060365671888,-0.0251776874739183,0.00591027886041969,0.224487538440934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39597,0.00392942910223035,0.00323803048095986,-0.00241711064045097,0.0102759688449117,0.224955441923883
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,39927,-0.00708678461954388,0.00585792867537402,-0.018568324823277,0.0043947555841892,0.226389902187603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,39576,0.00592615513576124,0.00490875291704968,-0.00369500058165612,0.0155473108531786,0.227356940357672
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,39500,-0.00794258483475689,0.00658750430601534,-0.020854093274547,0.00496892360503318,0.227957548189701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39575,0.00415582393380713,0.00344942129541442,-0.00260504180520512,0.0109166896728194,0.228310846935223
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42149,0.00835364405278228,0.00697269118256457,-0.00531283066504428,0.0220201187706088,0.230917873462722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39927,-0.00346953143111116,0.0028975169419649,-0.00914866463736237,0.00220960177514005,0.231169738580232
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41766,-0.0066860454332314,0.00558537273718186,-0.0176333759981078,0.00426128513164504,0.231303386365834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39597,0.00385841852611656,0.00323677262594068,-0.00248565582072718,0.0102024928729603,0.23326449055539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39590,-0.0070435147094151,0.00591461054196002,-0.0186361513716567,0.00454912195282654,0.233731508150047
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39895,0.00438769838355435,0.00368511710446646,-0.00283513114119991,0.0116105279083086,0.233814575882863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39512,0.00506810015628164,0.00425974143434313,-0.0032809930550309,0.0134171933675942,0.234163834950244
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42236,-0.00451935862052138,0.0038019071589983,-0.011971096652158,0.00293237941111528,0.234575171583261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39597,-0.00598153467800929,0.00503551769284005,-0.0158511493559758,0.00388807999995721,0.234910733110589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42056,0.00425303924424328,0.00358226600739771,-0.00276820213025623,0.0112742806187428,0.235150650562387
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39675,0.00463450049646862,0.00391654543260784,-0.00304192855144274,0.01231092954438,0.236710383190445
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39868,0.00498505827131422,0.00421400460069175,-0.00327439074604162,0.0132445072886701,0.236844373734977
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42222,-0.00769239503154137,0.00650906557349721,-0.0204501635555959,0.00506537349251315,0.237306835810385
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39512,-0.00639303689526563,0.00544150174996924,-0.0170583803252053,0.00427230653467408,0.240073856078347
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39696,-0.00787856859503642,0.00672201691898503,-0.0210537217562471,0.00529658456617423,0.241200434560744
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,39590,-0.00439189180247771,0.00375700256934914,-0.011755616838402,0.0029718332334466,0.242433726026173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41771,0.00475488753189728,0.0040716684136436,-0.00322558255884417,0.0127353576226387,0.242909265192918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,39858,-0.00594346000514365,0.0050894237543416,-0.0159187305636532,0.00403181055336589,0.242909726204556
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39479,-0.00688309537115473,0.0058948882616563,-0.0184370763640011,0.00467088562169161,0.242978416788179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,39590,0.00766879803351053,0.00659445590142374,-0.00525633553328,0.0205939316003011,0.244888850275137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39575,0.00812374200253449,0.006994849578262,-0.00558616317085902,0.021833647175928,0.245508960840115
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39526,0.00699229313720089,0.00603217213123027,-0.00483076424001043,0.0188153505144122,0.24641356957199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39500,0.00981291760943463,0.00847435338236524,-0.00679681502000123,0.0264226502388705,0.246907881228063
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,39597,0.00783436576668621,0.00677289671962525,-0.00544051180377929,0.0211092433371517,0.24741065443401
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39500,-0.00810917919702541,0.00706867153350406,-0.0219637754026934,0.00574541700864254,0.251324197372527
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42111,-0.00547869953975374,0.00478186597373735,-0.014851156848279,0.00389375776877147,0.251929582205017
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41771,-0.00711164775178546,0.00623359954248675,-0.0193295028550595,0.00510620735148857,0.253950040406741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39872,0.00520775553973375,0.00456970128627624,-0.00374885898136767,0.0141643700608352,0.254465895662251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,42063,0.00470869452715382,0.00414518709331565,-0.00341587217574485,0.0128332612300525,0.256000816191094
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39675,0.00363421255885403,0.00320034372130754,-0.00263846113490875,0.0099068862526168,0.256161374229544
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,39526,-0.0121792690822562,0.0107360676677802,-0.0332219617111054,0.00886342354659299,0.256640989462286
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39512,0.012394263848506,0.010938866415896,-0.00904591432665021,0.0338344420236623,0.257218870483025
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,39696,0.00516892417261477,0.0045659172625108,-0.00378027366190639,0.0141181220071359,0.257630738789904
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39526,0.00435299980164142,0.00384803626565542,-0.00318915127904321,0.011895150882326,0.257984686495908
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39872,0.00838757691865654,0.00741607225508433,-0.00614792470130874,0.0229230785386218,0.258079199405213
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41766,0.00847649727308166,0.00750518659574069,-0.00623366845457009,0.0231866630007334,0.258741870444734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42063,-0.0146519383641026,0.0129763352419703,-0.0400855554383643,0.0107816787101591,0.25886412512088
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42198,0.00586644367511731,0.00521506987576205,-0.00435509328137631,0.0160879806316109,0.260650326972184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41943,0.00524295649378487,0.00467490513768384,-0.00391985757607546,0.0144057705636452,0.262090689435469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39696,-0.0100721141276003,0.00900196064750691,-0.0277159569967138,0.00757172874151325,0.263215538318828
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39869,0.00263097862473581,0.00235985314617347,-0.00199433354176419,0.0072562907912358,0.264920983880635
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42063,-0.00293471275788654,0.00263410364730254,-0.00809755590659952,0.00222813039082643,0.265246751706049
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,41842,-0.00889027285965433,0.00800229587573706,-0.024574772776099,0.00679422705679031,0.2666034668087
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42042,0.00404252561504114,0.00364618150891931,-0.0031039901424407,0.011189041372523,0.267578963631313
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39526,0.00887461510654194,0.00800870751969275,-0.00682245163205586,0.0245716818451397,0.267834056502718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,39869,0.0140412294540965,0.0126987290897542,-0.0108482795618217,0.0389307384700147,0.26887165199724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39575,-0.0028670458090392,0.0025930703794903,-0.0079494637528402,0.0022153721347618,0.268899346040377
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,41766,-0.00550705592526843,0.00498091511743648,-0.0152696495554439,0.00425553770490708,0.268906315782126
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41766,0.00632882446628309,0.00574797890672796,-0.00493721419090372,0.0175948631234699,0.270894094871608
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41995,0.00870199733004164,0.00791761041581645,-0.00681651908495861,0.0242205137450419,0.271757879681134
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39869,0.0106620564744349,0.00970446609740253,-0.0083586970764741,0.0296828100253438,0.271933225083963
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39597,-0.00348670396174645,0.00318837825779756,-0.00973592534702967,0.00276251742353677,0.274169059203502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,41766,0.0070596176047639,0.00645900177650122,-0.00560002587717849,0.0197192610867063,0.274418646913882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39917,0.00219344301027679,0.00201127952691094,-0.00174866486246866,0.00613555088302224,0.275484940073945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39575,-0.00851754432551951,0.00783457932606309,-0.0238733198046032,0.00683823115356414,0.276984167735158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39526,-0.00493578491243044,0.00455122306188821,-0.0138561821137313,0.00398461228887046,0.27816870256802
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,42149,0.00724207221274934,0.00669593407544251,-0.00588195857511798,0.0203661030006167,0.279466157088731
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41842,0.00332691510538969,0.00309440368728478,-0.00273811612168849,0.00939194633246786,0.28233194237365
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39512,0.00561410086538779,0.00526266380037792,-0.00470072018335293,0.0159289219141285,0.286095104093864
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41995,0.00552216564196351,0.00517673425054483,-0.00462423348910436,0.0156685647730314,0.286114056064575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,41702,-0.00742047636845771,0.00696834220469183,-0.0210784270896537,0.00623747435273827,0.286948034147797
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,39872,0.00548299476698231,0.00515142594516693,-0.00461380008554488,0.0155797896195095,0.287186420304579
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42111,0.00312578070005233,0.00294712983738161,-0.00265059378121563,0.00890215518132029,0.288882228461224
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,42039,-0.00339191252031599,0.00321345593807212,-0.00969028615893734,0.00290646111830536,0.29120006888965
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41807,0.00614609873105854,0.00584615502273163,-0.00531236511349545,0.0176045625756125,0.293137238544202
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39869,0.00300560968400859,0.00287202849237163,-0.00262356616103979,0.00863478552905698,0.295347570641408
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,39696,0.00458549731795966,0.0043924680898729,-0.00402374013819123,0.0131947347741105,0.296533345661321
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41766,0.00403640970205545,0.00386923942658168,-0.00354729957404464,0.0116201189781555,0.296872537846214
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39696,-0.00425119048020996,0.0040820946720956,-0.0122520960375173,0.00374971507709741,0.297701598939687
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,41842,-0.00469671502762333,0.00452131337054866,-0.0135584892338987,0.00416505917865204,0.298919331575918
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39590,0.00878476583291642,0.00848685075935185,-0.00784946165541322,0.025418993321246,0.300643523851071
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39526,-0.0109330888406355,0.0105704063568515,-0.0316510853000644,0.00978490761879346,0.301013631879074
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39590,0.00514099885117761,0.00499111118431677,-0.00464157907008326,0.0149235767724385,0.303018158234212
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,39696,-0.00653685636942357,0.00635184970208348,-0.0189864817855072,0.00591276904666006,0.303442702774255
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,41842,-0.0053296993868871,0.00518563578536114,-0.0154935455261949,0.00483414675242073,0.304071496750447
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41995,-0.00635392546110631,0.00619186879217764,-0.0184899882937745,0.00578213737156187,0.304828812939141
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42092,0.0100679544623541,0.00982205795561717,-0.0091832791306556,0.0293191880553637,0.305364988826804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,39526,-0.00524361265103783,0.00511632503293723,-0.0152716097155948,0.00478438441351915,0.305443106306338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39696,-0.00766306252333112,0.00748378472634075,-0.022331280586959,0.00700515554029675,0.305878616990933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42155,0.00559260881862943,0.00546467516768474,-0.00511815451003267,0.0163033721472915,0.306131812025063
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39526,-0.00387508904571916,0.0037874676046428,-0.011298525550819,0.00354834745938072,0.306266874986835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,39760,0.00352091567577486,0.00344141863420654,-0.00322426484726994,0.0102660961988197,0.306282706067137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,39597,0.00398972516979412,0.00390394147376356,-0.00366200011878245,0.0116414504583707,0.306815870672552
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39597,0.00228511740688091,0.00223846255465778,-0.00210226920024834,0.00667250401401016,0.307351585863314
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,39500,-0.00474852395122006,0.00465803941433703,-0.0138782812033206,0.00438123330088051,0.308023651910999
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41857,-0.00458828038062874,0.0045058888204316,-0.0134198224686747,0.0042432617074172,0.308560971498316
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,39500,-0.00729300408037555,0.00716982102951924,-0.0213458532982333,0.00675984513748216,0.309090018627736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41943,0.00679114216918438,0.00668077759910411,-0.00630318192505967,0.0198854662634284,0.30940039345514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39590,0.00408754965604814,0.00403233119512224,-0.00381581948639145,0.0119909187984877,0.310751137639123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39696,0.00338155710960985,0.00334286818668982,-0.00317046453630219,0.0099335787555219,0.311764045141158
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,42213,0.00645491234147872,0.00642588269956967,-0.00613981774967785,0.0190496424326353,0.315147041464801
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39590,0.00554167168848603,0.00554224297297829,-0.00532112453855143,0.0164044679155235,0.317382408836796
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39927,-0.00289769527030915,0.00289862105116886,-0.0085789925306001,0.00278360198998181,0.317486451983416
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39597,-0.00305679874451309,0.00305958976653162,-0.00905359468691507,0.00293999719788889,0.317774153526881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39500,0.00679747963250625,0.00681166414069282,-0.00655338208325169,0.0201483413482642,0.318341461975223
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41766,-0.00591803113973084,0.00593071956967334,-0.0175422414962906,0.0057061792168289,0.318365318770968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39858,0.00504734123495422,0.0050599297827409,-0.00487012113921794,0.0149648036091264,0.318537437776335
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCN,Decorin,41828,-0.00250510953737665,0.00251414822036578,-0.00743284004929358,0.00242262097454028,0.319071692534097
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,39597,0.00510439274668785,0.00513659707995007,-0.00496333753001429,0.01517212302339,0.320375995745206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,41995,0.00311316634615578,0.00314726400688184,-0.00305547110733263,0.00928180379964419,0.322599829056375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,39590,-0.00528271893977476,0.0053416713406506,-0.0157523947674499,0.00518695688790042,0.322702685235273
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,39904,0.0100621500537774,0.0101769468564544,-0.00988466578487326,0.0300089658924281,0.322821357715733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,42157,-0.00454033503454283,0.00459452600695315,-0.013545606008171,0.00446493593908535,0.323069740474026
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39669,-0.00672895304222455,0.00681219668875698,-0.0200808585521882,0.00662295246773913,0.323281895112317
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39868,0.00274436931004815,0.00278235207672634,-0.00270904076033548,0.00819777938043179,0.323983215827368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,39500,-0.00712931908436362,0.00726978737680793,-0.0213781023429072,0.00711946417417992,0.326773420974561
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42016,0.0092591686697429,0.00944845302655639,-0.00925979926230763,0.0277781366017934,0.327120261876173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,39512,-0.00342441967211312,0.00351727438584753,-0.0103182774683743,0.00346943812414805,0.330276579902125
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,42174,0.00374311308008396,0.00384511621940219,-0.00379331470994433,0.0112795408701122,0.330336103149395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,42072,-0.00429876068790427,0.0044335492485823,-0.0129885172151256,0.00439099583931704,0.33226429401147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41828,0.00350324381860549,0.00361781366674533,-0.00358767096821536,0.0105941586054263,0.332896419717299
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,41973,-0.00613848208474433,0.00635808391348182,-0.0186003265551687,0.00632336238568003,0.334331416886539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39512,0.0071123495583854,0.00737839766917307,-0.00734930987319382,0.0215740089899646,0.335096220028534
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,41842,0.00358459556858252,0.00372497567000982,-0.00371635674463673,0.0108855478818018,0.335909560348652
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41771,0.00884744990715689,0.00923031429051294,-0.00924396610224847,0.0269388659165623,0.337817711167117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,41943,-0.00444777510295528,0.00464313416925987,-0.0135483180747046,0.00465276786879406,0.338117847909739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,39597,-0.00297816818056381,0.00311352535338098,-0.00908067787319052,0.0031243415120629,0.338827544747391
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41995,0.00873558631408152,0.00915795348227034,-0.00921400251116835,0.0266851751393314,0.340161731180666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,42236,-0.001796357146473,0.00188912480247436,-0.00549904175932275,0.00190632746637676,0.341675120112038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,39590,0.00620597118056831,0.00652691869149455,-0.00658678945476101,0.0189987318158976,0.341713061898865
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41675,-0.00406785490454555,0.00428068286151183,-0.0124579933131087,0.00432228350401764,0.341986661779622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,39661,0.00345662991344809,0.00364910119017459,-0.0036956084192941,0.0106088682461903,0.343529469783181
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39833,-0.00397906723874269,0.00421079907972224,-0.0122322334349983,0.0042740989575129,0.344695919660535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,39872,0.00388568360438257,0.00411563121062146,-0.00418095356843549,0.0119523207772006,0.345124361441251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39526,-0.00482606840723491,0.00512849459544418,-0.0148779178143055,0.00522578099983567,0.346710176310229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,39872,0.00233478915377736,0.00248119269841615,-0.00252834853511828,0.00719792684267301,0.346727745464943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39512,-0.00572401317622496,0.00608302938449257,-0.0176467507698304,0.00619872441738048,0.346735585810569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41766,0.0031125753532074,0.00330994080655484,-0.00337490862764008,0.00960005933405488,0.347044078535002
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,41792,-0.00508435406421342,0.00543714845776808,-0.0157411650414389,0.00557245691301202,0.349746628949173
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41842,0.00582008596619501,0.00622996718233887,-0.00639064971118918,0.0180308216435792,0.350213579283109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39869,0.0025167847100111,0.00269850021370367,-0.0027722757088481,0.00780584512887029,0.351015238095901
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39872,-0.00761509468075806,0.00816986891809908,-0.0236280377602323,0.00839784839871615,0.351307350241512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42024,0.00390346643603567,0.00418981371280424,-0.00430856844106065,0.012115501313132,0.351530920433553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42210,0.00388911361580771,0.0041894695287362,-0.00432224666051524,0.0121004738921307,0.353264840645092
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41968,0.00402594280458279,0.0043441647976326,-0.0044886201987771,0.0125405058079427,0.354074506563282
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39868,0.00280483007484184,0.003027574306849,-0.0031292155665822,0.00873887571626588,0.354243360160138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39500,-0.00396303140509359,0.00428588123809493,-0.0123633586317597,0.00443729582157247,0.355157378926477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39512,-0.00359089462712283,0.00388736766587505,-0.0112101352522379,0.00402834599799226,0.355645124244468
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,39512,0.00662379149053378,0.00717473931227682,-0.00743869756152879,0.0206862805425963,0.355918161630396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39526,-0.00506744154935587,0.00550127352951748,-0.0158499376672101,0.00571505456849839,0.35699782377887
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39512,-0.00398315239433664,0.00432758638086599,-0.012465221700834,0.00449891691216071,0.357379058906374
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39895,-0.0108161257513028,0.0117945302781493,-0.0339334050964753,0.0123011535938698,0.359138162953954
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,39512,-0.0044874745821718,0.00489838449419867,-0.0140883081908012,0.0051133590264576,0.359627782003912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,39575,0.00788198521181659,0.00861407142120268,-0.00900159477374066,0.0247655651973738,0.360205037512345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41590,0.00622419953255003,0.00682775336938716,-0.0071581970714488,0.0196065961365489,0.361994730114964
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41919,0.00255139811896236,0.00280555946535085,-0.0029474984331253,0.00805029467105002,0.363151275703603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,41900,0.00405771066889655,0.00446366914520452,-0.00469108085570432,0.0128065021934974,0.363338759439907
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,39858,-0.00263936781931197,0.00290803274092098,-0.00833911199151709,0.00306037635289316,0.364102241303944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39526,-0.00370405431614391,0.00411839106195409,-0.0117761007975739,0.0043679921652861,0.368462899831035
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,39575,-0.00179571930984803,0.00200168106679382,-0.00571901420076391,0.00212757558106785,0.369682244604658
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39590,-0.00352382751829447,0.00392882208262419,-0.0112243188002379,0.00417666376364894,0.369782827113549
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42008,-0.00261866703101643,0.00292039967148519,-0.00834265038712741,0.00310531632509455,0.369905236588477
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,42048,0.0087605669429903,0.00981976729397476,-0.0104861769532002,0.0280073108391808,0.372336056501233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39512,-0.00395079832124469,0.00443920408959048,-0.012651638336842,0.00475004169435266,0.3734967940312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,41766,0.00534533466288756,0.00604984662348006,-0.00651236471913336,0.0172030340449085,0.376955966607764
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41828,0.00303201625291579,0.00343258127245101,-0.0036958430410882,0.00975987554691977,0.377087547268541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41771,-0.00341414295324832,0.003871809134413,-0.0110028888566978,0.00417460295020116,0.377903625528211
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,39917,0.0024842930176315,0.00283053414568222,-0.00306355390790564,0.00803213994316865,0.380137987289048
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,39458,-0.00422473811005462,0.00482115299520435,-0.0136741979806551,0.00522472176054591,0.380890663735758
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,39526,0.00376031898616414,0.00429145921149903,-0.00465094106837396,0.0121715790407022,0.380922541388346
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,42085,-0.00294866728779885,0.00337479755613447,-0.00956327049782241,0.00366593592222471,0.382279993596599
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,41842,-0.00300378332822369,0.00345253874322657,-0.00977075926494776,0.00376319260850039,0.384304363004142
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39500,0.00611358927379306,0.00704313353865375,-0.00769095246196829,0.0199181310095544,0.385401833246578
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39512,-0.00461436466421845,0.00531737008845648,-0.0150364100375931,0.00580768070915625,0.385527969096541
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39526,-0.00527925553698496,0.00615003421116083,-0.0173333225908602,0.00677481151689027,0.390684519098524
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39597,-0.00206492868943028,0.00240599712045599,-0.00678068304552402,0.00265082566666346,0.3907773450721
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42106,-0.00457365672845868,0.00533769952489288,-0.0150355477972487,0.00588823434033136,0.391537928833015
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39500,0.00735088240511085,0.00858479485269167,-0.00947531550616482,0.0241770803163865,0.391868555066653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39526,-0.00710665061745268,0.00831868796956793,-0.0234112790378058,0.00919797780290047,0.392957818074291
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39526,0.00766728638304286,0.00904299654189692,-0.0100569868390751,0.0253915596051608,0.396528890888092
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,39450,-0.00319454927164864,0.00377011909501958,-0.010583982697887,0.00419488415458974,0.396827791910345
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41995,0.00225621997707847,0.00266657030343033,-0.00297025781764498,0.00748269777180192,0.397504786564467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,39512,-0.00763421616212636,0.00904909421065034,-0.025370440815001,0.0101020084907483,0.398886731006266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39500,-0.00452733908650873,0.00536807810166687,-0.0150487721657758,0.00599409399275833,0.399033484178283
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39895,0.004864369273055,0.00577025486744292,-0.00644533026713313,0.0161740688132431,0.399241989492955
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,39597,-0.00356972146245951,0.00428234642161591,-0.0119631204488267,0.00482367752390767,0.404530126927762
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39597,0.00838093055470396,0.0100562708125063,-0.0113293602378083,0.0280912213472162,0.404635343173724
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39590,0.0027505027396022,0.00330611402030854,-0.00372948074020255,0.00923048621940694,0.405458457016215
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,39500,0.00365013202275966,0.0043976969736139,-0.00496935404552359,0.0122696180910429,0.406551364402429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39597,-0.00492612495569564,0.0059357606438535,-0.0165602158176485,0.00670796590625721,0.406609796393867
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,42213,-0.0027420936180912,0.00330650730950301,-0.0092228479447171,0.0037386607085347,0.406947996145842
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39526,0.00397943443688557,0.00480083260665112,-0.00543019747215062,0.0133890663459218,0.407176239551053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42063,-0.00558551849775568,0.00675971202671575,-0.0188345540701186,0.0076635170746072,0.408651223451598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39500,-0.00532515327657796,0.00645146659132388,-0.0179700277955728,0.00731972124241685,0.409152680350947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39526,-0.00589942422811374,0.00715686158340891,-0.0199268729315952,0.00812802447536773,0.409785269063946
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39512,-0.00442693732566454,0.00538618561212539,-0.0149838611254303,0.00612998647410122,0.41114845561333
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39500,-0.00358969175245443,0.00437393533566379,-0.0121626050103554,0.00498322150544659,0.41183472480961
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,39597,-0.00235839843845813,0.00287427247987226,-0.00799197249900776,0.0032751756220915,0.411937441551647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,41766,0.00408158229140838,0.00498576619814815,-0.00569051945696199,0.0138536840397787,0.413002688596216
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39901,-0.0022955746587269,0.00280476330130395,-0.00779291072928265,0.00320176141182885,0.413114255006303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,39590,-0.00529529509070971,0.00647063814335711,-0.0179777458516896,0.00738715567027022,0.413170839683622
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39500,-0.0030014425966424,0.00368041095396045,-0.0102150480664049,0.00421216287312009,0.414793495824953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39512,0.00351198742508523,0.00432809769212277,-0.0049710840514754,0.0119950589016459,0.417131287497038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,42072,-0.00419555779149712,0.00517781154318375,-0.0143440684161373,0.00595295283314303,0.417784629589644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,39858,0.00346874907647847,0.00428585040062096,-0.00493151770873862,0.0118690158616956,0.418331487676038
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,41708,0.00269018063733242,0.00333275688595793,-0.00384202285914512,0.00922238413380997,0.419569493400441
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,39597,0.00760444414254714,0.0094293049357231,-0.0108769935314701,0.0260858818165644,0.41998979189597
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,41766,0.00341104208232719,0.00425327040660105,-0.00492536791461087,0.0117474520792652,0.422578419624148
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,41995,0.00652503197393008,0.00814557138113688,-0.0094402879330982,0.0224903518809584,0.423115343860478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,41642,-0.00230659552306589,0.00288621788632295,-0.00796358258025888,0.0033503915341271,0.4242030289945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,41567,-0.00206291975925837,0.00258302165115813,-0.00712564219552829,0.00299980267701156,0.424510367396366
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39526,-0.00500184632036683,0.00628257553594471,-0.0173156943708185,0.0073120017300848,0.425964575451851
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41766,0.00749149576183869,0.00942047180557161,-0.0109726289770817,0.025955620500759,0.426490727699467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39590,-0.00245071689958455,0.00309389894741181,-0.00851475883651169,0.00361332503734259,0.428312015268632
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42236,0.00219061777548707,0.00276795571654857,-0.00323457542894812,0.00761581097992226,0.428712231741343
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39576,-0.00338639293260385,0.00428357756284312,-0.0117822049557764,0.00500941909056868,0.429222257334642
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,39597,0.002882187645869,0.00364706895846721,-0.00426606751272673,0.0100304428044647,0.429384188476147
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39858,-0.00531189879528053,0.00674079315558729,-0.0185238533802316,0.00790005578967055,0.430699952452624
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,41944,-0.0109740272858306,0.0139943773445261,-0.0384030068811017,0.0164549523094405,0.432951920603184
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39590,0.00551444679553453,0.00704596408296672,-0.00829564280708025,0.0193245363981493,0.433855952960569
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41741,0.00460283387307501,0.00589462123544586,-0.00695062374839888,0.0161562914945489,0.434902904200436
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39590,0.00689748864209611,0.00889542265330205,-0.0105375397583759,0.0243325170425681,0.438121485519455
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42063,-0.0027186735698486,0.00350873155601515,-0.00959578741963829,0.00415844027994109,0.438453205678598
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,41842,-0.00408034631961805,0.00527416163726658,-0.0144177031286605,0.00625701048942443,0.439152596612308
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39696,-0.00356251399663512,0.00460657397069535,-0.012591398979198,0.00546637098592776,0.439329175904307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39590,0.00878140114689696,0.0113643344642204,-0.013492694402975,0.031055496696769,0.439707193160645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,39500,-0.00354375995599584,0.00459809196010741,-0.0125560201978064,0.00546850028581469,0.44090012489195
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39897,-0.0015622392310762,0.00202715840647804,-0.00553546970777316,0.00241099124562076,0.440927723106127
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41842,0.00450036258940967,0.00584617647024014,-0.00695814329226101,0.0159588684710804,0.441434712672616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41771,0.00387728297852598,0.00505532631494636,-0.0060311565987689,0.0137857225558209,0.443113175590197
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39512,-0.00423836037159151,0.0055386545391511,-0.0150941232683277,0.00661740252514465,0.444149454369323
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39500,-0.00716394177550119,0.00936575993634456,-0.0255208312507365,0.0111929476997341,0.444343075743198
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39500,0.00432479781901602,0.0056942637638873,-0.00683595915820309,0.0154855547962351,0.447569467398989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42072,-0.00379280967907481,0.00500819352432644,-0.0136088689867546,0.00602324962860501,0.44887087145555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39597,0.00221187552388809,0.00292432733600431,-0.00351980605468036,0.00794355710245655,0.449443170515947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39526,0.00402225002609488,0.00533260790750455,-0.00642966147261403,0.0144741615248038,0.45070068190201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,42125,-0.00309670502764301,0.0041064166370955,-0.0111452816363502,0.00495187158106416,0.450794082745251
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42175,0.00344509068367351,0.00457965981518324,-0.00553104255408565,0.0124212239214327,0.451908313323953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42048,-0.00462769152230699,0.00616856015128877,-0.016718069418833,0.007462686374219,0.453143703520844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41842,0.00301526561647034,0.00402634477026778,-0.0048763701332545,0.0109069013661952,0.453940360634397
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",42187,0.0059501224309512,0.00796214099968523,-0.00965567392843186,0.0215559187903343,0.454894328586589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,41771,-0.0132276455942143,0.0177436972278786,-0.0480052921608563,0.0215500009724278,0.455992373868512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,39858,-0.00463608672779342,0.00628443835618744,-0.0169535859059208,0.00768141245033397,0.460706678074137
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39526,-0.00231526465091458,0.00314751234119024,-0.00848438883964745,0.00385385953781828,0.461998738365304
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42070,0.00277977175578083,0.00379415829109162,-0.00465677849475875,0.0102163220063204,0.463787620343123
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RETN,Resistin,42034,0.00342066915542012,0.00467718500060431,-0.00574661344576432,0.0125879517566046,0.464576860303841
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,42121,0.00279945861830056,0.00384535306115299,-0.0047374333815593,0.0103363506181604,0.466619572426666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39858,0.00477690444859867,0.00660163645824377,-0.00816230300955912,0.0177161119067565,0.46933006786319
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,39500,-0.00485476327443334,0.0067233751448755,-0.0180325785583893,0.00832305200952264,0.470265488192051
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39590,0.0029071842275614,0.00403369244212465,-0.00499885295900291,0.0108132214141257,0.471093867935875
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,41842,0.00337283383560582,0.00468031078427592,-0.00580057530157499,0.0125462429727866,0.471141828507991
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41900,0.0027072239144278,0.0037635431433665,-0.00466932064657054,0.0100837684754261,0.471951166829798
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39526,-0.00600590560254664,0.00835695181347974,-0.0223855311569669,0.0103737199518737,0.472358530872571
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41771,0.00403074674994672,0.00561794342326053,-0.00698042235964393,0.0150419158595374,0.473092376432151
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,41842,0.0108205464006398,0.0150958188761464,-0.0187672585966071,0.0404083513978867,0.473515736577105
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39597,0.00696407536612086,0.00973334118909384,-0.0121132733645031,0.0260414240967448,0.474323597384161
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,41754,0.00438415084450264,0.00616722048760811,-0.00770360131120926,0.0164719030002145,0.477171491722599
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,41842,-0.00730993489374078,0.0102903204703942,-0.0274789630157134,0.0128590932282319,0.477487235191723
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42063,-0.00266747941097026,0.00376723224274764,-0.0100512546067556,0.00471629578481511,0.478911528588924
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,42092,-0.00252383349447219,0.00356988632476311,-0.00952081069100788,0.00447314370206351,0.479591941512479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39696,0.0053510020583404,0.00759035452568072,-0.00952609281199382,0.0202280969286746,0.480841257433953
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39590,0.00366376801452016,0.00521651824868061,-0.00656060775289384,0.0138881437819342,0.482482197084135
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42048,-0.00328326762119158,0.00468007622321444,-0.0124562170186919,0.00588968177630872,0.482977294688997
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39500,-0.00384617968203105,0.00549312305993141,-0.0146127008794966,0.0069203415154345,0.483829300719257
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39915,0.00870287361303255,0.0125011074299418,-0.0157992969496533,0.0332050441757184,0.486337791557915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,39512,-0.0042565927899945,0.00611654171066299,-0.016245014542894,0.00773182896290495,0.486496918300454
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,39590,0.00535504877248132,0.00769594170482415,-0.00972899696897401,0.0204390945139367,0.486551505914469
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39526,-0.00464034466823894,0.00667103556193015,-0.017715574369622,0.00843488503314415,0.486696758565261
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39512,0.00249517077429724,0.00360142499961743,-0.00456362222495291,0.00955396377354739,0.488431773028912
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41766,-0.00293694814043502,0.00424944445780972,-0.0112658592777421,0.00539196299687203,0.489491658379453
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39858,-0.00448178508854717,0.00650462348654359,-0.0172308471221726,0.00826727694507828,0.490827840088191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41771,0.00951561637282868,0.0138313102034123,-0.0175937516258593,0.0366249843715167,0.491479696273616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,42236,0.00190281996843851,0.00277052361772994,-0.00352740632231217,0.0073330462591892,0.492214910315656
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39500,-0.00189784149625241,0.00278743495931927,-0.00736121401651818,0.00356553102401335,0.495977147142177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,39847,-0.00455049500750051,0.00670680467573937,-0.0176958321719497,0.00859484215694865,0.497475484528701
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39512,-0.00288323830619235,0.00430693272464867,-0.0113248264465038,0.00555834983411904,0.503228227277638
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39872,0.00264371195257539,0.00395552318134088,-0.00510911348285274,0.0103965373880035,0.503917753023512
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39590,-0.0026382347437292,0.00397775686434831,-0.0104346381978519,0.0051581687103935,0.507186376266336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,42092,0.00221769808848276,0.00335863718556859,-0.00436523079523168,0.00880062697219719,0.509074521406577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,39526,-0.0054231599965874,0.00823605662637383,-0.0215658309842801,0.0107195109911053,0.510252866781513
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39590,0.00757314456197001,0.0115666801875934,-0.0150975486057131,0.0302438377296531,0.512650184357756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39590,-0.00263843968290873,0.00403050982108638,-0.010538238932238,0.00526135956642056,0.512728165475951
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,39526,-0.00242848681513505,0.00371978057453865,-0.00971925674123079,0.0048622831109607,0.513861857074786
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39512,-0.00497615017606671,0.00762964764426152,-0.0199302595588193,0.00997795920668587,0.51427795242628
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,39869,-0.0185821354674134,0.0284966793554321,-0.0744356270040604,0.0372713560692336,0.514362394194393
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,42091,-0.00380986523365064,0.00585424681629655,-0.0152841889935919,0.0076644585262906,0.515195350914886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41828,-0.00539143855680432,0.00830500069474704,-0.0216692399185085,0.0108863628048999,0.516233447926727
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39500,0.00342592412062407,0.00529490251892244,-0.00695208481646391,0.013803933057712,0.517630632893042
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,42187,-0.00307617978825335,0.00481940168649982,-0.012522207093793,0.00636984751728629,0.523295153361247
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39696,0.00312872885113682,0.00490525979831459,-0.00648558035355977,0.0127430380558334,0.523596582058507
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41771,-0.00336557349582055,0.0052767509499229,-0.0137080053576694,0.00697685836602833,0.523607350001525
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39526,0.00758563626132613,0.0119261627025134,-0.0157896426356002,0.0309609151582524,0.52475713009741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,39526,-0.00332085037448547,0.0052628765034701,-0.0136360883212869,0.00699438757231592,0.528056791860201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41771,0.00210529023768207,0.00334257046787863,-0.00444614787936004,0.00865672835472417,0.528809090874763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39512,0.00320757533006653,0.00509649738621267,-0.0067815595469103,0.0131967102070433,0.529120957927947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39512,-0.00294506045008629,0.0046864582569644,-0.0121305186337365,0.00624039773356394,0.529742501009138
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,39597,0.00183454324329411,0.00293399538545511,-0.00391608771219791,0.00758517419878612,0.531805957365673
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39590,-0.00278505445675723,0.00446192698480575,-0.0115304313469765,0.00596032243346204,0.532521030523655
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42187,0.00408938372679655,0.00657684034231217,-0.00880122334413531,0.0169799907977284,0.534093378100853
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39590,-0.00244028774324827,0.00400678922542126,-0.0102935946250739,0.0054130191385774,0.542511700343881
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,42072,-0.00196262488581013,0.00323386689817706,-0.00830100400623716,0.00437575423461691,0.543929339197219
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39927,-0.00189993199399919,0.00313105355082867,-0.0080367969536234,0.00423693296562501,0.543993966001874
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42097,0.00176538314646668,0.00294964686815299,-0.00401592471511319,0.00754669100804654,0.549511993619979
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,42021,0.00287333024988022,0.00480163168050422,-0.00653786784390806,0.0122845283436685,0.54957846119923
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,39872,0.00288748896194847,0.00484592226702321,-0.00661051868141703,0.012385496605314,0.551281035227938
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,42044,-0.00511007529824646,0.00860801448112846,-0.0219817836812582,0.0117616330847653,0.552761853287114
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HLA_A,,39872,0.00213956619216682,0.0036072859694073,-0.00493071430787148,0.00920984669220512,0.553110383282689
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39590,0.00330231237464112,0.00557625559313353,-0.0076271485879006,0.0142317733371829,0.553722391167573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,39858,0.00726893118168609,0.0123129667659608,-0.016864483679597,0.0314023460429692,0.554969438903425
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42088,0.00424220266304205,0.00718903548304746,-0.00984830688373099,0.0183327122098151,0.555137893392404
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,41828,-0.00694288136823019,0.0117659447577579,-0.0300041330934356,0.0161183703569752,0.555145233765021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39575,-0.00491630544122153,0.00840072741577499,-0.0213817311761405,0.0115491202936975,0.558409289988567
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39869,-0.00667725952715234,0.0114163026543413,-0.0290532127296614,0.0156986936753567,0.558634673136269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39500,-0.00213551088760792,0.00366785446439922,-0.00932450563783039,0.00505348386261454,0.560428220719414
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,41771,0.00629021580390566,0.0108184204407925,-0.0149138882600476,0.027494319867859,0.560956796288109
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,39597,-0.00273623933226253,0.00473108277875055,-0.0120091615786136,0.00653668291408854,0.563037174967558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,39500,0.00389619516830041,0.00679459771567129,-0.00942121635441531,0.0172136066910161,0.566368501009766
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39512,-0.00279384689832756,0.00487716113014298,-0.0123530827134078,0.00676538891675268,0.566762903708889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39696,-0.00460055337929101,0.00804333731399477,-0.0203654945147208,0.0111643877561387,0.567353402679176
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42222,-0.00229083483369517,0.00402028226718415,-0.0101705880773761,0.00558891840998577,0.568809592167821
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,41995,-0.00202758409560596,0.00357716072440877,-0.00903881911544714,0.00498365092423522,0.570850184983497
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,39575,0.00544632180428853,0.00969607558928264,-0.0135579863507054,0.0244506299592825,0.574329363890029
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39872,-0.00432322584920487,0.00769728368761111,-0.0194099018769227,0.0107634501785129,0.574361559706539
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,42048,0.00303905750384095,0.00543951481416445,-0.00762239153192137,0.0137005065396033,0.576375709344169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,39512,-0.00262361382644716,0.00470970443655196,-0.011854634522089,0.00660740686919468,0.577494107800856
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,42135,0.00953187296997783,0.0171450440560774,-0.0240724133799339,0.0431361593198895,0.578250807617493
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,39512,0.00240403698758224,0.00434039216243977,-0.0061031316507997,0.0109112056259642,0.579675385509334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,39526,-0.00444064136153548,0.00811849559094309,-0.0203528927197839,0.011471609996713,0.584404773713191
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39597,-0.00269777377592043,0.00495231466764919,-0.0124043105245128,0.00700876297267198,0.585936467446819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,42108,0.00229150960035342,0.00420950588280442,-0.00595912192994325,0.0105421411306501,0.586198995781171
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,41766,0.00302525706827422,0.00555846138073153,-0.00786932723795959,0.013919841374508,0.586270686487466
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,41997,-0.00207324215698092,0.00381976012859609,-0.00955997200902926,0.00541348769506741,0.587298831368341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39597,-0.00243380953722472,0.00453720661498976,-0.0113267345026047,0.00645911542815521,0.591685076537992
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39675,-0.00307062020652292,0.00575140224538818,-0.0143433686074838,0.00820212819443792,0.593427867722423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39927,0.00309583626283381,0.00582191087524981,-0.00831510905265581,0.0145067815783234,0.594905402546478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41828,0.00253524673665583,0.00476827117047107,-0.00681056475746747,0.0118810582307791,0.594948973730177
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,41771,-0.0051776683078546,0.00974531919930617,-0.0242784939384947,0.0139231573227855,0.595221271321384
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39512,0.00271718971476813,0.00511678228354378,-0.00731170356097769,0.0127460829905139,0.595405437128
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,41828,-0.00407864600116093,0.00769214114573993,-0.0191552426468112,0.0109979506444893,0.595957588173256
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39696,-0.00214448752357607,0.00406925205867372,-0.0101202215585766,0.00583124651142442,0.598205542139947
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41771,-0.00709532619064385,0.013546911805271,-0.033647273328975,0.0194566209476873,0.600454513034064
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,39868,-0.00543798941946536,0.0103994958714066,-0.0258210013274222,0.0149450224884915,0.601047900639182
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,39696,-0.00132457714393686,0.00254141385578509,-0.00630574830127564,0.00365659401340193,0.60223998170801
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42174,0.00397412984371827,0.00767832966389761,-0.011075396297521,0.0190236559849576,0.604761593183201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,39597,0.00338949590899413,0.00660567170375406,-0.00955762063036382,0.0163366124483521,0.607878362502994
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,41747,-0.00197379455571782,0.00386424869563571,-0.00954772199916381,0.00560013288772818,0.609511225791674
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,39895,-0.00168275742897724,0.00330070693940018,-0.00815214303020159,0.00478662817224711,0.610189440488661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41842,-0.00300049269463719,0.00589182002323698,-0.0145484599401817,0.00854747455090728,0.610575571422989
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,39868,0.00149312051088131,0.00293541448611099,-0.00426029188189623,0.00724653290365884,0.611002295812502
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,39675,0.00170072064138472,0.00334962562131723,-0.00486454557639705,0.00826598685916648,0.611649629584407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39590,-0.00426739911679231,0.00847004584260833,-0.0208686889683046,0.01233389073472,0.614396259984733
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41766,-0.00469445020808057,0.00932127541335189,-0.0229641500182503,0.0135752496020891,0.614531622221455
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41766,0.00159764532471241,0.00318195597252293,-0.00463898838143253,0.00783427903085734,0.615608841596824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42063,0.00196513524957373,0.00393887212673984,-0.00575505411883636,0.00968532461798383,0.617852271643653
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41842,0.00337792312872613,0.00681218486590257,-0.00997395920844291,0.0167298054658952,0.619997986003023
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39597,-0.00183801629366377,0.00371562330883931,-0.00912063797898882,0.00544460539166128,0.620841270147769
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41732,0.00157556722610487,0.00319086767501563,-0.00467853341692577,0.00782966786913551,0.621474114940644
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,39858,0.00230893614369071,0.00468956123951171,-0.00688260388575224,0.0115004761731337,0.622476918177352
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39590,0.00218863230678881,0.00444528630873638,-0.00652412885833449,0.0109013934719121,0.622482475073685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,41828,0.00209650897124298,0.00426099389816165,-0.00625503906915385,0.0104480570116398,0.622710922210835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,39590,-0.00258022629055005,0.00527206676109961,-0.0129134771423053,0.00775302456120519,0.624557990291189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39512,-0.00366596753860508,0.00750303159419981,-0.0183719094632367,0.0110399743860265,0.62513602462492
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39575,0.00137216687114488,0.00281177869251051,-0.00413891936617571,0.00688325310846548,0.625554836612065
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,39512,0.00253992352477216,0.00522593181481979,-0.00770290283227462,0.012782749881819,0.626960555095573
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,39526,0.00301472152726464,0.00626030390442352,-0.00925547412540546,0.0152849171799347,0.63012710458563
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39512,0.00260987952515025,0.00546234660176516,-0.00809631981430947,0.01331607886461,0.632805999600754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39872,0.00125338685483412,0.00265312847369836,-0.00394674495361466,0.0064535186632829,0.636637279959839
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42063,-0.0027363260357075,0.00580854057387031,-0.0141210655604933,0.0086484134890783,0.637586476826266
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,39658,0.00188118108762695,0.00399777157270365,-0.0059544511948722,0.0097168133701261,0.637966099775592
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,41724,0.00242877669131029,0.00518524736244816,-0.0077343081390881,0.0125918615217087,0.639505405838998
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39696,-0.00311511737699861,0.00673168075385475,-0.0163092116545539,0.0100789769005567,0.643549229696338
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,41828,0.00706963132210541,0.015326622291557,-0.0229705483693462,0.0371098110135571,0.644616222107334
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39590,0.00284562591789583,0.00617270235655156,-0.00925287070094523,0.0149441225367369,0.644806550151022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39696,0.00268219287844621,0.00582541371216691,-0.00873561799740094,0.0141000037542934,0.645216918475801
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,39526,-0.00264591934489731,0.00574747145304958,-0.0139109633928745,0.00861912470307987,0.645265330931645
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39858,0.00270725479316246,0.00588355741111211,-0.00882451773261729,0.0142390273189422,0.645425269216943
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,42142,-0.00148912312236392,0.00324520785650165,-0.00784973052110716,0.00487148427637932,0.646336084239395
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39575,-0.0133317830203788,0.0292373850783399,-0.0706370577739249,0.0439734917331674,0.648410426657253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41828,0.00235823908382461,0.00522059710308535,-0.00787413123822268,0.0125906094058719,0.651479361836925
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,42187,-0.00145394116954522,0.00323627841112645,-0.00779704685535308,0.00488916451626263,0.653248883570586
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42048,0.0017974179273255,0.00400155113257987,-0.00604562229253104,0.00964045814718205,0.653308837831037
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39575,0.00452303429779361,0.0101071718277934,-0.0152870224846814,0.0243330910802686,0.654517570122242
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,41842,-0.00192381113313671,0.00431462917926259,-0.0103804843244914,0.00653286205821797,0.655690504084659
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39526,-0.00158920090398959,0.00356453827853792,-0.00857569592992392,0.00539729412194473,0.655724262316971
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39526,-0.00448811527224017,0.0101068493367458,-0.024297539972262,0.0153213094277816,0.657003152706426
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,41842,0.00147630841000983,0.00335766209407089,-0.00510470929436912,0.00805732611438879,0.660173575550536
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39500,-0.00212277967017429,0.00483094970032864,-0.0115914410828184,0.00734588174246985,0.660371383945179
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,42236,-0.00267737344488653,0.00613197706001592,-0.0146960484825177,0.00934130159274467,0.662390365122831
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39481,0.0023119606658265,0.00531131973314767,-0.00809822601114292,0.0127221473427959,0.663361081883106
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,39591,-0.00336172591969383,0.00778377577760451,-0.0186179264437987,0.011894474604411,0.665830675544054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,41842,0.00150538718565784,0.00349455745150977,-0.0053439454193013,0.00835471979061699,0.666634995336387
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41771,0.00151931482894498,0.00352993024994343,-0.00539934846094415,0.00843797811883411,0.666904969534612
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,42050,0.0016699960123594,0.00391086435822088,-0.00599529812975352,0.00933529015447233,0.669375559853613
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39500,0.00426662362214115,0.01004818343656,-0.0154278159135165,0.0239610631577988,0.671124705981768
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,41842,-0.002745381847856,0.00664589561471053,-0.0157713372526886,0.0102805735569766,0.679544186428621
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39869,-0.00255099206228169,0.00618532547647027,-0.0146742299961634,0.00957224587160004,0.680034697451844
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42222,-0.00110885702084962,0.00269596420096769,-0.00639294685474629,0.00417523281304706,0.680857151403424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,42187,0.00125191391422115,0.00307424493174644,-0.00477360615200187,0.00727743398044417,0.683848076659307
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39590,0.00308764065904847,0.00759719528805841,-0.011802862105546,0.017978143423643,0.684443047702432
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,39597,-0.00163669422779626,0.00402909736619204,-0.00953372506553266,0.00626033660994015,0.68458990448795
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42072,-0.00111961964314007,0.00276197530633127,-0.00653309124354936,0.00429385195726923,0.685212604852169
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39872,0.00411952258606923,0.0101803904196512,-0.0158340426364472,0.0240730878085856,0.685740484853791
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41842,-0.00189743144610382,0.00469742557034347,-0.011104385563977,0.00730952267176939,0.686270665220575
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,39500,-0.00161945008342174,0.00401528521502728,-0.0094894091048752,0.00625050893803172,0.686719779677619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41995,0.00139882295038518,0.00346995941478128,-0.00540229750258613,0.00819994340335649,0.686863645055778
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,41943,0.00159032425833488,0.00399130163450215,-0.00623262694528933,0.0094132754619591,0.690306707176777
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41766,-0.00141737884611124,0.00357187428305461,-0.00841825244089828,0.0055834947486758,0.691509173858973
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,42092,0.00354840123498867,0.00899940172418793,-0.0140904261444197,0.021187228614397,0.693370951860198
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39512,-0.00238749506041555,0.00606591421689493,-0.0142766869255296,0.00950169680469851,0.693890008742021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42039,-0.00146902683795687,0.0037332761684437,-0.00878624812810653,0.00584819445219279,0.693959895051006
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39858,-0.00153470249443275,0.00390610640116156,-0.0091906710407094,0.00612126605184389,0.694402049547133
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,39696,-0.00118245485347651,0.00302702319663168,-0.0071154203188746,0.00475051061192158,0.696076101731504
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,39917,-0.000804551716126817,0.00206141410815113,-0.00484492336810303,0.00323581993584939,0.696328600457741
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42072,-0.00134867412636882,0.00346719315901743,-0.00814437271804298,0.00544702446530534,0.697295951455893
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,39500,0.00221736483258853,0.0057189381791021,-0.00899175399845158,0.0134264836636286,0.698228479205167
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,41828,-0.00253033634182969,0.00664892778913356,-0.0155622348085315,0.0105015621248721,0.703533602800054
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39526,-0.00290189644309846,0.00762631959073123,-0.0178494828409317,0.0120456899547348,0.703573729454428
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39858,-0.00222457363166813,0.00586027559678183,-0.0137107138013605,0.00926156653802426,0.704247871998387
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42108,-0.00152999247627658,0.0040387382282881,-0.00944591940372125,0.00638593445116809,0.704820563472245
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39575,-0.00359903045125461,0.00965037435342647,-0.0225137641839705,0.0153157032814613,0.70919877252275
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39526,-0.00225285675712441,0.00605941750721202,-0.01412931507126,0.00962360155701114,0.710053234207348
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39927,0.00166001964846943,0.00447374469349761,-0.00710851995078588,0.0104285592477247,0.710601123872254
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,42063,-0.00218794027571416,0.00590359485187173,-0.0137589861853827,0.00938310563395443,0.710932729401166
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39526,-0.00164222748667904,0.00443166117314741,-0.010328283386048,0.00704382841268989,0.710967231639496
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42034,-0.0012316833931199,0.00332654347739498,-0.00775170860881407,0.00528834182257427,0.711195192911076
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42236,-0.000917564729319794,0.00249944915054175,-0.00581648506438163,0.00398135560574204,0.713545066877189
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39696,0.0019133366462639,0.00525907118414081,-0.00839444287465209,0.0122211161671799,0.716002004174368
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41766,-0.00240689482246491,0.00662738811692913,-0.015396575531646,0.0105827858867162,0.716480764898763
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39675,0.00104033058020585,0.00287804910289559,-0.00460064566146951,0.00668130682188121,0.717754459271201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C5,Complement C5,39917,0.000594357418190761,0.00164575306717385,-0.00263131859346999,0.00382003342985151,0.717996921125667
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41766,0.00193601469442793,0.00537357413494138,-0.00859619061005717,0.012468219998913,0.718640276721053
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39597,0.00244339708298452,0.00686400067709882,-0.0110100442441292,0.0158968384100982,0.721867813401101
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41842,0.00120137065624039,0.0033803146357767,-0.00542404602988194,0.00782678734236271,0.722294095070456
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,39500,-0.00194809851791285,0.00549288902236855,-0.0127141610017552,0.00881796396592952,0.722852478105446
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,41842,0.0013088266007602,0.00372602419522521,-0.00599418082188121,0.00861183402340161,0.725394189836199
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,39590,0.00106129628079453,0.00303300186052886,-0.00488338736584205,0.0070059799274311,0.726408344815885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39696,0.00262652702199862,0.00751325631549446,-0.0120994553563705,0.0173525094003678,0.72665627332553
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39858,0.00136936372920922,0.00397349001166783,-0.00641867669365974,0.00915740415207817,0.730382796368431
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39904,0.00113956070002175,0.00331994714707514,-0.00536753570824552,0.00764665710828902,0.731419303835578
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39590,-0.0011783866837544,0.00343991445621518,-0.00792061901793616,0.00556384565042736,0.731933952663491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39597,-0.00266524542490368,0.00784699782510313,-0.0180453611621058,0.0127148703122985,0.734125395289718
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,41842,-0.00179113171798023,0.00528349258667664,-0.0121467771878664,0.00856451375190598,0.73461115170984
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39526,0.00128518679431368,0.0038013167217069,-0.00616539398023185,0.00873576756885921,0.735301936454639
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42106,-0.0021343061117039,0.00633114808006541,-0.0145433563486321,0.0102747441252243,0.736037695694776
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,39696,0.00213780387695705,0.00640452760313503,-0.0104150702251876,0.0146906779791017,0.738540024062845
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,39500,-0.00336585981577601,0.0101422989652889,-0.0232447657877422,0.0165130461561901,0.739998640166201
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39500,0.00188939229981857,0.00571776819858957,-0.00931743336941699,0.0130962179690541,0.741072158073922
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39696,0.00186236848924602,0.00565774187510311,-0.00922680558595609,0.0129515425644481,0.742032127825262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41771,-0.00279920667486063,0.00857471350291609,-0.0196056451405762,0.0140072317908549,0.744089854163546
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,39696,-0.00183548822895784,0.00567886917728852,-0.0129660718164433,0.00929509535852767,0.74653950881424
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39696,0.00190767236402305,0.00591239963301091,-0.00968063091667834,0.0134959756447244,0.746961710361505
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39895,0.0012151600401615,0.00376668403198166,-0.00616754066252256,0.00859786074284555,0.746998580486453
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,41771,0.00188501225674722,0.00588483043125314,-0.00964925538850893,0.0134192799020034,0.748732986363824
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39597,-0.00205897821482514,0.00645485187711772,-0.0147104878939759,0.0105925314643256,0.749746613786734
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39500,-0.00139657583991619,0.00438660646260898,-0.0099943245066298,0.00720117282679742,0.75020832693449
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,39590,-0.00201896864676375,0.00635484884522026,-0.0144744723833954,0.010436535089868,0.750714587625438
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39895,-0.00168755479843522,0.00532953006048419,-0.0121334337169842,0.0087583241201138,0.751520866749685
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,42112,0.000941783533168587,0.00298017801817801,-0.00489936538246032,0.00678293244879749,0.751995347613562
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39512,0.00164608027326768,0.00522188910485381,-0.00858882237224579,0.0118809829187811,0.752595358366662
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,41828,-0.00111397201569631,0.00355449712528123,-0.00808078638124752,0.00585284234985491,0.753983303422022
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39842,0.00195445678749033,0.00625145050359053,-0.0102983861995471,0.0142072997745278,0.75455958246834
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39597,-0.00103425314461542,0.00331608653620799,-0.00753378275558307,0.00546527646635223,0.755130284069396
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41766,-0.00142153421391008,0.00456853245649112,-0.0103758578286327,0.00753278940081252,0.755685637606939
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,39872,0.00117444352765388,0.00382446842355089,-0.00632151458250587,0.00867040163781363,0.758783025661727
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39696,0.00186086875207671,0.0060926472137912,-0.010080719786954,0.0138024572911075,0.7600454659375
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42108,0.00362105863863212,0.0120179564857989,-0.0199341360735338,0.027176253350798,0.763187311227746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39696,0.00130255292970389,0.00433240494055351,-0.00718896075378099,0.00979406661318876,0.763684324618028
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39526,0.00385342983290464,0.0129171725370763,-0.0214642283397649,0.0291710880055742,0.765465859149325
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39927,-0.00120610539362181,0.00404540852826112,-0.00913510610901361,0.00672289532176998,0.76560040557467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39526,0.00232338797396126,0.00779916601731441,-0.012962977419975,0.0176097533678975,0.765783545538702
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41766,0.00246699127177522,0.00829371998695035,-0.0137886999026475,0.0187226824461979,0.766125435464915
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39858,0.00143368357416939,0.00484957988594675,-0.00807149300228624,0.010938860150625,0.767517754779944
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41924,-0.00103845938144695,0.00357241516376085,-0.00804039310241822,0.00596347433952432,0.771294225515654
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39032,-0.00179437032027513,0.00620141724390908,-0.0139491481183369,0.0103604074777867,0.772320507519045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39597,0.000972491036001864,0.00339684091221043,-0.00568531715193057,0.0076302992239343,0.774659278662617
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,42050,0.000732614632395588,0.0025607165255479,-0.00428638975767829,0.00575161902246947,0.774807841613311
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,39597,0.00132272050630576,0.00467799104126765,-0.00784614193457883,0.0104915829471903,0.777370768543382
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39597,-0.00131708442413982,0.00468152398778626,-0.0104928714402009,0.00785870259192125,0.778457471280679
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39927,-0.000873275176284449,0.00311498171478998,-0.00697863933727281,0.00523208898470391,0.779216563175164
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,39597,0.000523978968255686,0.00187096686324411,-0.00314311608370277,0.00419107402021414,0.779438385007528
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39500,0.00165923498452793,0.00594982106753802,-0.0100024143078466,0.0133208842769024,0.780348801156779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39500,-0.000815139887050654,0.00292556069933955,-0.00654923885775618,0.00491895908365487,0.780536457778933
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39597,0.00124507890078359,0.00447593433431531,-0.00752775239447443,0.0100179101960416,0.780885678307803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,39597,0.00162555040817732,0.00593052200282766,-0.00999827271736489,0.0132493735337195,0.784013657101649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39696,0.00126558149511051,0.00463523615401493,-0.00781948136675875,0.0103506443569798,0.784831426946825
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,42174,-0.000834207516098335,0.00306420971369762,-0.00684005855494567,0.005171643522749,0.785439855727457
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,42157,0.00123861496554831,0.00456904538679745,-0.0077167139925747,0.0101939439236713,0.78632721042036
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39500,-0.00162846135372779,0.00602504893499214,-0.0134375572663124,0.0101806345588568,0.786948546999409
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39512,-0.00139421299277686,0.00520967699982196,-0.0116051799124279,0.00881675392687419,0.788997005729303
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,39500,0.00210404647563479,0.0080229629298495,-0.0136209608668702,0.0178290538181398,0.793131314240803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42222,-0.00129389739124278,0.00498240197571135,-0.011059405263637,0.00847161048115145,0.795104134031448
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42020,0.00116388643431173,0.0044839652590757,-0.00762468547347663,0.00995245834210009,0.795202287819962
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39500,0.00177887339316201,0.00688003925100406,-0.011706003538806,0.01526375032513,0.795982946097746
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39689,0.00284259613979666,0.011029998354773,-0.0187762006355584,0.0244613929151517,0.796631642964804
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,41828,-0.000763303238281978,0.00298555273421141,-0.00661498659733635,0.00508838012077239,0.798213007215293
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,39927,0.000632930635744788,0.00250357623146934,-0.00427407877793512,0.0055399400494247,0.800419155503162
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,39512,0.00110614638691901,0.00437743278468342,-0.00747362187106049,0.00968591464489851,0.800510258891136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42173,0.000781958007829703,0.00309866325499298,-0.00529142197195653,0.00685533798761594,0.800771787132676
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,39590,0.00110707464675516,0.00444474248711606,-0.00760462062799231,0.00981876992150263,0.803307350138703
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,39512,-0.001297336977071,0.00522362600064336,-0.011535643938332,0.00894096998418998,0.803860964331118
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,39904,-0.00228778321812693,0.00932389934384735,-0.0205626259320677,0.0159870594958139,0.806176233708136
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,39512,-0.00135302099037632,0.00551820181581311,-0.01216869654937,0.00946265456861737,0.806312093513011
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39512,-0.00269858700094313,0.0111158981445726,-0.0244857473643054,0.0190885733624192,0.8081895051934
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42236,0.00185760102917488,0.00766137853262613,-0.0131587008947723,0.0168739029531221,0.808425048998616
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,39339,0.00185093157937625,0.0077189961116871,-0.0132783007995305,0.016980163958283,0.81049828886084
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,39590,0.00157802647465544,0.00665841316905293,-0.0114724633366883,0.0146285162859992,0.812663240283529
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,41842,0.00149999951267942,0.00633561610844858,-0.0109178080598798,0.0139178070852386,0.812849213191755
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39512,0.00120300628210147,0.00509303363314321,-0.00877933963885923,0.0111853522030622,0.813277077456231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,39597,-0.00147712502484872,0.00627039025216556,-0.0137670899190932,0.0108128398693958,0.813769603709326
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,42111,-0.00105796060569216,0.00454282863972589,-0.00996190473955491,0.00784598352817059,0.815853557645691
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39590,-0.00106292454842221,0.00456968250867688,-0.0100195022654289,0.00789365316858448,0.816073572161223
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39512,-0.000985194656121315,0.00443081948920796,-0.00966960085496891,0.00769921154272628,0.824045251766882
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39500,0.00135695910145901,0.00616509852617836,-0.0107266340098506,0.0134405522127686,0.825794754604052
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39479,-0.00185744424932964,0.00848317706819558,-0.018484471302993,0.0147695828043337,0.826688271442736
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,39597,0.00239151897345698,0.011001683712011,-0.0191717811020845,0.0239548190489985,0.82791816371619
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39895,0.00067972040111231,0.00313845280843349,-0.00547164710341733,0.00683108790564195,0.828541002362259
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39597,-0.000693490089482954,0.00321880882500225,-0.00700235538648736,0.00561537520752145,0.829421036561783
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39512,-0.00137452835539656,0.00646747780868639,-0.0140507848604219,0.0113017281496288,0.831698112776312
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,42172,0.00100957109691044,0.00478522912919082,-0.00836947799630357,0.0103886201901244,0.832908743197765
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41828,0.00138148154237212,0.00658460342474597,-0.01152434117013,0.0142873042548742,0.83382324132835
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39526,0.00119801136211543,0.00573135158572373,-0.0100354377459031,0.0124314604701339,0.834430494846641
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39512,0.0011608400298046,0.00557594877136647,-0.00976801956207367,0.0120896996216829,0.835086846531863
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,42222,-0.000882705865951921,0.00438215069901075,-0.00947172123601299,0.00770630950410914,0.840363716459756
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39526,0.00129551987807126,0.00646706758551582,-0.0113799325895397,0.0139709723456823,0.841229588143779
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,39689,0.00216117696935071,0.0109040751912307,-0.0192108104054615,0.0235331643441629,0.842892990803437
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39526,-0.00161438407525516,0.00821000556854017,-0.0177059949895939,0.0144772268390836,0.844115918529577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,39868,0.00104393940095101,0.00535852341975096,-0.00945876650176088,0.0115466453036629,0.845538564922487
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,39564,0.00139914037916546,0.00736646077102087,-0.0130391227320354,0.0158374034903664,0.849364469728233
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42111,0.000597695323593934,0.00316644197152129,-0.0056085309405878,0.00680392158777567,0.850284318789903
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,42135,0.000871633085364744,0.00462074572288667,-0.00818502853149312,0.00992829470222261,0.85038194515009
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,39526,-0.00126191915060874,0.00676259821241697,-0.014516611646946,0.0119927733457285,0.851975606545555
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39526,-0.00098252300098717,0.00549588521049193,-0.0117544580135513,0.00978941201157701,0.858118244816021
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41766,-0.000777956703713088,0.00437097309668265,-0.00934506397321107,0.0077891505657849,0.858739460258503
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42111,-0.000658844037754737,0.00374064341194156,-0.0079905051251602,0.00667281704965073,0.860193504508423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39500,0.00121797458679945,0.00695069721868065,-0.0124053919618146,0.0148413411354135,0.860901724870031
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42174,0.000894073628338803,0.0051175245198497,-0.00913627443056661,0.0109244216872442,0.861311509711649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39221,0.00211765098156158,0.01214329672918,-0.0216832106076312,0.0259185125707544,0.861563496025262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39904,-0.00261501711505557,0.0152026209447602,-0.0324121541667855,0.0271821199366744,0.863432007726781
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39491,0.00154920610248428,0.00905712796373145,-0.0162027647064294,0.0193011769113979,0.864188985566803
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42009,-0.000625347076248998,0.00369667088124109,-0.00787082200348153,0.00662012785098353,0.865669464548192
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39500,0.000776326049793798,0.00461710626261345,-0.00827320222492857,0.00982585432451617,0.866475272667231
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41916,-0.000507212710543127,0.0030378517792788,-0.00646140219792958,0.00544697677684333,0.867400696339649
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,39597,0.000829221524906481,0.00497558360913515,-0.0089229223489984,0.0105813653988114,0.867642105876568
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39500,0.000982506875208196,0.00591195584736559,-0.0106049265856284,0.0125699403360447,0.86801065328722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,41771,0.00242201929038703,0.014601737872479,-0.0261973869396719,0.0310414255204459,0.868260238267754
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41766,-0.00100510323201258,0.00609684214554591,-0.0129549138372826,0.0109447073732574,0.869059569215144
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,41842,0.000899601182311849,0.00560663946272111,-0.0100894121646215,0.0118886145292452,0.872526821879609
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39575,0.000721426465386917,0.0045248679302674,-0.00814731467793718,0.00959016760871102,0.873328377408584
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39590,-0.000936074370817315,0.00608427373893036,-0.0128612508991208,0.0109891021574862,0.877729685980577
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,41771,-0.00130187333821052,0.00858380265716574,-0.0181261265462554,0.0155223798698343,0.8794524842558
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39696,-0.0013282077700035,0.00878118441271692,-0.0185393292189287,0.0158829136789217,0.879776441949589
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41771,0.000621465809068572,0.00427725461891077,-0.00776195324399653,0.00900488486213368,0.884479798079715
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39278,-0.000821113835002751,0.00567958140061739,-0.0119530933802128,0.0103108657102073,0.885050784442937
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41919,-0.000527473731730231,0.00368381244957462,-0.00774774613289648,0.00669279866943602,0.886144731500968
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39512,-0.000975778705571267,0.00689367620315515,-0.0144873840637554,0.0125358266526128,0.887440501117001
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42236,-0.000422662998855342,0.00300252722318045,-0.00630761635628903,0.00546229035857835,0.888054448619479
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39696,0.00131442640553084,0.00947026922711379,-0.0172473012796122,0.0198761540906739,0.889614631532647
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,41995,0.000289770122730024,0.00209086704282958,-0.00380832928121596,0.00438786952667601,0.88977741625722
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,39868,-0.000580113776490282,0.00418764984942138,-0.00878790748135619,0.00762767992837563,0.889824293201452
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39858,-0.000733680022734849,0.0053124808746046,-0.0111461425369599,0.00967878249149017,0.890159926244262
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,39868,-0.00045761113195855,0.00331815639874022,-0.00696119767348937,0.00604597540957227,0.890313014972527
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39696,-0.000613111775786199,0.00450401309624332,-0.0094409774444231,0.00821475389285071,0.891724408449486
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,39526,-0.00133923610275502,0.0100311595015076,-0.02100030872571,0.0183218365202,0.893794407226886
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39597,0.000309822780987447,0.00241182886156844,-0.00441736178768669,0.00503700734966158,0.897787547903885
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39590,-0.000682481951766474,0.00557450078576568,-0.0116085034918672,0.0102435395883343,0.90256131295637
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39904,-0.000345207484027016,0.0028573463109486,-0.00594560625348628,0.00525519128543225,0.903840495216478
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42174,-0.00167536090981956,0.014065673456803,-0.0292440808851534,0.0258933590655143,0.905190052878341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,41842,-0.000585279530495765,0.0049414560638893,-0.0102705334157188,0.00909997435472726,0.905718669471899
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41766,0.000661581319012813,0.00558616591765518,-0.0102873038795913,0.011610466517617,0.905727105259784
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39590,0.000901875444593786,0.00765074838815557,-0.0140935913961911,0.0158973422853787,0.906164353590467
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39590,-0.000438828539719468,0.00373254482095372,-0.00775461638878875,0.00687695930934982,0.906411959046429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,39858,0.0004502212626205,0.00387158262581984,-0.00713808068398639,0.00803852320922739,0.907425824936753
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39512,-0.0006090234900271,0.00531957465354193,-0.0110353898109693,0.00981734283091508,0.908853656849766
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,39526,0.000826326449741023,0.00733813900317659,-0.0135564259964851,0.0152090788959671,0.910344135683204
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39512,0.000514191796919595,0.00466016883417716,-0.00861973911806763,0.00964812271190682,0.912143676059826
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39512,-0.00039524498063002,0.00358776165011072,-0.00742725781484704,0.006636767853587,0.912280717889369
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,41806,0.000505175164410445,0.00469137817547902,-0.00868992605952843,0.00970027638834932,0.914249892009889
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,42060,0.00223690136256533,0.0210203404082735,-0.0389629658376507,0.0434367685627813,0.91525385400954
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,39904,-0.00049898266054165,0.00473540166911605,-0.0097803699320091,0.00878240461092581,0.916081846603633
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42048,-0.000368748470075312,0.00366052116218911,-0.00754336994796597,0.00680587300781535,0.919761055227045
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41766,-0.000725347576584856,0.00721540763889412,-0.0148675465488173,0.0134168513956476,0.919927006852484
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39526,0.000590554108422889,0.00592546953197749,-0.011023366174253,0.0122044743910988,0.920613163332044
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39597,-0.000621964595245326,0.00626344669028304,-0.0128983201082001,0.0116543909177094,0.920901338393411
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,42222,-0.000524506658812899,0.00529499834226918,-0.0109027034096605,0.0098536900920347,0.921094469509542
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,39597,-0.000800398128910097,0.00812454280407612,-0.0167245020248993,0.0151237057670791,0.921524297655967
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39512,0.000531502905488729,0.00547697550903941,-0.0102033690922285,0.011266374903206,0.922693916918172
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41766,-0.000472763461069357,0.00491155486412042,-0.0100994109947454,0.00915388407260666,0.923319232290229
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39696,0.000679481534239674,0.00720796615469524,-0.013448132128963,0.0148070951974423,0.924897863009739
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,42063,-0.000340789449121895,0.00373071609907115,-0.00765299300330135,0.00697141410505756,0.927218290921535
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41828,0.000569996715300588,0.00637977419360528,-0.0119343607041658,0.0130743541347669,0.92880960923932
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,39868,-0.000209115265981452,0.00239927633803977,-0.00491169688853939,0.00449346635657649,0.930547757390429
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,42126,-0.000381274734077598,0.00437779254378482,-0.00896174811989585,0.00819919865174065,0.930598942547117
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,41842,-0.000559345337121657,0.00662571162947087,-0.0135457401308846,0.0124270494566413,0.932723451161636
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41766,0.000437147669987495,0.0051917295498091,-0.00973864224763833,0.0106129375876133,0.932898079382119
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,39597,0.00021526620025091,0.00283070750187432,-0.00533292050342276,0.00576345290392458,0.939383261508077
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41903,0.000300289801010576,0.00445950817410704,-0.00844034622023921,0.00904092582226037,0.94631445194514
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41995,-0.000166145077625543,0.00256250810468988,-0.0051886609628177,0.00485637080756661,0.948304830102407
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,39696,-0.000247034292778663,0.00389970985544605,-0.00789046560945292,0.00739639702389559,0.949491459459666
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,39526,-0.000387493161652711,0.00642896011898143,-0.0129882549948563,0.0122132686715509,0.951939252528196
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,41995,0.00120949050793252,0.0208863064286492,-0.0397276700922198,0.0421466511080849,0.953822535190977
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39869,0.00107921921669646,0.0188741983773729,-0.0359142096029544,0.0380726480363473,0.954403137825156
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,39590,-0.000251836601737612,0.00441036941069812,-0.00889616064670593,0.0083924874432307,0.954465760207464
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39512,0.000239269922248696,0.00445684072095972,-0.00849613789083236,0.00897467773532975,0.957186325006027
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39869,-0.000955078029902048,0.0182251384849254,-0.0366763494603559,0.0347661934005518,0.958207371634016
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41842,0.000251772540804213,0.00485316859871183,-0.00926043791267098,0.0097639829942794,0.958626709575865
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41629,0.000476462877152473,0.00923237897076414,-0.0176189999055452,0.0185719256598502,0.958841985801388
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41995,0.000189699045614854,0.00374638646295367,-0.00715321842177434,0.00753261651300405,0.959616964453819
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,39597,-0.00017013557542148,0.00337983932124798,-0.00679462064506753,0.00645434949422457,0.959853668226661
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39526,-0.00032761441846522,0.0065471495821777,-0.0131600275995335,0.0125047987626031,0.960092029596069
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39696,-0.000226007204343312,0.0048820365976967,-0.00979479893582884,0.00934278452714222,0.963077048107751
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,39858,0.000171120011228463,0.00378052869059267,-0.00723871622233317,0.0075809562447901,0.963898072463157
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,42174,9.65026750250502e-05,0.00247735550333364,-0.00475911411150888,0.00495211946155898,0.968927710718603
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39597,-0.000270581423318104,0.00724699399095912,-0.014474689645598,0.0139335267989618,0.970216937060815
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39575,-0.000185940830919478,0.00519234601283912,-0.0103629390160841,0.00999105735424519,0.971434062157322
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39696,0.000267947561466295,0.00758217839827883,-0.0145931220991602,0.0151290172220928,0.971809960053304
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39872,-0.000127702387038017,0.00373443108227683,-0.0074471873083006,0.00719178253422457,0.97272150830206
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39696,0.000227179233729485,0.00716875907437871,-0.0138235885520528,0.0142779470195118,0.974719699676785
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,39872,-0.000420033938464722,0.0171507988402009,-0.0340355996652586,0.0331955317883291,0.980461687917759
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39858,-0.000117575289661942,0.00517481329888391,-0.0102602093554744,0.0100250587761505,0.981873480558491
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,39839,0.0001238165184572,0.00577227541820877,-0.011189843301232,0.0114374763381464,0.982886901959945
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,39597,-9.75766587300216e-05,0.00517853998111577,-0.0102475150217169,0.0100523617042569,0.984967088622588
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,39597,6.78030574022916e-05,0.00363981775042403,-0.00706623973342881,0.00720184584823339,0.98513808720823
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,42187,-6.46373611496793e-05,0.00378317878844011,-0.0074796677864923,0.00735039306419294,0.986368686946253
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,39479,-6.50756990211772e-05,0.00395688001669124,-0.007820560531736,0.00769040913369365,0.986878712166355
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,39904,6.60255232981863e-05,0.00476290872954727,-0.00926927558661446,0.00940132663321084,0.988939974234872
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39696,-9.607987898081e-05,0.00694963857785291,-0.0137173714915725,0.0135252117336109,0.988969716654423
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39526,-6.67608402299268e-05,0.00590557901341428,-0.0116416957065219,0.0115081740260621,0.990980547354483
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39597,2.99124368056627e-05,0.00269241347289866,-0.0052472179700757,0.00530704284368703,0.991135968462336
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,39597,2.46311886767293e-05,0.00324739098568599,-0.00634025514326782,0.00638951752062128,0.993948308035193
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,39500,-1.87282510773591e-05,0.00470969253310493,-0.00924972561596302,0.0092122691138083,0.996827266287341
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39526,2.26211318063274e-05,0.00811279474433112,-0.0158784565670827,0.0159236988306953,0.997775290018269
NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39500,4.79643578322938e-06,0.00342611617592193,-0.00671039126902376,0.00671998414059022,0.998883017143209
